PROCESS FOR PRODUCING ANTIBIOTIC COMPOUNDS DERIVED FROM CEPHALOSPORINS

27-12-1988 дата публикации
Номер:
CA0001247596A1
Принадлежит:
Контакты:
Номер заявки: 454824
Дата заявки: 22-05-1984

PROCESS FOR PRODUCING ANTIBIOTIC COMPOUNDS DERIVED FROM CEPHALOSPORINS

[1]

The present invention relates to antibiotic compounds derived from cephalosporins, processes for the production

[2]

5 thereof and pharmaceutical compositions containing the same.

[3]

These compounds correspond to the formula:

[4]

[5]

. the COOA group at the 4 position is an acid radical, or an alkaline or alkaline-earth salt or an amino acid or amine salt, for example triethylamine or ethanolamines, or an easily hydrolyzable or metabolically labile and

[6]

20 pharmaceutically acceptable ester radical;

[7]

. X denotes an oxygen atom or a sulfur atom;

[8]

. n is zero or 1;

[9]

. Ri and R2 each denote independently hydrogen or a lower alkyl group, preferably a methyl group; or

[10]

25 . Ri and R2 taken together with the carbon atom to which they are linked form a cyclobutyl or cyclopentyl nucleus;

[11]

. B is the rèsidue of a primary or secondary amine selected from the following groups:

[12]

- Z-NH-R where Z is an alkylene group with a sttàight or

[13]

30 branched chain alkylene group having from 2 to 7 carbon atoms, optionally interrupted by a sulfur atom and optionally substituted by a hydroxyl, thiol, methylthio, amino, acetamido, carbamoyl, phenyl, hydroxyphenyl or imidazolyl group, Z can also be a σyclopentylidene or cyclohexylidene 35 group, and R represents a hydrogen atom or an alkyl group having from 1 to 3 carbon atoms,

[14]

- Z*-Aik-NH-R where Z represents a 1,2-phenylene or 1,3phenylene or 1,4-phenylene group optionally substituted by a halogen atom or by 1 or 2 methoxy groups or by 1,2 or 3 methyl groups or Z' represents a 1,2-cyclohexylene, 1,3cyclohexylene or 1,4-cyclohexylene group, Aik represents a straight or branched alkyl group having from 1 to 3 carbon atoms, and

[15]

R is as defined above,

[16]

- Z'-N-CO-Y-NH-R" where Z' is as defined above,

[17]

R'

[18]

Y denotes an alkyl group (CH2)m in which m = 0,1,2,3 or 4, a branched alkyl group having 2 or 3 carbon atoms

[19]

10

[20]

or also Y with NH-R" constitutes a ring

[21]

R' and R", identical or different, have the same meaning as that given for R above,

[22]

15 -− Z"-NH~R where Z" is a 1,3-cyclohexylene or 1,4cyclohexylene group and R is as previously defined,

[23]

R3i f Jl (NH-C)n - Aik -NH-R where R3 represents a

[24]

s ό hydrogen atom or a methyl group, 20 n ≈ 0 or 1 and Aik and R are as previously defined,

[25]

1 -s

[26]

(NH-C)n - Aik 6 NH-R

[27]

where n ≈ 0 or 1 and Aik and R are as previously defined,

[28]

25 - a 2-piperidyl, 3-piperidyl or 4-piperidyl group optionally substituted on the nitrogen atom by a -C0-Alk-NH2 group

[29]

or -CQ·K NH where Aik is as previously defined. n

[30]

Thfer-Salts that the compounds of Formula (I) are

[31]

30 capable of giving with the pharmaceutically acceptable acids form an integral part of the invention.

[32]

Consequent on the presence in the formula of an oxime group, the compounds (I) exist in 2 isomeric forms syn and anti. The syn isomers whose therapeutic activity is higher 35 are the preferred compounds.

[33]

It is understood that the compounds (I) indicated above can exist:

[34]

- either in the form indicated in Formula (I),

[35]

- or in tautomeric form (I'):

[36]

[37]

According to the reaction diagram below, the process of the invention consists of first acylating 4-tertiobutyl-l-S-oxide 7-amino-3-bromomethyl-3-cepheme carboxylate (II) with 15 the acid (III) to obtain the compound (IV) described in European patent application number 60,745. To the compound IV, is then added the acid B - (CH2)n - COOH or the thioacid B(CH2)n COSH whose amine function must be previously protected, according to a known method, by a protective group 20 like tertiobutoxycarbonyl or trichlorethoxycarbonyl, for example, B' then represents the group B in which the amine function is protected.

[38]

The addition of the sodium or potassium salt of the acid B' - (CH2)nC00H to the compound (IV) is preferably done 25 in an aprotic polar solvent, for example dimethylformamide, whilst the addition of the sodium or potassium salt of the thioacid B# - (CH2)nC0SH σan be done in an apolar solvent like tetrahydrofuran. The compound (V) is obtained.

[39]

In the case of the thioacids, to prepare the compounds 30 (V), it is possible to use the thioacid itself

[40]

instead of an alkali salt. The operation is then in anhydrous acetone in the presence of potassium bicarbonate and sodium iodide.

[41]

Finally, to end with the compound (I) , the protective groups on the amines and the tertiσbutyl esters are removed by a known process, in particular by hydrolysis in an acid medium by using, for example, trifluoracetic acid or a mixture of formic acid and hydrochloric acid.

[42]

[43]

(IV) + B'-CCH2)jj- C - XH

[44]

0

[45]

-> CV)

[46]

[47]

(V) + H+ CD

[48]

Tr represents trityl> tBü tertiobutyl> X, Rj, R2>n> B' and B have the previously indicated meanings.

[49]

The compounds (I) of the invention in which A is other than H are obtained from compounds (I) in which A is H by reactions known in themselves.

[50]

5 Thus the inorganic salts are obtained by the action on compounds (I), in which A is H, of an inorganic base such as soda or potash or sodium bicarbonate in an equimolecular amount; the salification reaction is carried in a solvent such as 10 water or ethanol and the salt obtained is isolated by evaporation of the solution.

[51]

The salts of organic bases are obtained by the action on a solution of the acid I (A = H), in a solvent or a mixture of suitable solvents, of an equimolecular 15 amount of the organic base. The salt is isolated by precipitation with ether.

[52]

The esters are obtained by known esterification processes; for example there will advantageously be used the action of a halogen 20 derivative on a salt such as the sodium salt of the acid; preferably the reaction will be carried out in a solvent capable of dissolving the starting acid derivative, for example in dimethyl-formamide.

[53]

The syn and anti form isomers are obtained by 25 a suitable choice of reagents.

[54]

The following examples enable the scope of the invention to be further understood without however limiting it.

[55]

Thus as is usual in this family of compounds, 30 the products according to the invention do not have a distinct melting point but only points of decomposition which do not permit them to be characterized.

[56]

The products will therefore be characterized by their nuclear magnetic resonance spectrum recorded at 35 60 MUz or at 250 MHz, the internal standard being hexamethyldisiloxane. The spectra are recorded in deuteriated dimethylsulfoxide with the exceptions indicated in the description of the spectrum; 50 mg of product in 0.5 ml of solvent at 60 MHz and 10 mg in 0.5 ml at 250 MHz. The chemical displacements are measured at ± 0.01 ppm and the coupling constants at

[57]

5 ± 0.5 Hz.

[58]

The following abbreviations^ will be used:

[59]

- S : singlet

[60]

- D : doublet

[61]

- D of D : doublet of doublet

[62]

10 - S. e. : widened singlet

[63]

- M : multiplet

[64]

- Q : quadruplet

[65]

- AB : AB system

[66]

- J : represents the coupling constant.

[67]

15 In addition elementary microanalyses were carried out in each case and are in agreement with the formulae indicated.

[68]

The infra-red spectra also serve to characterize the products obtained. They were recorded 20 between 4,000 cm”1 and 600 cm”1 from a preparation constituted by a potassium bromide tablet containing the product at a concentration of about 2%; when the spectrum is recorded in solution at 1% in a chlorinated solvent, the nature of the latter is mentioned. The 25 elongation vibration frequency of the carbonyl groups of the molecule is noted ( £) CO).

[69]

EXMSM--i

[70]

7-f2~(2-Amino 4-thiazolvli 2-(2-carboxv 2-propvl oxvimino) acetamidol 3 -f 4 30 pjperidinvlΐcarbonvl oxvmethvl 3-cepheme 4carboxvlic 1-β-S-oxide acid trifluoroaσetate svn isomer. SR 41 862.

[71]

a) 7 - r 2-(2-tritvlamino-4-thiazolvl)

[72]

2-(2-tertiobutoxvcarbonvl 2-propvl 35 oxvimino' acetamidol 3 - f1tertiobutoxvcarbonvl 4-pjp℮ridinvl carbonvl oxvmethvli 3-c℮Pheme 1-β-

[73]

S-oxide carboxvlate of Tertiobutvl: svn isomer.

[74]

[75]

tBu and T have the previously indicated meanings, Boc denotes the tertiobutoxycarbonyl group.

[76]

To a solution of 1.38 of 4-tertiobutyl 1-β-S-oxide 7-[2-(2-tritylamino 4-thiazolyl) 2-(2tertiobutoxycarbonyl 2-propyl oxyimino) acetamido] 3-bromomethyl 3-cepheme carboxylate syn isomer, in 20 ml of anhydrous dimethylformamide, are added 1 g of l-tertiobutyloxycarbonyl 4-piperidinyl carboxylic acid and 1.5 of potassium bicarbonate.

[77]

After 17 hours of stirring at ambient temperature (20-25"C) the reaction mixture is poured on to 200 ml of ice water. After vigorous stirring, the crystals were filtered and washed with water. They are then taken up with 70 ml of dichloromethane. The organic phase is then washed with a saturated solution of sodium chloride, dried over magnesium sulfate and evaporated. The lacquer obtained is chromatographed on a column of 50 g of silica. It is eluted with a dichloromethane-ethyl acetate mixture 90-10 (vol/vol). After evaporation of the fractions containing the

[78]

compound and trituration in hexane, 1.3 g of the expected compound is obtained.

[79]

IR Spectrum; 9 CO

[80]

. 1805 cm1: C ≈ 0 at 8 of the β lactame

[81]

-1

[82]

. 1735 cm : C = 0 of the tertiobutyl esters and

[83]

of the ester at the 3 position

[84]

-I

[85]

. 1695 cm : C = 0 of the tertiobutoxycarbonyl protecting group of the piperidine.

[86]

NMR Spectrum at 250 MHz.

[87]

1H at 8.75 ppm (S, NH Tr) - 1H at 8.10 ppm (D, J=9 Hz, CONH) - 15 H at 7.25 ppm (M, H aromatics) - 1H at 6.73 ppm (S, H thiazole) - 1H at 5.81 ppm (M, Hj) - 1H at 5.25 ppm (D, J≈13 Hz, CH^ 0C0) - 1H at 4.94 ppm (D, J=4 Hz, Hβ) - 1H at 4.55 ppm (D, J=13 Hz, CH2 OCO) - 1H at 3.90 ppm (D, J=17 Hz, CH2SO) - 2H at 3.79 ppm (D, J=12 Hz, gCN Boc equatorials) - 1H at 3.53 ppm (D, J=17 Hz, CH2 SO) - 2H at 2.75 ppm (M, HCH Boc arials) - 1H at 2.50 ppm (M, acco2) - 2H at 1.75 ppm (D, J=12 Hz, HCHC02 equatorials) - 9H at 1.46 ppm (S, C02, tBU) - 2H at 1.40 ppm (M, HCCHC02 axials) - 6H at 1.39 ppm (S, (CH3)2C) - 9H at 1.36 ppm (S, C02tBU - 9H at 1.29 ppm <sΠS& N) .

[88]

b) SR 41 862.

[89]

0.8 g of the compound obtained above was dissolved in 10 ml of trifluoroacetic acid. After 45 minutes at 23 °C the acid was evaporated under vacuum without heating and the oily residue was crystallized by the addition of 50 ml of isopropyl ether. The crystals were filtered and washed with isopropyl ether and then with hexane. They were then dried under vacuum over phosphoric anhydride. 0.66 g of the expected products was obtained.

[90]

IR Spectrum; 3 CO

[91]

. 1795 cm”1: C ≈ 0 at 8 of the β lactam . 1735 cm”1: C = 0 of the ester at 3

[92]

. 1680 cm”1 wide band: C = 0 of the acids of the molecule, of the amide at 7, of the ions CF3CO2- .

[93]

NMR Spectrum at 250 MHz.

[94]

5 2H at 8.60 ppm (S.e., NH2+) - 1H at 8.50 ppm (D, J+9 Hz, CONH) - 3H at 8.40 ppm (S.e., NH3+) - 1H at 6.68 ppm (S, H thiazole) - 1H at 6.0 ppm (D of D, J3 = 9 Hz, J2=4 Hz, H2) “ 1H at 5.16 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.97 ppm (D, J=4 Hz, Hg) - 1H at 4.60 ppm (D, J=13 Hz, 10 CH^OCO) - 1H at 3.90 ppm (D, J=17 Hz, CH^SO) - 1H at 3.55 ppm (D, J=17 Hz, CHgSO) - 2H at 3.25 ppm (M, CHgNH)

[95]

- 2H at 2.90 ppm (M, CHgNH) - 1H at 2.66 ppm (M, CHC02)

[96]

- 2H at 1.90 ppm (M, CH^CH) - 2H at 1.70 ppm (M, CH2CH)

[97]

- 6H at 1.44 ppm (2S, CH3)2C).

[98]

15 EXAMPLE 2

[99]

7-f 2 -(2-amino 4-thiazolvl) 2-(2-carboxv 2-propvl oxyΐmino) acetanidol (3-amino propionvll 3-thio-mβthvl 3-c℮pheme 4carboxvlic β 1-s-oxide acid trifluoracetate 20 svn isomer SR 41884.

[100]

a) Tertiobutoxvcarbonvl 3-amino thiopropionic acid.

[101]

1.8 g of tert iobutoxycarbonyl 3-aminσ propionic acid was solubilized in 50 ml of anhydrous 25 dichloromethane.

[102]

The triple-neck flask was provided with a calcium chloride trap and cooled in a bath of water and ice. In order, there were added 1.4 ml of triethylamine and 1.3 ml of isobutyl chloroformate. After 20 minutes stirring 30 in the cold, 1.5 ml of triethylamine was added and a light current of hydrogen sulfide was bubbled through for 15 minutes. Then the mixture was stirred in the cold for 45 minutes before being evaporated to dryness. 150 ml of sulfate buffer (pH 2) were added and the 35 thioacid was extracted twice with 70 ml of dichloromethane. The combined organic phases were dried over magnesium sulfate and evaporated.

[103]

The oily product obtained was used as such.

[104]

b) 7- r2-(2-tritvlamino 4-thiazolvlï 2-f 2tertiobutoxvcarbonyl 2-propvl oxv iτnino1 acetamidol (3-tertiobutoxvcarboxvl-amino5propionvl^ 3-thiomethvl 3-cβpheme 1 β-S-oxlde carboxvlate of 4-Tertiobutvl; svn isomer.

[105]

To a solution of 0.46 g of 4-Tertiobutyl 1 β S-oxide 7-[2-(2-tritylamino 4-thiazolyl) 2- (210 tertiobutoxy-carbonyl 2-propyl oxyimino) acetamido] 3-bromomethyl 3-cepheme carboxylate syn isomer, in 10 ml of tetrahydrofurane, were added 0.4 g of the thioacid described above as well as 0.6 g of potassium bicarbonate. After 4 hours stirring at ambient 15 temperature the solvent was evaporated and the residue taXen up again with 100 ml of water and 50 ml of dichloromethane. After decantation the aqueous phase was extracted with 50 ml of dichloromethane. The organic phases were combined, dried over magnesium 20 sulfate and evaporated.

[106]

The lacquer so obtained was chromatographed on a column of silica (40 g), it was eluted with a mixture of dichloromethane-ethyl acetate 90-10 (vol/vol).

[107]

IR spectrum; D co

[108]

25 . 1805 cm : C = 0 at 8 of the β lactame . 1720 cm : C = 0 of the tertiobutylic esters

[109]

. 1690 cm : C == 0 of the amide at 7, of the thioester at 3 and of the 30 tertiobutoxy carbonyl protecting the amine.

[110]

N M R Spectrum at 250 MHz fCD CL3ΐ.

[111]

1H at 7.75 ppm (D, J≈9 Hz, CONH) - 15H at 7.27 ppm (M, H ar Trit) - 1H at 6.95 ppm (S.e., NH-Trit) - 1H at 6.63 35 ppm (S, H thiazole) - 1H at 6.21 ppm (D of D, J^≈9 Hz, J2≈4 Hz, Hj) 1H at 4.85 ppm (S.e., NH-Boc) - 1H at 4.50 ppm (D, J=4 Hz, Hg) - 1H at 4.29 ppm (D, J=13 Hz, CH^S CO) - 1H at 3.75 ppm (D, J=13 Hz, CHg S CO) - 1H at 3.58 ppm (A of AB, J=17 Hz, CH2 SO) - 2H at 3.36 ppm (M, CH2 NH Boc) - 1H at 3.22 ppm (B of AB, J=17 Hz, CH2 SO) - 2H at 2.75 ppm (T, J=6 Hz, CH2 - CS) - 15H at 1.52 ppm (S, 5 Boc NH and (CH3)2 C) - 18H at 1.39 ppm (2S, C02 t Bu).

[112]

C) SR 41 884

[113]

The whole of the compound obtained above was solubilized in 10 ml of trifluoroacetic acid. After 45 minutes at 23“C the acid was evaporated under vacuum 10 without heating, and the oily residue was crystallized by the addition of 50 ml of isopropyl ether. The crystals were filtered and washed with isopropyl ether and then with hexane. They were then dried under vacuum over phosphoric anhydride.

[114]

15 0.37 g of the expected product was obtained.

[115]

IR Spectrum: 0 CO

[116]

. 1785 cm "*■: C = 0 at 8 of the β lactam . 1680 cm1 wide band: C = O of the acids of the molecule, of the amide 20 at 7, of the thioester, of the CF3CO;}” ions.

[117]

NMR Spectrum at 250 MHz.

[118]

1H at 8.40 ppm (D, J==9 Hz, CONH)- 3H at 7.80 ppm (S.e., NH3) - 3H at 7.30 ppm (S.e., NH3) - 1H at 6.78 ppm (S, 25 H, thiazole) - 1H at 5.95 ppm (D of D, Jα=9 Hz, J2=4 HZ, Hj) - 1H at 4.92 ppm (D, J≈4 Hz, H6) - 1H at 4.18 ppm (D, J=13 Hz, CH^S CO) - 1H at 3.79 ppm (D, J=13 Hz, CH2 S CO) - 2H at 3.66 ppm (S, CH2 SO) - 2H at 3.0 ppm 30 ppm (S, (CHj )2 C). ~ (M, CHg NH) - 2H at 2.92 ppm (M, CH2 COS) - 6H at 1.44

[119]

EXAMPLE 3 Trifluoroacetate of

[120]

[121]

To 0.46 g of 4-Tertiobutyl 1 β-S-oxide 7-[2(2-tritylamino 4-thiazolyl) 2-(2-tertiobutoxy carboxylamino 2-propyl oxyimino) acetamido] 3-bromomethyl 310 cepheme carboxylate syn isomer in 10 ml of anhydrous acetone, were added 0.4 of 3-tertiobutoxycarbonylamino thio-propionic acid, 0.6 g of potassium bicarbonate and 0.25 g of sodium iodide.

[122]

After 2 hours stirring at room temperature, 15 the solvent was evaporated to dryness. The residue was taken up again in 100 ml of water and extracted with 50 ml of dichloromethane. The organic phase is separated and the aqueous phase reextracted with 50 ml of dichloromethane. The organic extracts were combined, 20 dried over magnesium sulfate and evaporated to dryness.

[123]

The product obtained was chromatographed on a silica column by eluting with a dichloromethane-ethyl acetate mixture 90-10 (vol/vol).

[124]

An identical product (IR spectrum and NMR 25 spectrum) to the product of Example 2 b) was obtained.

[125]

b) SR_41-9M.

[126]

The deprotection was carried out as indicated in Example 2 c).

[127]

By operating as in Example 1, the compounds 30 according to the invention were prepared in the form of trifluoroacetate, described in Table I below.

[128]

[129]

0- C -(·CH9) B, TFA ii <- n

[130]

These compounds are identified by a reference number. For each among them the values of Rlf R2, B and n and the NMR spectrum are given.

[131]

The acid B' - (CH2)n -COOH which reacts on 15 (IV) to give (V) is an aminoacid of the L series or of the D series or racemic; the corresponding indication appears in Table I, at column B.

[132]

The chromatographic eluant is also given which serves to isolate (V) : the last intermediate 20 product before deblocking the acid and amine functions of the molecule. This intermediate V is characterized by its infra-red spectrum, the wavelengths indicated in

[133]

- 1

[134]

cm correspond in order to the elongation vibration frequencies of the carbonyl at the 8 position of the 25 beta lactam, the tertiobutylic esters and the ester at the 3 position, the amide at the 7 position and the carbamate protecting the amine. When 2 wavelengths only are indicated, the second corresponds to a wide band which covers the elongation vibration frequencies 30 both of the esters, of the amide and of the protective carbamate of the amine.

[135]

The list of NMR spectra of the compounds mentioned in Table I is given following this table.

[136]

/ TA3LEAÜ I /
SR nαnA -c \BChroma t off rnphy eluant from intermediate V vol/volIR uCO cm"* intermediate VNMR no.
41 7300Λ ch3 ch3(CH2)2 NHjCH2 Cl2 85 Ac 0 εt 151805 1725 1590i
41 731""-CH - NH2 ©CH2 Cl2 92.5 Ac 0 Εt 7.51805 17232
41 73211*-CH - NH2 © kN^0HCH2 Cl2 90 Ac 0 Εt 101305 17253
41 733""-CH - NH2 © ch3m o o1305 17254 ■
41836"■ψ -nh2 © CH .«ζV ch3CH2 Cl2 95 Ac 0 εt 51805 17305

[137]

ChromatographyIK
A -CBeluant from inteπnedi ato VOCO cm'1NiMR no.
Vvol/volintermcdi ate
*2V

[138]

41 807 A

[139]

ch3 ch3

[140]

©

[141]

CH - NH2

[142]

ch3 - CH2-C0-NH2

[143]

CH2 Cl2 50

[144]

AcEt 50

[145]

1805

[146]

1735

[147]

1680

[148]

41 810 ■CH - NH2 ©

[149]

CH20H

[150]

CH2 Cl2 80

[151]

AcEt 20

[152]

1805

[153]

1725

[154]

“pH*nh2 ©
ch2- CH - CH3
£h3
-CH -NH, ©
CH -CH,CH,
ch3

[155]

41 354 ·<ch2>3NH2

[156]

■(ch2)5nh2

[157]

CH2 Cl2 90

[158]

AcEt 10

[159]

1805

[160]

1725

[161]

41 855 CH2 Cl2 90

AcEt 10

[162]

1805

[163]

1725

[164]

1690

[165]

41 855 (ch2)7nh2

[166]

CHj Clg 90

[167]

AcEt 10

[168]

1805

[169]

1725

[170]

1595

[171]

10

[172]

41 857

[173]

-CH - NH, ©

[174]

I2

[175]

CH2S - CH2NHCOCH3

[176]

CH2 Cl2 100

[177]

Ha

[178]

1.5

[179]

1805

[180]

1725

[181]

1630

[182]

11

[183]

41 858 ch3

[184]

- C - NH,

[185]

£h

[186]

3

[187]

CH2 Cl2 90

[188]

AcEt 10

[189]

1805

[190]

1725

[191]

12

[192]

41 859 “pH* nh2 ©

[193]

CH2 Clg 92.5

[194]

AcEt 7.5

[195]

1810

[196]

1725

[197]

13

[198]

41 860 Cl, 92.5

[199]

AcEt 7.5

[200]

1805

[201]

1725

[202]

14

[203]

ChromatographyIR
Aniuant fromNMR no.
5R no,-CBintermediate Vintermediate
Nr2vol/volV
418850A-ÇH - NH2 © CH - OHCH2 Cl2 85■ 130515
ch3 ch3i»,Ac 0 εt 151720
-CH - NH, ©CH2 Cl2 1001805
41885"12c. c172016
ch2 co mh2Ma OH 1.51680
-CH - NH, ©CH, Cl, 951805
41387l 22 217
ch2 - ch2 s ch3 .Ac 0 Et 51725
41888“CH - NH2 φCH, Cl2 100180518
(ch2)4 - NH2Me OH 11720
41889-ÇH - ,NH2 ©CH, Cl, 801805
1u C19
!Yj HNAc 0 Et 201755 1720
© iCH2 Cl2 901805 .20
41891<■1*iC 6
CH 3Ac 0 Et 101725
CH, Cl, 901805
41967il(CH2)4 nh2r1725 169021
41975V~11180522
A\JAc 0 Et 7.51725 .
H2N '-
41 976->0 HjN N-'CH2 Cl2 92.5 Ac 0 Et 7.51805 173023
T

[204]

-a

[205]

- 18 -

[206]

R.ΠiromatographyIR
SR no./i?luant fromNMR no.
n- C *2Bintermediate Vintermediate
vol/volV
420310-CH - NH2CH2 ci2 35180534
CH - OH1725
ch3 ®Ac 0 εt 151675
42042""-(θ)- CHjNHgCH2 C12 90 Ac o εt io1310 17301690 ' cci435
CHj -C -CH-.NHl 2 2CH- Cl-' 901805
42 073H"c c172536
Ac o εt io1690
ch3
42 117■■»tQ-cφΐCH2 Cl2 100 Me OH 11810 17251585 cci437
CH- Cl- 901805
42 120It»4 438
Ac o εt io1725
CDCH- Cl- ·90180539
42 121H,"-ch-ch2ch2nh24 41730
ch3Ac o εt io1690
42 139-CH - NH2 CH - CH3CH2 Cl2 951805 172540
‘ ®Ac 0 εt 51690
CH- Cl- 901805
42 140-ch2 ch2 nh ch34 4173041
Ac o εt io1690
CH- Cl, 1001305
42 131M-(CH2)3NH CH, CH34 4173042
Me OH 11635 CH2 Cl2
42 182»c 2 I 3CH2 Cl2 901805 173543
CH3 (DAc o εt 101685

[207]

SR no.nΛ -c \βChromatography eluant from intermediate V vol/volIR ΐ) CO cm intermediate VNMR no.
42 1330X ch3 ch3-(CH2)5MH ch3CH2C12 100 Me OH 11310 17351690 CCI444
42 191h- CH2oCH2 Cl2 35 Ac 0 εt 151805 1730 1690. 45
42 192n~0o ■CH2 Cl2 90 Ac o εt io1805 1730 169046
42 193U-ch2-<^Ô)-ch2nh2CH2 Cl2 90 Ac 0 Εt 101805 172047
42 194u-0CH2NH2CH2 Cl2 90 Ac o εt io1805 172548
42 19S11- ch2,-(ch2)3 nh2CHj Clj 35 Ac 0 εt 151805 1730 169049
42 19611"CH2 Cl 2 90 Ac o εt io1305 1725. 168550
42 197. 11- CH2-(CH2)4 nh2CH2 Cl2 85 Ac 0 Εt' 151805 1725 169051
42 198■oCHZ Cl2 90 Ac 0 Εt 101805 1725 159552

[208]

/R1 -0Chromatography1R
SR nrvnBeluant from intermediate Vt)C0 cm * intermed iateNMR no.
vol/volV
42 2000©o o1805 172553
42 201"-CH-CH,NH1 2 2 /-s ch3 ®CH2 Cl2 90 Ac o εt1805 1725 159054
CH, 13CH- Cl. 92.51805
4 2 208"-C - CH-NH-i. C55
32 !Ac 0 Εt 7.51725
- CH - CH2CH2NH2CH- Cl- 90180555
42 209II11CH3 ®d d1725
Ac o εt . io1690
1180557
42 210""d d
h2n ^Ac 0 εt 7.51725
42 211"^ n.ÇHgHHgCH2 Cl2 85 Ac o εt1805 1725 159058
180559
42 212IIX»d c1725
\>Ac o εt io1590
-CHCH- Cl- 85180560
42 213»ch3-(CH2)3HH2d · *1730
Ac 0 εt 151590
CH- Cl- 851305
42 214»»„(ch2)4nh26 d173061
Ac 0 εt 151590
42 215■CXCH2 Cl2 90 Ac o εt io1305 1735 159062
1

[209]

Λ -c \ChromatographyIR
SR no.nβrluant from intermediate V()CO cm'1 intermediateNMR no.
R2VO1/volV
- CH -CH2 Cl2 90181063
42 21501CH3-%%DESCRIPTION%%)-CH2NH2Ac 0 Et 1017254
42 2 1 7"^ ^)"»CH2NH2CH2 Cl2 90 Ac 0 Et 101810 1725 169064
42 320ACH2 Cl2 . 95180565
ch3 ch3CH2NH2Ac 0 Et 51725
42 321och2 Cl2 1001805 173066
℮'h2NH2Me OH 11690
42 3711«-o Nhch2 Clj 10067
Me OH 0.7
42 372-och2 ci2 10068
N NHMe OH 0.7/
Æ) oCH- Cl- 1001805
42 3740\ / «c c172569
NHC CH2NH2Me CH 11690
42 379I.II-(θVCH3CH2 Cl2 90180570
\ / ^ CH2NH2Ac 0 Et 101725
ÆVcHgNHjCH- Cl- 951805
42 380"2 2 Ac 0 Et 5172571
' CH3
42 395""-<Ô)-ch2nh ch3CH2 Cl 2 90 Ac 0 Et 101805 1725 168572

[210]

-a

[211]

- 24 -

[212]

SR no.ΛB‘Chromatography eluant from \ntermediate V vol/volIR Î CO cm1 intermediate VMMR no.
42 4630-/θVCH2NH2 "-ch3CH2 Cl2 100 Me OH 11805 172082
42 464«-(5)-CH2NHCH3CH2 Cl2 100 Me OH 11805 1720 169083
42 465"A ch3 ch3■@ΐ ^NHC(CH2)2MH2CH2 Cl2 100 Me OH 1.51805 1725 169084
42 466'■»?n"nhc' ch2nh2CH2 Cl 2 100 Me OH 1.51805 172085
42 467»/ \ 0 ■\θ)"NH^CH2NH2CH2 Clj 100 Me OH 21805 172086
42 47116-o N-' Hch2ci2 100 Me OH 0,51805 C Cl, 1720 ^ 167587
42 472---o NNHCH2 Cl2 95 Ac 0 Et 51805 C Cl, 1725 * 167588
42 473"'oCHj Clj 100 Me OH 0.51805 C Cl. 17254 168589
42 474"a\ ch3 ch3-Q}m·CH2 Cl g 95 Ac 0 Et 51805 · C Cl, 1725H 168590
42 5370»'-C-CH2NH CH3CH2 Cl2 100 Me OH 11805 ' 1725 169091

[213]

5R no.n-C \BChromatography rlua∩t from intermediate V vol/volIR 2 CO cm-1 intermediate VNMR no.
42 5380A ch3 ch3Ol ^CH2NH-CH2CH3CH2 Cl2 100 Me OH 11805 1725 159092
42 539»<ô)CH < /CH3 CHjMHCHnch3CH2 Cl2 100 île 0H 0.81805 1725 158593
42 540<>A CH3^ CH2!IH2CH2 Cl2 100 Me 0H 0.71805 172094
42 541A ch3x CH2flH2CH2 Cl2 100 Me 0H 0.71805 172095
42 542ch7 CH2NH2CH2 Cl2 100 Me 0H 0.51805 172096
42544Λ CH3 CHj-<oV Cl ^ nhcoch2nh2CH2 Cl2 100 Me. OH 11802 172097
42545"«^-d NHCO(CH2)2NH2CH2 Cl2 100 Me OH 11803 172098
42545"<§>Nhco(ch2)ΛCH2 Clj 100 Me OH 11805 172099
42547./~s\ \j^NHC0CH2NH2ch2 ci2 100 Me OH 1.51805 1720100
*

[214]

S

[215]

5R no,nR, / 1 -C \-BChromatography eluant from intermediate VIR 0 CO cm"1 intermediateNMR no.
R2vol/volV
42 5480-^O^-NHC0 CH,NH2CH2 Cl2 Me OH100 21802 1720101
42 549/ v 0 / \ "ch2 ci21001805102
ch3 ch3-/N-C-CH^NH2Me OH11720
<5)-CH2NH2CH- C1-,1001805
42 581"c c103
FHe OH0,81725
-%%DESCRIPTION%% )- CH-NHCH-CH? Cl-1001805
42 58211"c c1725104
\ (z 3 FMe OH0,81590
42 583"IICH2 Cl21001805 1720105
nhcoch2nhch3Me OH0.51685
/γ\CH- Cl-1001802 '
42 584w«<0 )-NHCOCH,MHCH,c c106
\ /z 3Me OH11720
CH- Cl-1001805
42 585««s-sC ά1720107
ch3 nhcoch2nh2Me OH0.81690
CH- Cl-1001805
42 58511>-(C ά1725108
CH3 NHC0(CH2)2NH2Me OH11690
r\ V·NHCO(CH2),HH2 rCH2 Cl21001805
42 537Me OH1.51720 1690109
42 6 5 7_/-\ /CH3 \-/NsCOCH2NH2CH2 Cl2 Me OH100 0,71805 1725 1675110

[216]

o

[217]

3R no.Π8Chromatography yluant from intermediate V vol/volIR 9 CO cm * intermediate VNMR no.
42 65306 ■•^O^ÎtHC0(CH2)2NH2CH2 Cl2 100 Me OH 11805 1720in
42 675-y- t û / \-c-ch2nh2CH2 Cl2 90 Ac 0 Et 101805 1725112
42 676-X ch3 ch3Br ch2nh2CH2 Cl2 100 Me 0H 0.51805 1720113
42 677""CH-NH,CH2 Cl2 100 Me OH 0.51805 1720114
42 6 8 7°-φ . NHCO(CH2)3NH2CH2 Cl2 100 Me OH 0.91805 1725 1690115
42 688"»<^ÔyNHC0(CH2)3NH2ch2 ci2 100 Me OH 0.81805 1720116
42 689«<[θyNHC0tCH2)4NH2ch2 ci2 100 Me OH 0.81805 • 1720117
42 690"IICH, X^^JLNHCOCHjîlHjCH2 Cl2 100 Me OH 11805 1715118
42811"IICIs Trans -O*CH2 Cl2 100 Me OH 0,51805 CH2C1 1725119
42 812«S,CBΛCH2 Cl2 92.5 Ac 0 ET 7.51805 1725120

[218]

?R no.nΛ -c8Chromatography eluant from intermediate V vol/volIR *∂C0 cm * intermediate VNMR no.
12 8110A ch3 ch3CHj. JIHCOCHjjflHj -<o)CH3CH2 Cl2 100 He OH 11805 1725 1690121
12 815-0 AV NHC·/~\Hch2 ci2 100 He OH 0.71805 1725 1690m
12 815.<0^ ΐr^4 NHC-^/NHCH2 Cl2 100 Me OH 0.71805 1725 1590123
42 817"0 /O/-NH-C-CH NHgW ch3ch2 ci2 100 Me OH 0.91805 1720124
42 818ό"CH2 Cl2 100 Me OH 0.91805 1720125
42 731"A CHj CBj- 0 -/ ;n-c-ch-nh, AiHj *CH2 Cl2 100 Me OH 11805 CH,CU 1725 L 1575126
42 782«"-\ S -/Jn-C(CH2)2NH2ch2 ci2 100 Me OH 1.5'1805 1725127
42 733"".-. 0 Vc-{CH2)3NH2ch2 ci2 100 Me OH 1128
42 845-"OK>CH2 Cl2 100 Me OH 11805 CH-Cl, 1725 L i 1680129
42 848""-<^0)-ch2nh2 ch3CH2 Cl2 100 Me OH 0.71805 1720130

[219]

SR noR. %3Chromatography eluant from intermediate V vol/volIK ∂CO cm'1 i ntermedΐ ate VNMR no.
42 8490£-^θy~CH2NH2 ch3o o o1805 1720131
42852"ch3 ch3CH2 Cl2 100 Me OH 0.51805 1725132
42357""^-NH-COCH-NHj N CH3'CH2 Cl2 100 Me OH 1.51805 1725133
42852"s Vch2ch2nh2 trCH2 Cl2 100 Me OH 11805 1725134
42869--y~zhmz rCH2 Cl2 85 Ac 0 εt 151805 1725135
42870">-CH2NH2 N 'CH2 Cl2 80 Ac 0 Εt 201805 1720136
42901»A ch3 ch3-^Q^-ch2nhcoch2»h2CH2 Cl2 100 Me OH 11805 1720 1680137

[220]

KMK SPECTRAi

[221]

The spectra are recorded at 60 Mtlz, indicated by

[222]

(a) or at 2.50 MHz, indicated by (b); when there exist two dinsteroo-isomers in a molecule, the split signals are indicated by

[223]

NMR n° 1 - ftp ;

[224]

1H at 8.44 ppm (D, J=9 Hz, CONH) - 3H at 7.90 ppm (S.e., NHj) ~ 3H at 7.50 ppm NH^) - 1H at 6.78 ppm (S, H 5 thiazol) - 1H at 5.97 ppm (D of D, Jx = 9 Hz, J2=4 Hz, H7) - 1H at 5.18 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.94 ppm (D, J=4 Hz, H5) - 1H at 4.64 ppm (D, J=13 Hz, CH2OCO) - 1H at 3.90 ppm (D, J=17 Hz, CH2 SO) - 1H at 3.58 ppm (D, J=17 Hz, CH2 SO) - 2H at 3.00 ppm (M, 10 CH2NH2) - 2H at 2.61 ppm (M, CH2 C02) - 6H at 1.44 ppm (S~ («13)2 C). ~~

[225]

NMR n' 2 - fb):

[226]

4H at 8.45 ppm (M, NH3,CONH) - 3H at 7.35 ppm (S.e., NH^) - 5H at 7.25 ppm (M, H aromatics - 1H at 6.82 ppm 15 (S, H thiazol) - 1H at 6.0 ppm (D of D, Jx=9 Hz, J2=4 Hz, H7) - 1H at 5.20 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.92 ppm (D, J≈4 Hz, H6) - 1H at 4.81 ppitT (D, J=13 Hz, CH20C0) - 1H at 4.31 ppm (S.e., CH NH2) - 1H at 3.50 ppm (D, J=17 Hz, CH2 SO) - 1H at 3.30 ppm (D, J=17 Hz, CH^ 20 SO) - 2H at 3.10 ppm (M, CH2C6H5) - 6H at 1.44 ppm (2 S, (CH3)2 C). ~

[227]

NMR n· 3 - fbΐ :

[228]

5H at, 8.45 ppm (S.e., NH2, OH, CONH) “ 3H at 7.50 ppm (S.e., NH3)- 2H at 6.95 ppm (D, J=8 Hz, H meta OH) - 1H 25 at 6.78 ppm (S, H thiazol) - 2H at 6.68 ppm (D, J=8 Hz, H ortho OH) - 1H at 6.0 ppm (D of D, Jx=9 Hz, J2=4 Hz, H7) - 1H at 5.16 ppm (D, J≈13 Hz, CH^OCO) - 1H at 4.92 ppm (D, J≈>4 Hz, Hg) - 1H at 4.74 ppm (D, J=13 Hz, CHa 0C0) - 1H at 4.19 ppm (M, CHNH2) - 1H at 3.66 ppm (D, 30 J=>17 Hz, (CHgSO) - 1H at 3.34 ppm (D, J=17 Hz, CH^SO) 2H at 2.93 ppm (M, CH2 - CH - NH2) - 6H at 1.44 ppm (2 S, (CH3)2 C). “

[229]

NMR n" 4 - fb):

[230]

1H at 8.50 ppm (D, J=9 Hz, CONH) - 3H at 8.40 ppm (S.e. 35 NH3) - 3H at 7.60 ppm (S.e. NH3) - 1H at 6.79 ppm (S, H thiazol) - 1H at 6.00 ppm (D of D, J3=9 Hz, J2=4 Hz,

[231]

H7) - 1H at 5.45 ppm (D, J=13 Hz, CHsOCO) - 1H at 4.97 ppm (D, J=4 Hz, Hg) - 1H at 4.80 ppm (D, J=13 Hz,

[232]

CHgOCO) - 1H at 4.08 ppm (M, CHNH2) - 1H at 3.92 ppm (D, J=17 Hz, CHjgSO) - 1H at 3.58 ppm (D, J=17 Hz, CH2SO)

[233]

- 6H at 1.44 ppm (S, (CH3)2C) - 3H at 1.34 ppm (D, J=7 5 Hz, CH3CH).

[234]

NMR n° 5 - :

[235]

1H at 8.45 ppm (D, J=9 Hz, CO NH) - 3H at 8.40 ppm (S.e., NHg) - 3H at 7.60 ppm (S.e., Sh^) - 1H at 6.78 ppm (S, H thiazol) - 1H at 6.0 ppm (D of D, Jj=9 Hz, 10 J2=4 Hzn H7) - 1H at 5.25 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.95 ppm (D, J≈4 Hz, H6) - 1H at 4.82 ppm (D, J=13 Hz, CH2OCO) - 2H at 3.92 ppm (M, CH NH2 and CH2SO) 1H at 3.56 ppm (D, J=17 Hz, CH^SO) - 1H at 2.11 ppm (M, CH (CH3)2) - 6H at 1.44 ppm (2 S, (CH3)2 C) - 6H at 0.9 15 ppm (D, J=7 Hz, (CH3)2 CH).

[236]

NMR n" 6 - (bï:

[237]

1H at 8.45 ppm (D, J=9 Hz, CONH) - 3H at 8.35 ppm (S.e., NH3) - 4H at 7.40 ppm (S.e., CONH2, &H3) - 1H at 6.92 ppm (S.e., CONH2) - 1H at 6.76 ppm (S, H thiazol) - 1H 20 at 6.0 ppm (D of D, Jχ=9 Hz, J2=4 Hz, Hj) - 1H at 5.25 ppm (D, J=13 HZ, CHgOCO) - 1H at 5.00 ppm (D, J=4 Hz, Hg) - 1H at 4.82 ppm (D, J=13 Hz, CH3OCO) - 1H at 4.00 ppm (M, CH NH2) - 1H at 3.95 ppm (D, J=17 Hz, ClfgSO) 1H at 3.56 ppm (D, J≈17 Hz, CH2SO) - 2H at 2.20 ppm (M, 25 CH2-CONH2) - 2H at 1.95 ppm (M, CH2-CH) - 6H at 1.44 ppm (2~S, (CH3)2C). ~

[238]

MMBL. nα .7 - (b) Î

[239]

1H at 8.50 ppm (D, J≈9 Hz, CONH) - 3H at 8.40 ppm (S.e., italg) - 3H at 7.40 ppm (S.e., &%) - 1H at 6.76 ppm (S, H 30 thiazol) - 1H at 6.0 ppm'(D of D, Jx≈9 Hz, J2=4 Hz, l^j)

[240]

- 1H at 5.25 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.92 ppm (D, J=4 Hz, H6) - 1H at 4.82 ppm (D, J=13 Hz, CH2OCO) 1H at 4.16 ppm (M, CHNH2) - 1H at 3.95 ppm (D, J=17 Hz, CHgSO) - 1H at 3.81 ppm (A of AB, J=13 Hz, CHgOH) 35 1H at 3.69 ppm (B of AB, JAB=13 Hz, CHgOH) - 1H at 3.55 ppm (D, J=17 Hz, CHg SO) - 6H at 1.44 ppm (2 S, (CH3)2 C). ~ NMR n” 8 - (aï :

[241]

8H between 5.5 and 8.5 ppm (widened signal, NH2, C02H, TFA) - 1H at 8.40 ppm (D, J=9 Hz, CONH) - 1H at 6.82 ppm 5 (S, H thiazol) - 1H at 6.0 ppm (D of D, Jχ=9 Hz, J2=4 Hz, H^) - 1H at 5.15 ppm (A of AB, Jab~13 Hz» CH20C0) 1H at 5.0 ppm (D, J=4 Hz, H6) - 1H at 4.67 ppm (B of AB, J=13 Hz, CH^OCO) - 1H at 3.85 ppm (A of AB, J=17 Hz:

[242]

CH2S0) - 1H at 3.62 ppm (B of AB, J=17 Hz, CH2SO) - 2H 10 at 2.80 ppm (M, CH2NH2) - 2H at 2.40 ppm (M, CH2C02) 2H at 1.80 (M, CH2CH2CH2) - 6H at 1.43 ppm (S, (CH3)2C). ~

[243]

NMR n’ 9 - faΐ:

[244]

8H between 5.5 and 8.7 ppm (wide signal, C02H, NH2, TFA) 15 - 1H at 8.40 ppm (D, J=9 Hz, CONH) - 1H at 6.87 ppm (S, H thiazol) - 1H at 6.0 ppm (D of D, J3=9 Hz, J2 = 4 Hz, H7) - 1H at 5.15 ppm (A of AB, J=13 Hz, CH2OCO) - 1H at 5.0 ppm (D, J=4 Hz, H6) - 1H at 4.60 ppm (B of AB, J=13 Hz, CH2OCO) - 1H at 3.85 ppm (A of AB, J=17 Hz, CH2SO)20 1H at 3.60 ppm (B of AB, J=17 Hz, CH2S0) - 2H at 2.80 ppm (M, CH2NH2) - 2H at 2.30 ppm (M, CH2CO) - 12 H at 1.45 ppm (S.e., (CH3)2C and CH2(CH^)3CH2).

[245]

NMR n* 10 - fa):

[246]

8H between 5.5 and 8.0 ppm (wide signal, NH2, C02H, TFA) 25 - 1H at 8.45 ppm (D, J==9 Hz, CONH) - 1H at 6.87 ppm (S, H thiazol) - 1H at 6.0 ppm (D of D, Jx≈9 Hz, J2=4 Hz, H7) - 1H at 5.15 ppm (A of AB, J=13 Hz, CH20C0) - 1H at 5.0 ppm (D, J=4 Hz, H^) - 1H at 4.65 ppm (B of AB, J≈13 Hz, CHgOCO) - 1H at 3.85 ppm (A of AB, J=17 Hz, CHgSO) 30 1H at 3.62 ppm (B of AB, J=17 Hz, CH2S0) - 2H at 2.80 ppm (M, ℮H2NH2) - 2H at 2.30 ppm (M, CH^CO^ - 6H at 1.45 ppm (S, (CH3)2C) - 10H at 1.35 ppm (S.e., CH2(CH2)5CH2).

[247]

NMR n“ 11 - (a):

[248]

35 2H at 8.40 ppm (M, CONH, CH3CONH) - 8H at 7.50 ppm (S.e., Sh3, C02H) - 1H at 6.90 ppm (S, H thiazol) - 1H at 6.05 ppm (D of D, J!=9 Hz, J2=4 Hz, H7) - 1H at 5.40 CONH, CH3CONH) - 8H at 7.50 ppm 1H at 6.90 ppm (S, H thiazol) - 1H J!=9 Hz, J2=4 Hz, H7) - 1H at 5.40 ppm (A of AB, J==13 Hz, CH2OCO) - 1H at 4.98 ppm (D, J=4 Hz, Hg) - 1H at 4.90 ppm" (B of AB, J=13 Hz, CH20C0) 3H at 4.30 ppm (M, CH·^NHCOCH;j,CHNH2) - 1H at 4.00 ppm (A 5 of AB, Jab=17 Hz» CH2SO) - 1H at 3.65 ppm (B of AB,JAB=17 Hz, CH2SO) - 2H at 3.00 ppm (M, CHgS) - 3H at 1.80 ppm (S, CH3CONH), - 6H at 1.45 ppm (S,(CH3)2C).

[249]

NMR n° 12 - fa^;

[250]

8H between 6.5 and 9 ppm (wide signal, C02H, TFA, NH2) 10 - 1H at 8.5 ppm (D, J=9 Hz, CONH) “ 1H at 6.90 ppm (S~H thiazol) - 1H at 6.0 ppm (D of D, J^-9 Hz, J2=4 Hz, H^)

[251]

- 1H at 5.30 ppm (A of AB, J=13 Hz, CH20C0) -- 1H at 5.0 ppm (D, J=4 Hz, H^) - 1H at 4.80 ppm (B of AB, J=13 Hz, CH2OCO) - 1H at 3.92 ppm (A of AB, J=17 Hz, CHg SO) - 1H 15 at 3.67 ppm (B of AB, J=17 Hz, CH2SO) - 12H at 1.45 ppm (S, (CH3)2C-C02H, (CH3)2CNH2).

[252]

NMR n· 13 - (aï :

[253]

8H between 6.5 and 9.5 ppm (wide signal, C02H» NH2, TFA)

[254]

- 1H 8.5 ppm (D, J=9 Hz, CONH) - 1H at 6.90 ppm (S, H 20 thiazol) - 1H at 6.05 ppm (D of D, Jχ=9 Hz, J2=4 Hz, H7)

[255]

- 1H at 5.30 ppm (A of AB, J≈13 Hz, CHgOCO) - 1H at 5.05 ppm (D, J=4 Hz, Hg) - 1H at 4.90 ppm (B of AB, J=13 Hz, CH20C0) - 3H at 3.80 ppm (M, CHNH2 and CH2S0) - 3H at 1.50 ppm (M, CH2-CH) - 6H at 1.45 ppm (S, 7ch3)2C) 25 6H at 0.85 ppm (D, J=7 Hz, (CH^CH).

[256]

NMR n‘ 14 - (a) :

[257]

8H between 7 and 9 ppm (wide signal, NH2, C02H, TFA) 1H at 8.50 ppm (D, J=9 Hz, CONH) - 1H at 6.90 ppm (S, H thiazol) - 1H 6.08 ppm (D of D, Jx=9 Hz, J2≈4 Hz, H7) 30 1H at 5.30 ppm (A of AB, Jab≈13 Hz' CH2OCO) - 1H at 5.05 ppm (D, J=4 Hz, Hg) - 1H at 4.49 ppm (B of AB, Jab=13 HZ, CHgOCO) - 3H at 3.90 ppm (M, CH2SO and CH CH2) - 1H at 1.80 ppm (M, CH CH3) - 6H at 1.45 ppm (S, (CH^)2C) 2H at 1.30 ppm (M, CH2 CH3) - 6H at 0.88 ppm (M, CH^ CH2 35 and CH^CH).

[258]

NMR n° 15 - :

[259]

1H at 8.5 ppm (D, J=9 Hz, CONH) - 3H at 8.30 ppm (S.e., NHS) - 3H at 7.40 ppm (S.e., &H3) - 1H at 6.76 ppm (S, H thiazol) - 1H at 6.0 ppm (D of D, Jχ=9 Hz, J2=4 Hz, H7)

[260]

- 1H at 5.24 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.92 ppm (D, J=4 Hz, Hg) - 1H at 4.84 ppm (D, J=13 Hz, CH^OCO) 5 1H at 4.10 ppm (M, CH-NH2) - 1H at 3.97 ppm (M, CH-OH) 1H at 3.94 ppm (D, J=17 Hz, CH^SO) - 1H at 3.55 ppm (D, J =17 Hz, CH^SO) - 6H at 1.44 ppm (S, (CHg^C) - 3H at 1.14 ppm (D, J=7 Hz, CHjCH).

[261]

NMR n° 16 - (b):

[262]

10 1H at 8.5 ppm (D, J=9 Hz, CONH) - 3H at 8.40 ppm (S.e., Ntfj) - 1H at 7.66 ppm (S, CONH2) - 3H at 7.50 ppm (S.e., NH3) - 1H at 7.22 ppm (S, CO NH2) - 1H at 6.78 ppm (S, H thiazol) - 1H at 6.0 ppm (D of D, J±=9 Hz, J2=4 Hz, Hj)

[263]

- 1H at 5.29 ppm (D, J=13 Hz, CH^OCO) - 1H at 4.92 ppm 15 (D, J≈4 Hz, Hg) - 1H at 4.79 ppm (D, J=13 Hz, CH2OCO) 1H at 4.26 ppm (M, CHNH2) - 1H at 3.92 ppm (D, J=17 Hz, CH2 SO) - 1H at 3.52 ppm (D, J=17 Hz, CH2SO) - 2H at 2.71 ppm (M, CH2CONH2) - 6H at 1.44 ppm (S,(CH3)2C).

[264]

NMR n0 17-fbi;

[265]

20 1H at 8.50 ppm (D, J≈9 Hz, CONH) “ 3H at 8.45 ppm (S.e., iiWj) - 3H at 7.45 ppm (S.e., NH3) - 1H at 6.78 ppm (S, H thiazol) - 1H at 6.0 ppm (D of D, Jχ=9 Hz, J2=4 Hz, H7)

[266]

- 1H at 5.24 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.98 ppm (D, J≈4 Hz, Hg) - 1H at 4.82 ppm (D, J=13 Hz, CH2OCO) 25 1H at 4.13 ppm (M, CHNH2) - 1H at 3.92 ppm (D, ~J≈17 Hz, CH2S0) - 1H at 3.10 ppm (D, J=17 Hz, CH2S0) - 1H at 2.1θ ppm (M, CH2S) - 5H at 2.0 ppm (M, CH3S~ and CH2-CH2-S) - 6H at 1.44 ppm (S, (CH3)2C).

[267]

NMR n* 13 - (hi

[268]

30 4H at 8.50 ppm (M, CONH, NH3) - 3H at 7.80 ppm (S.e., NH^) - 3H at 7.50 ppm (S.e.,”!^) - 1H at 6.79 ppm (S, H thiazol) - 1H at 6.0 ppm (D of D, Jx=9 Hz, J2=4 Hz, H7)

[269]

- 1H at 5.24 ppm (D, J=13 Hz, CHgOCO) - 1H at 4.97 ppm (D, J=4 Hz, Hg) - 1H at 4.82 ppm (D, J≈13 Hz, CH2OCO)35 1H at 3.97 ppm (M, CHNH2) - 1H at 3.92 ppm (D, J^Ï7 Hz, CH2SO) - 1H at 3.60 ppm (D, J=17 Hz, CH2SO) - 2H at 2.75 ppm (M, CH2NH2, - 1H at 1.75 ppm (M CH^CH) - 11H at 1.40 ppm (S.e. TfCH^C, (CH2)3CH2NH2).

[270]

NMR n· 19- fb):

[271]

, , +

[272]

1H at 9 ppm (S, H2 îmidazol) - 3H at 8.6 ppm (S.e., NH3)

[273]

- 1H at 8.5 ppm (D, J=9 Hz, CONH) - 1H at 7.40 ppm (S, 5 H4 imidazol) - 3H at 7.30 ppm (S.e., NH3) - 1H at 6.79 ppm (S, H thiazol) - 1H at 6.0 ppm (D of D, J^=9 Hz, J2=4 Hz, H7) - 1H at 5.22 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.97 ppm (D, J=4 Hz, H6) - 1H at 4.90 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.40 ppm (M, CHNH2) - 1H at 3.89 ppm 10 (D, J=17 Hz, CH2SO) - 1H at 3.52 ppm (D, J=17 Hz, CH2SO)

[274]

- 2H at 3.20 ppm (M, CH2CH) - 6H at 1.44 ppm (S, (CH3)2 C) .

[275]

NMR n‘ 20 -fbΐ:

[276]

1H at 8.50 ppm (D, J=9 Hz, CONH) - 3H at 8.40 ppm (S.e., 15 NH^) - 3H at 7.40 ppm (S.e., NH3) - 1H at 6.77 ppm (S, H thiazol) - 1H at 6.0 ppm (D of D, Jχ=9 Hz, J2=4 Hz, H7)

[277]

- 1H at 5.76 ppm (D, J=13 Hz, CH^OCO) - 1H at 4.95 ppm (D, J=4 Hz, Hg) - 1H at 4.81 ppm (D, J=13 Hz, CH^OCO)1H at 4.06 ppm (M, CHNH2) - 1H at 3.95 ppm (D, J=17 Hz, 20 CH^SO) - 1H at 3.63 ppm (D, J=17 Hz, CHgSO) - 6H at 1.44 ppm (S, (CHj^C) - 3H at 1.36 ppm (D, J=7 Hz, CH3CH).

[278]

NMR n‘ 21 - (a^;

[279]

8H between 6.5 and 9 ppm (widened signal, NH2, C02H, TFA) - 1H at 8.35 ppm (D, J=9 Hz, CONH) - 1H at 6.80 ppm 25 (S, H thiazol) - 1H at 6.0 ppm (D of D, Jx=9 Hz, J2=4 HZ, Hjz) - 1H at 5.15 ppm (A of AB, JAB=13 Hz, CHjOCO)1H at 5.0 ppm (D, J=4 Hz, Hg) - 1H at 4.65 ppm (B of AB, JAB≈13 HZ, CH20C0) - 1H at 3.95 ppm (A of AB, JAB=17 Hz, CH2SO) - 1H at 3.65 ppm (B of AB, JAB≈17 Hz, CH2SO) - 2H 30 at 2.80 ppm (M, CH2NH2) - 2H at 2.35 ppm (M, CH^CO)10H at 1.45 ppm (S.e., (CH3)2C + CH2(CH2)2CH2).

[280]

NMR n' 22 - (a):

[281]

8H between 6 and 9 ppm (wide signal, TFA, NH2, C02H)1H at 8.42 ppm (D, J=9 Hz, CONH) - 1H at 6.85 ppm (S, H 35 thiazol) - 1H at 6.05 ppm (D of D, Jj=9 Hz, J2==4 HZ, 1*7)

[282]

- 1H at 5.30 ppm (A of AB, J=13 Hz, CH^OCO) - 1H at 5.05 ppm (D, J=4 Hz, Hg) - 1H at 4.68 ppm (B of AB, JAB=13 Hz, CH20C0) - 1H at 4.0 ppm (A of AB, JAB=17 Hz, CH2S0)

[283]

- 1H at 3.65 ppm (B of AB, JAb=17 Hz> CH2SO) - 8H at 1.75 ppm (M, H, cyclopentane) - 6H at 1.45 ppm (S, (CH3)2C).

[284]

5 NMR n· 23 - (a^:

[285]

8H between 7 and 10 ppm (wide signal, TFA, NH2, C02H) 1H at 8.50 ppm (D, J=9 Hz, CONH) - 1H at 6.92 "ppm (S, H thiazol) - 1H at 6.10 ppm (D of D, J3=9 Hz, J2=≈4 Hz, H7)

[286]

- 1H at 5.35 ppm (A of AB, J=13 Hz, CH2OCO) - 1H at 5.0 10 ppm (D, J=4 Hz, H6) - 1H at 4.75 ppm (B of AB, J=13 Hz, CH^OCO) ~ 1H at 4.0 ppm (A of AB, JAb=17 Hz, CH2SO) - 1H at 3.70 ppm (B of AB, JAb=17 Hz/ CH2SO) - 16H~between 1 and 2.3 ppm (M, (CH3)2C and cyclohexane).

[287]

NMR n° 24 - (a);

[288]

15 9H between 8 and 10 ppm (wide signal, NH2, OH, C02H, TFA) - 1H at 8.55 ppm (D, J=9 Hz, CONH) - 2H at 7.10 ppm (D, J=8 Hz, H meta OH) - 1H at 6.90 ppm (S, H thiazol)2H at 6.80 ppm (D, J=8 Hz, H ortho, OH) - 1H at 6.10 ppm (D of D, J3=9 Hz, J2=4 Hz, H7) - 1H at 5.80 ppm (A 20 of AB, J≈13 Hz, CH20C0) - 1H at 5.05 ppm (D, J==4 Hz, Hg)

[289]

- 1H at 4.80 ppm (B of AB, J=13 Hz, CHj;OCO) - 1H at 4.30 ppm (M, CflNH2) - 2H at 3.70 ppm (M, CHgSO) - 2H at 3.0 ppm (M, CHg-CgH^OH - 6H at 1.46 ppm (S, (CMjJgC).

[290]

MMR_.n° 25 - (a).ΐ

[291]

25 10H between 6.5 and 9.5 ppm (wide signal, NH2, C02H, TFA) - 1H at 8.40 ppm (D, J=9 Hz, CONH) " 1H at 6.85 ppm (S, h thiazol) - 1H at 6.05 ppm (D of D, Jx=9 Hz, J2=4 Hz, H7) - 1H at 5.30 ppm (A of AB, Jab313 Hz, CH20C0)1H at 5.0 ppm (D, J=4 Hz, Hg) - 1H at 4.85 ppm (B of AB,30 JAB=13 Hz, CH20C0) - 1H at 4.20 ppm (M, CHNH2) - 2H 3.80 ppm (M, CH2S0) - 2H at 2.95 ppm (M, CH2NH2) - 2H at 2.20 ppm (M, CH2CH2NH2) - 6H at 1.45 ppm (S, (CH3)2C).

[292]

NMR n° 26 - fb^:

[293]

3H at 8.60 ppm (S.e., NH3) - 1H at 8.44 ppm (D, J=9 Hz, 35 CONH) - 1H at 6.78 ppm (S, H thiazol) - 1H at 6.0 ppm (D of D, Jλ=9 Hz, H7) - 1H at 5.16 ppm (2D, J=13 Hz, CH^OCO)* - 1H at 4.97 ppm (D, J=4 Hz, Hg) - 1H at 4.66 ppm (2D, J==13 Hz, CH2OCO) * - 1H at 3.92 ppm (D, J=17 Hz, CH2SO) - 1H at 3.56 ppm (D, J=17 Hz, CH2SO) - 5H between 2.5 and 3.5 ppm (M, CH2N and CHC02) - 4H between 1.5 and 2.0 ppm (M, (CH2)2 CH2N) - 6H at 1.44 ppm (S, 5 <CH3)2C). ~

[294]

NMR n· 27 - (bi:

[295]

-4*

[296]

3H at 8.50 ppm (S.e., NH3) - 1H at 8.44 ppm (D, J=9 Hz,

[297]

CONH) - 3H at 7.80 ppm (S.e., NH^) - 3H at 7.30 ppm (S.e., NH^) - 1H at 6.78 ppm (S, H thiazol) - 1H at 6.0 10 ppm (D of D, Jχ=9 Hz, J2=4 Hz, Hy) - 1H at 5.26 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.97 ppm (D, J=4 Hz, Hg) - 1H at 4.84 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.08 ppm (M, ℮HC02) - 1H at 3.94 ppm (D, J=17 Hz, CH2SO) - 1H at 3.56 ppm (D, J=17 Hz, CH2S0) - 2H at 2.80~ppm (M, CH2NH2)15 4H at 1.60 ppm (M, 7cH2>2CH2 NH2) - 6H at 1.44 ppm (S, (CH3)2C) .

[298]

NMR n° 28 - (b):

[299]

1H at 8.37 ppm (D, J=9 Hz, CONH) - 3H at 7.90 (S.e., NΗ3) - 3H at 7.20 ppm (S.e., NH3) - 1H at 6.76 ppm (S, H 20 thiazol) - 1H at 6.0 ppm (D of”D, Jx==9 Hz, J2=4 Hz, Hy)

[300]

- 1H at 5.16 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.97 ppm (D, J≈4 Hz, Hg) - 1H at 4.66 ppm (D, J=13 Hz, CH^OCO)1H at 3.92 ppm (D, J=17 Hz, CH2SO) - 1H at 3.58 ppm (D, J=17 Hz, CH2S0) - 1H at 3.50~ppm (M, CH NH2) - 2H at 25 2.56 ppm (M7 CH2|CHNH2) 6H at 1.44 ppm (S, (CH^C) - 3H at 1.16 ppm (D, J=6 Hz, CH3-CH).

[301]

NMR n° 29 - (b):

[302]

1H at 8.44 ppm (D, J≈9 Hz, CONH) “ 3H at 7.95 ppm (S.e., fa^) - 3H at 7.50 ppm (S.e., NH3) - 1H at 6.78 ppm (S,H 30 thiazol) - 1H at 6.0 ppm (D of~D, Jx≈9 Hz, J2=4 Hz, Hy) 1H at 5.20 ppm (2D, J≈13 Hz, CH^jOCO) * ~ 1H at 4.95 ppm (M, Hg) - 1H at 4.62 ppm (2D, J=13 Hz, CH2OCO) * - 1H at 3.94 ppm (D, J=17 Hz, CH2SO) - 1H at 3.58 ppm (D, J=17 Hz, CH2SO) - 1H at 3.0 ppm (M, CHC02) - 2H at 2.75 ppm 35 (M, CH^NH2) - 6H at 1.44 ppm (M, (CH3)2 C) - 3H at 1.10 ppm (D, J≈7 Hz, CH3CH).

[303]

NMR n’ 30 - (bΐ:

[304]

4" +■*

[305]

4H at 8.45 ppm (M, NH^, CONH) - 8H at 7.35 ppm (M, NH3,

[306]

H aromatic) - 1H at 6.78 ppm (S, H thiazol) - 1H at 6.0 5 ppm (M, H7) - 1H at 5.05 ppm (2D, J=13 Hz, CH2OCO)* - 1H at 4.94 ppm (2D, J=4 Hz, H6)* - 1H at 4.60 ppm (M, CH NH2) - 1H at 3.66 ppm (2D, J=17 Hz, CH2SO)* - 1H at 3.40 ppm (2D, J=17 Hz, CH2SO)* - 2H at 3.0 ppm (M, CH2C02) 6H at 1.44 ppm (S, (CH3)2C).

[307]

10 NMR n' 31 -− ;

[308]

1H at 8.40 ppm (D, J=9 Hz, CONH) - 3H at 7.74 ppm (S.e., 4- -V

[309]

NH3) - 3H at 7.40 ppm (S.e., NH3) - 1H at 6.81 ppm (S, H

[310]

thiazol) - 1H at 6.0 ppm (D of~D, Hz, J2=4 Hz, H7) 1H at 5.13 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.97 ppm (D, 15 J=4 Hz, Hg) - 1H at 4.63 ppm (D, J=13 Hz, CH2OCO) - 1H at 3.90 ppm (D, J=17 Hz, CH2SO) - 1H at 3.55 ppm (D, J=17 Hz, CH^SO) - 1H at 3.16 ppm (M, CHNH2) - 2H at 2.40 ppm (M, CH2CO) -1H 1.77 ppm (M, CH2CHNH2) - 1H at 1.61 ppm (M, CH2CHNH2) - 6H at 1.44 ppm~(2S, (CH3)2C) - 1H at 20 1.1 ppm (D, J=7 Hz, CHβ-CH).

[311]

NMR n* 32 - (a) :

[312]

7H between 7 and 9 ppm (NH, NH2, C02H, TFA) - 1H at 8.50 ppm (D, J≈9 Hz, CONH) - 1H at 6.90 ppm (S, H thiazol)1H at 6.05 ppm (D of D, Jχ=9 Hz, J2=4 Hz, ) - 1H at 25 5.15 ppm (A of AB, J=13 Hz, CHgOCO) - 1H at 5.0 ppm (D, J=4 Hz, Hg) - 1H at 4.70 ppm (B of AB, J=13 Hz, CH2OCO)

[313]

- 1H at 3.95 ppm (A of AB, JAB≈17 Hz, CH2S0) - 1H at 3.65 ppm (B Of AB, JAB =17 Hz, CHgSO) - 2H at 2.90 ppm (M, CH2NH) - 3H at 2.45 ppm (D, J=6 Hz, CHgNH) - 2H at 30 2.4 ppm (M, CH2C0) - 2H at 1.70 ppm (M, CH2CH2CH2) - 6H at 1.42 ppm (S, (CH3)2C).

[314]

NMR n* 33 - (al:

[315]

7H between 7 and 9.5 ppm (NH2, NH, C02H, TFA) - 1H at 8.46 ppm (D, J=9 Hz, CONH) - 1H at 6.90 ppm (S, H 35 thiazol) - 1H at 6.05 ppm (D of D, Jχ=9 Hz, J2=4 Hz, Hj)

[316]

- 1H at 5.15 ppm (A of AB, JAB=13 Hz, CH20C0) - 1H at 5.0 ppm (D, J=4 Hz, Hg) - 1H at 4.70 ppm (B of AB,JAB=13 Hz' CH2OCO) - 1H at 3.90 ppm (A of AB, JAB=17 Hz, CH2SO) - 1H at 3.65 ppm (B of AB, JAB≈17 Hz, CH2SO) - 2H at 2.75 ppm (M, CH^ NH CH3) - 5H at 2.45 ppm (M, CH·jNH and CH2CO) - 10H at 1.45 ppm (S.e., (CH3)2C and CH2 5 (CH2)2CH2).

[317]

NMR~n’ 34 -raΐ:

[318]

8H between 6 and 9 ppm (widened signal, NH2, TFA, OH, C02H) - 1H at 8.47 ppm (D, J=9 Hz, CONH) - 1H at 6.90 ppm (S, H thiazol) - 1H at 6.15 ppm (D of D, J^=9 Hz, 10 J2=4 Hz, H7) - 1H at 5.35 ppm (AB, JAB=13 Hz, CI^OCO)1H at 5.0 ppm (D, J=4 Hz, H6) - 1H at 4.85 ppm (B of AB,JAB=13 Hz' CH2OCO) - 4H at 3.95 ppm (M, CHjSO and CHOH CHNH2) - 6H at 1.45 ppm (S, (CH^C) - 3H at 1.20 ppm (D, J=7 Hz, CH3CH0H).

[319]

15 NMR n‘ 35 - (bΐ:

[320]

1H at 8.50 ppm (D, J=9 Hz, CONH) - 3H at 8.35 ppm (S.e., NH3) - 2H at 7.94 ppm (D, J=8 Hz, H ortho CO) - 2H at 7.55ppm (D, J=8 Hz, H meta CO) - 1H at 6.84 ppm (S, H thiazol) - 1H at 6.0 ppm (D of D, Jx==9 Hz, J2=4 Hz, Hj) 20 - 1H at 5.44 ppm (D, J≈13 Hz, CH^OCO) - 1H at 4.99 ppm (D, J≈4 Hz, Rg) - 1H at 4.86 ppm (D, J=13 Hz, CH^OCO) 3H at 4.1 ppm (M, CH2NH2, CH^SO) - 1H at 3.72 ppm (D, J≈17 Hz, CH2SO) - 6H at 1.44 ppm (2S, (CH^C).

[321]

NMR if 36 - (a):

[322]

25 3H at 9.30 ppm (S.e., NH3) - 1H at 8.55 ppm (D, J=9 Hz, CONH) “ 3H at 8.05 ppm (S.e., NH3) - 1H at 6.92 ppm (S, H thiazol) - 1H at 6.05 ppm (D of D, J-±≈9 Hz, J2=4 Hz, H7) - 1H at 5.30 ppm (A of AB, JAB=13 Hz, CH^OCO) - 1H at 5.05 ppm (D, J=4 Hz, Hg) - 1H at 4.70 ppm (B of AB,30 JAB=13 Hz' CH2OCO) - 1H at 3.95 ppm (A of AB, JAB=17 Hz, CH2SO) - 1H at 3.65 ppm (B of AB, JAB=17 Hz, CH^SO) - 2H at 3.0 ppm (S.e., CH2NH2) - 6H at 1.45 ppm (S, (CHAC-ON) - 6H at 1.17 ppm (S, (CH^)2C02CH2).

[323]

NMR n‘ 37 - (b):

[324]

35 8H between 6 and 9 ppm (wide signal, C02H, TFA, NH2)~ 1H at 8.50 ppm (D, J=9 Hz, CONH) - 1H at 6.90 ppm (S, H thiazol) - 1H at 6.0 ppm (D of D, J^=9 Hz, J2=4 Hz, H7)

[325]

- 1H at 5.15 ppm (D, J=13 Hz, CH^OCO) - 1H at 5.0 ppm (D, J=4 Hz, H6) - 1H at 4.58 ppm (D, J=13 Hz, CH2OCO)1H at 3.9 ppm (D, J=17 Hz, CH2SO) - 1H at 3.54 ppm (D, J=17 HZ, CH2SO) - 2H at 2.6 ppm (M, CH2NH2) - 1H at 2.25 ppm (T, J=12 Hz, CH C02) - 4H at 1.84 ppm (M, CH^CHCO)6H at 1.45 ppm (S, (CH^C) - 3H at 1.25 ppm (M, CHCH2NH2 and CH2CHCH2NH2) - 2H at 0.95 ppm (M, CH2CHCH2NH2).

[326]

NMR n‘ 38 - fb):

[327]

1H at 8.37 ppm (D, J=9 Hz, CONH) - 3H at 7.90 ppm (S.e., NH3) - 3H at 7.40 ppm (S.e., NH3) - 1H at 6.79 ppm (S, H thiazol) - 1H at 6.0 ppm (D of D, J3=9 Hz, J2=4 Hz, H7)

[328]

- 1H at 5.11 ppm (2D, J=13 Hz, CH^OCO) * - 1H at 4.98 ppm (D, J=4 Hz, H6) - 1H at 4.61 ppm (2D, J=13 Hz, CH2OCO)* - 1H at 3.90 ppm (D, J=17 Hz, CH2SO) - 1H at 3."59 ppm (D, J=17 Hz, CHgSO) - 1H at 3.0 ppm (S.e., CHNH2) - 1H at 2.40 ppm (M, CHC02) - 1H at 2.10 ppm (M, CH2CHNH2) - 3H at 1.80 ppm (M, CH2CHNH2) - 6H at 1.44 ppm (2S, (CH3)2C) - 4H between 1 and 1.5 ppm (M, CH22CH^-CH-CO^ .

[329]

3_§..-_Cfel:

[330]

1H at 8.5 ppm (D, J=9 He, CONH) " 6H between 7 and 8 ppm (wide signal, NH2, TFA) - 1H at 6.81 ppm (S, H thiazol)

[331]

- 1H at 6.0 ppm~(D of D, Jχ=9 Hz, J2≈4 Hz, Hj) - 1H at 5.15 ppm (2D, J≈13 Hz, CH2OCO)* - 1H at 5.0 ppm (D, J=4 Hz, H6) - 1H at 4.63 ppm (2D, J=13 Hz, CH^OCO)* - 1H at 3.89~ppm (D, J≈17 Hz, CH^SO) - 1H at 3.56 ppm (D, J=17 Hz, CH2SO) - 2H at 2.77 ppm (M, CH£NH2) - 1H at 2.52 ppm (M, CHC02) - 1H at 1.84 ppm (M, CH_2CH) - 1H at 1.56 ppm (M, CH2CH) - 6H at 1.44 ppm (S, (CH3)2C) - 3H at 1.06 ppm (D, J=7 HZ, CH3CH).

[332]

NMR n° 40 - (a):

[333]

1H at 8.45 ppm (D, J=9 Hz, CONH) - 8H at 7.30 ppm (S.e., NHj, C02H) - 1H at 6.80 ppm S, H thiazol) - 1H at 6.0 ppm (M, H7) - 1H at 5.20 ppm (A of AB, Jab≈13 Hz' CHgOCO) - 1H at 4.90 ppm (B of AB, JAB=13 Hz, CH^OCO) 1H at 4.90 ppm (D, J=4 Hz, Hg) - 3H at 3.80 ppm (M, CH2SO, CHNH2) - 1H at 2.00 ppm (M, CH(CH3)2) - 6H at 1.45 ppm (S, (CH3)2C) - 6H at 0.95 ppm (2D, J=7 Hz, (CH3)2CH).

[334]

NMR nα 41 - fa) :

[335]

5 2H at 8.50 ppm (S.e·, NHjg) - 1H at 8.45 ppm (D, J=9 Hz, CONH) - 3H at 7.30 ppm (S.e·, NH3) - 1H at 6.80 ppm (S, H thiazol) - 1H at 6.0 ppm (M, H7) - 1H at 5.15 ppm (A of AB, JAB=13Hz» CH2OCO) - 1H at 4.96 ppm (D, J=4 Hz, Hg) - 1H at 4.65 ppm (B of AB, 13 Hz, CH2OCO) - 1H at 10 3.90 ppm (A of AB, J=17 Hz, CH2SO) - 1H at 3.65 ppm (B of AB, J=17 HZ, CH^SO) - 2H at”3.00 ppm (M, CH_2NH) - 5H at 2.50 ppm (M, CH^NH, CH^CO^ - 6H at 1.42 ppm (S, (CH3)2C) .

[336]

NMR n° 42 - faΐ;

[337]

*+■ 4*

[338]

15 7H at 9.4 ppm (S.e·, NH3, NH2, C02H) - 1H at 8.45 ppm

[339]

(D, J=9 Hz, CONH) - 1H "at 6.85 ppm (S, H thiazol) - 1H at 6.00 ppm (M, Hj) - 1H at 5.00 ppm (D, J=4 Hz, Hg) 1H at (A of AB, JAB=13 Hz, CH2OCO) - 1H at 4.65 ppm (B of AB, JAB=13 Hz, CH^OCO) - 1H at 3.85 ppm (A of AB, 20 JAB≈17 Hz, CHgSO) - 1H at 3.60 ppm (B of AB, JAB=17 Hz, CH^SO) - 4H at 2.85 ppm (M, CH2NHCH2) - 2H at 2.40 ppm (M, CHj| CO) - 2H at 1.80 ppm (M, CH2CH2CH2NH) - 6H at

[340]

O

[341]

1.45 ppm (S, (CH3)2C) - 3H at 1.10 ppm (T, J=7 Hz, CH3 25 CH2NH).

[342]

NMR-n.; 4,3 - (a) ;

[343]

2H at 8.50 ppm (S.e., NH2) - 1H at 8.40 ppm (D, J=9 Hz, CONH) - 3H at 7.00 ppm (S.e., NH3) - 1H at 6.76 ppm (S, H thiazol) - 1H at 5.95 ppm (M, "H7) - 1H at 5.10 ppm (A 30 of AB, JAB =13 Hz, CHjjOCÔ) - 1H at 5.0 ppm (D, J=4 Hz, Hg) - 1H at 4.65 ppm (B of AB, JAB=13 Hz, CI^OCO) - 1H at 3.85 ppm (A of AB, JAB=17 Hz, CH2S0) - 1H at 3.50 ppm, B of AB, JAB=17 Hz, CH^SO) - 1H at 3.30 ppm (M, CHNH) “ 5H at 2.45 ppm (M, CH3NH and CHg CO) - 2H at

[344]

35 O

[345]

1.80 ppm (M, CH2CH2 CO) - 6H at 1.45 ppm (S, (CH3)2C)

[346]

o

[347]

3H at 1.10 ppm (D, J=7 Hz, CH3CH).

[348]

NMR n· 44 - (a):

[349]

1H at 8.40 ppm (D, J=9 Hz, CONH) - 7H at 7.80 ppm (S.e., NH/j, NH2, C02H) - 1H at 6.80 ppm (S, H thiazol) - 1H at 5 6.00 ppm (M, Hy) - 1H at 5.00 (M, H6) - 1H at 5.00 ppm (A Of AB, Jab=13 Hz/ CH2OCO) - 1H at 4.65 ppm (B of AB, Jab=13 Hz, CH2OCO) - 1H at 3.85 ppm (A of AB, Jab=17 Hz' CH^SO) - 1H at 3.55 ppm (B of AB, JAB=17 Hz > CH2SO) - 2H at 2.80 ppm (M, CH^NH) - 5H at 2.40 ppm (M, CH3NH, 10 CH2C02) - 12H at 1.45 ppm (S.e., (CHg^C and ChJ(CH2)3CH2NH). ~

[350]

NMR n· 45 - (b):

[351]

1H at 8.75 ppm (D, J=9 Hz, CONH) - 1H at 8.60 ppm (S.e., NH2) - 1H at 8.40 ppm (S.e., NH2) - 3H at 7.30 ppm 15 (sTe., NH^) - 1H at 6.78 ppm (S, H thiazol) - 1H at 5.91 ppm (D of D, Jχ=9 Hz, J2=4 Hz, H7) - 1H at 5.13 ppm (D, J=13 HZ, CH2OCO) - 1H at 4.95 ppm (D, J=4 Hz, Hg) - 1H at 4.61 ppm (D, J=13 Hz, CH2OCO) - 2H at 4.55 ppm (S, CHjjON) - 1H at 3.84 ppm (A of AB, Jab=17 Hz> CH2SO) - 1H 20 at 3.55 ppm (B of AB, JAB =17 Hz, CH2SO) - 2Ü at 3.20 ppm (M, CH^NH) - 2H at 2.90 ppm (M, CH2NH) - 1H at 2.64 ppm (M, C|iC02) - 2H at 1.95 ppm (M, CH2CH2NH) - 2H at 1.66 ppm (M, CH2CH2NH).

[352]

NMR n1 46 - (b):

[353]

25 1H at 8.75 ppm (D, J=9 Hz, CONH) - 1H at 8.60 ppm (S.e., NH2) - 1H at 8.40 ppm (S.e., NH2) - 3H at 7.30 ppm (S.e., [3) - 1H at 6.78 ppm (S, H thiazol) - 1H at 5.94 ppm (D of D, J]_≈9 Hz, J2≈4 Hz, Hy) - 1H at 5.13 ppm (D, J=13 Hz, CH^OCO) - 1H at 4.95 ppm (D, J≈4 Hz, Hg) - 1H 30 at 4.61 ppm (D, J=13 Hz, CH2OCO) - 1H at 3.90 ppm (A of AB, J=17 Hz, CHjSO) - 1H at"3.55 ppm (B of AB, J=17 Hz, CHjjSO) - 2H at 3.20 ppm (M, CH2 NH) - 2H at 2.90 ppm (M, CH2NH) - 1H at 2.64 ppm (M, Cfl) C02) - 4H at 2.40 ppm

[354]

O

[355]

35 (M, CHg-I C02H) - 6H between 1.5 and 2 ppm

[356]

CHj

[357]

^CH2

[358]

(CH2 /Kr CH2-CH2NH) .

[359]

x ch2 co2h

[360]

5 NMR n· 47 - (to :

[361]

1H at 8.79 ppm (D, J=9 Hz, CONH) - 3H at 8.30 ppm (S.e., NH^) - 2H at 7.97 ppm (D, J=8 Hz, H ortho CO) - 2H at 7.55 ppm (D, J=8 Hz, H meta CO) - 3H at 7.30 ppm (S.e., NH3) - 1H at 6.84 ppm (S, H thiazol) - 1H at 5.92 ppm (D 10 of D, Ji=9 Hz, J2=4 Hz, H7) - 1H at 5.40 ppm (D, J=13 Hz, CIPgOCO) - 1H at 4.95 ppm (D, J=4 Hz, H5) - 1H at 4.84 ppm (D, J=13 Hz, CHgOCO) - 2H at 4.56 ppm (S, CHjON) - 1H at 4.08 ppm (M, CH2NH2) - 1H at 4.00 ppm (A of AB, Jab≈17 Hz' CH^SO) - 1H at 3.71 ppm (B of AB,15 JAB=17 Hz, CH2S0).

[362]

NMR n° 48 - (b):

[363]

1H at 8.75 ppm (D, J=9 Hz, CONH) - 3H at 8.30 ppm (S.e., Î1H3) - 2H at 7.95 ppm (D, J=8 Hz, H ortho CO) - 2H at 7.55 ppm (D, J=8 Hz, H meta CO) - 3H at 7.30 ppm (S.e., 20 NH3) - 1H at 6.78 ppm (S, H thiazol) - 1H at 5.95 ppm (D of" D, Jλ≈9 Hz, J2=4 Hz, Hj) - 1H at 4.44 ppm (D, J=13 Hz, CH20C0) - 1H at 4.98 ppm (D, J=4 Hz, Hg) - 1H at 4.81 ppm (D, J=>13 Hz) - CHgOCO) - 1H at 4.10 ppm (S.e., CHgNH^ - 1H at 4.05 ppm (A of AB, Jab≈17 Hz' CH^SO)25 1H at 3.71 ppm (B of AB, Jab≈17 Hz' CHaSO) - 4H

[364]

0

[365]

1

[366]

2.40 ppm (M, CH2- c C02H) - 2H at 1.85 ppm

[367]

CH2

[368]

CH2 O

[369]

30 (M, CK£ )•

[370]

nch2 co2h

[371]

NMR n· 49 - (bΐ:

[372]

1H at 8.75 ppm (D, J=9 Hz, CONH) - 3H at 7.70 ppm (S.e., NH3) - 3H at 7.30 ppm (S.e., NH3) - 1H at 6.82 ppm (S, H 35 thiazol) - 1H at 5.90 ppm (D of D, Jχ=9 Hz, J2=4 Hz, H7)

[373]

- 1H at 5.10 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.95 ppm (D, J=4 Hz, Hg) - 1H at 4.56 ppm (D, J=13 Hz, CH2OCO)2H at 4.53 ppm (S, CH20N) - 1H at 3.84 ppm (A of AB,

[374]

44

[375]

5 NMR n· 50 - fbΐ:

[376]

10 (D, J==4 Hz, Hg) - 1H at 4.63 ppm (D, J=13 Hz, CH2OCO)15 CH2

[377]

20 1H at 8.75 ppm (D, J=9 Hz, CONH) - 3H at 7.60 ppm (S.e., 25 CH2OCO) - 2H at 4.57 ppm (S, CH^ON) - 1H at 3.81 ppm (A 30 1H at 8.75 ppm (D, J=9 Hz, CONH) - 3H at 7.70 ppm (S.e., Jab=17 Hz, CH2SO) - 1H at 3.55 ppm (B of AB, JAB=17 Hz, CH^SO) - 2H at 2.76 ppm (M, CH2NH2) - 2H at 2.40 ppm (M, CH^CC^) - 2H at 1.72 ppm (M, CH2CH2CH2NH2).

[378]

NMR n· 50 - fbΐ:

[379]

1H at 8.75 ppm (D, J=9 Hz, CONH) - 3H at 7.75 ppm (S.e., NH3) - 3H at 7.25 ppm (S.e., NH3) - 1H at 6.77 ppm (S, H thiazσl) - 1H at 5.94 ppm (D of D, Jj=9 Hz, J2=4 Hz, H7)

[380]

- 1H at 5.11 ppm (D, J=13 Hz, CH^OCO) - 1H at 4.95 ppm (D, J==4 Hz, Hg) - 1H at 4.63 ppm (D, J=13 Hz, CH2OCO)1H at 3.89 ppm (A of AB, J=17 Hz, CH2SO) - 1H at 3.55 ppm (B of AB, J≈17 Hz, CH^SO) - 2H atH.78 ppm (M,

[381]

O

[382]

CH2NH2) - 6H at 2.40 ppm (M, CH2 -4 C02H, CH2C02) - 4H 4H

[383]

at 1.85 ppm (M, CH2CH2NH2, CH2 ).

[384]

CH2

[385]

ch2

[386]

ch2 COoH

[387]

COoH

[388]

).

[389]

NMR n" 51 - (:

[390]

1H at 8.75 ppm (D, J=9 Hz, CONH) - 3H at 7.60 ppm (S.e., NH3) -− 3H at 7.30 ppm (S.e., NKh|) - 1H at 6.82 ppm (S, H thiazol) - 1H at 5.87 ppm (D of D, Jx=9 Hz, J2=4 Hz, Hj) - 1H at 5.61 ppm (D, J=13 Hz, CHgOCO) - 1H at 4.92 ppm (D, J=4 Hz, H^) - 1H at 4.58 ppm (D, J=13 Hz, CH2OCO) - 2H at 4.57 ppm (S, CH^ON) - 1H at 3.81 ppm (A of AB, J≈13 Hz, CH2S0) - 1H at 3.55 ppm (B of AB, J=13 Hz, CHgSO) - 2H at 2.75 ppm (M, CH^NH;j) - 2H at 2.31 ppm (M, CH2CO2) - 4H at 1.50 ppm (M, CH^(CH2)2CH2N)·

[391]

1H at 8.75 ppm (D, J=9 Hz, CONH) - 3H at 7.70 ppm (S.e., NH3) - 3H at 7.30 ppm (S.e., NH3) - 1H at 6.78 ppm (S, H thiazol) - 1H at 5.92 ppm (D of D, Jx=9 Hz, J2=4 Hz, H7)

[392]

- 1H at 5.13 ppm (D, J=13 Hz, CH^OCO) - 1H at 4.95 ppm (D, J=4 Hz, Hg) - 1H at 4.58 ppm (D, J=13 Hz, CH2OCO) 1H at 3.86 ppm (A of AB, J≈17 Hz, CH^SO) - 1H at 3.55 ppm (B of AB, J=17 HZ, CH2SO) - 2H at 2.74 ppm (M,

[393]

35 1H at 3.86 ppm (A of AB, J≈17 Hz, CH^SO) - 1H at 3.55 5 10 15 20 25 30 35 CH2NH2) - 6H at 2.40 ppm (M, CH2 C02 + CH2-j C02H) “ CH2

[394]

/ ch2 o

[395]

2H at 1.85 ppm (M, CH2 />^ ) - 4H at 1.50 ppm (M, CH2 co2h

[396]

ch2ch2ch2co2).

[397]

NMR n° 53 - fbΐ:

[398]

1H at 8.80 ppm (D, J=9 Hz, CONH) - 3H at 8.40 ppm (S.e., NH3) - 3H at 7.40 ppm (S.e., NH3) - 1H at 6.78 ppm (S, H thiazol) - 1H at 5.95 ppm (D ofD, Jx=9 Hz, J2=4 Hz, H7)

[399]

- 1H at 5.25 ppm (D, J=13 Hz, CHgOCO) - 1H at 4.95 ppm (D, J=4 Hz, Hg) - 1H at 4.78 ppm (D, J=13 Hz, CH2OCO) ~ 1H at 4.08 ppm (M, CHNH2) - 1H at 3.95 ppm (A "of AB, J=17 HZ, CH2SO) - 1H at 3.60 ppm (B of AB, J=17 Hz,

[400]

O

[401]

CH2SO) - 4H at 2.40 ppm (M, CHa -j C02H) - 2H at 1.80 ' CH2

[402]

ch2 o

[403]

ppm (M, CHg ) - 3H at 1.36 ppm (D, J≈7 Hz,nch2 co2h

[404]

CH3CH).

[405]

NMR Π * ■■ ■5 4 - (M:

[406]

1H at 8.75 ppm (D, J=9 Hz, CONH) - 3H at 7.87 ppm (S.e., NHg) - 3H at 7.30 ppm (S.e., NH3) - 1H at 6.78 ppm (S, H thiazol) - 1H at 5.95 ppm (D of D, Hz, J2≈4 Hz, Hy)

[407]

- 1H at 5.19 ppm (2D, J=>13 Hz, CH^OCO) * - 1H at 4.95 ppm (D, J=>4 Hz, H6) - 1H at 4.64 ppm (2D, J=13 Hz, CHgOCO) *

[408]

- 1H at 3.92 ppm (A of AB, J=17 Hz, CH2SO) - 1H at 3.55 ppm (B of AB, J≈17 Hz, CH2SO) - 1H at 3.0 ppm (M, CHC02)

[409]

- 2H at 2.80 ppm (M, CH2NH2) - 4H at 2.40 ppm (M,

[410]

0 0

[411]

CIÎ2-|C02h) "2H at 1·80 PPm (M, CH2

[412]

cn_2

[413]

) C02H

[414]

3H at 1.08 ppm (D, J=7 Hz, CH^CH).

[415]

NMR n° 55 - (bï:

[416]

1H at 8.75 ppm (D, J=9 Hz, CONH) - 3H at 7.80 ppm (S.e., NHjj) - 3H at 7.30 ppm (S.e., NH^) - 1H at 6.80 ppm (S, H 5 thiazol) - 1H at 5.95 ppm (M, H7) - 1H at 5.20 ppm (D, J=13 Hz, CHpOCO) - 1H at 4.95 ppm (S.e., H6) - 1H at 4.63 pprn (D, J=13 Hz, CH2OCO) - 1H at 3.90 ppm (A of AB, J=17 Hz, CH^SO) - 1H at 3.58 ppm (B of AB, J=17 Hz, CH2SO) 2H at 2.93 ppm (M, CH2NH2) - 4H at 2.40 ppm (M, 10 0 O

[417]

CH2 j C02H) - 2H at 1.90 ppm (M, CH2 1 C02H) CH_2 CHj - CH2

[418]

-6H at 1.14 ppm (S, (CH3)2C).

[419]

NMR n° 56 - (bl:

[420]

15 1H at 8.75 ppm (D, J=9 HZ, CONH) - 3H at 7.75 ppm (S.e., NH3) - 3H at 7.35 ppm (S.e., NH3) - 1H at 6.80 ppm (S, H thiazol) - 1H at 5.95 ppm (D of D, Jx=9 Hz, J2=4 Hz, H7)

[421]

- 1H at 5.15 ppm (2D, J=13 Hz, CH^OCO)* - 1H at 4.95 ppm (D, J=4 Hz, H6) - 1H at 4.60 ppm (2D, J=13 Hz, CH2OCO) * 20 - 1H at 3.90 ppm (A of AB, J=17 Hz, CH2S0) - 1H at 3.56 ppm (B of AB, J=17 Hz, CH2SO) - 2H at 2.74 ppm (M, CH^NH;j) - 1H at 2.50 (M, CHC02) - 4H at 2.40 ppm (M,

[422]

O O

[423]

CH2-I C02H) - 3H at 1.90 ppm (M, CH2 I-C02H and 25 CH2 CH-2 · CH2 CH3CH2NH2) - 1H at 1.55 ppm (M, CH2CH2NH2) - 3H at 1.08 ppm (D, J=>7 Hz, CH3CH) .

[424]

m-n:.-S.7,_r- (hi.:

[425]

1H at 8.80 ppm (D, H≈9 Hz, CONH) - 3H at 8.40 ppm (S.e., 30 NH3) - 3H at 7.40 ppm (sie., NH^) - 1H at 6.79 ppm (S H thiazol) - 1H at 5.95 ppm (D of D, Hz, J2=4 Hz, Hj)

[426]

- 1H at 5.28 ppm (D, J=13 Hz, CHgOCO) - 1H at 4.95 ppm (D, J=4 Hz, Hg) - 1H at 4.75 ppm (D, J=13 Hz, CH2OCO)1H at 3.95 ppm (A of AB, J=17 Hz, CH^SO) - 1H at 3.61 35 ppm (B of AB, J=17 Hz, CHgSO) - 4H at 2.40 ppm (M, Ch2-| C02H) - 2H at 2.10 ppm (M, CH2 cyclopentane)~ GH2

[427]

O

[428]

2H at 1.90 (M, CH2 |\ ) - 6H at 1.80 ppm (M, CHg

[429]

ch2 ch2 ~

[430]

cyclopentane).

[431]

NMR n° 58 - fb\ :

[432]

1H at 8.75 ppm (D, J=9 Hz, CONH) - 3H at 2.70 ppm (S.e., ÜHj) - 3H at 7.30 ppm (S.e., NH3) - 1H at 6.84 ppm (S, H thiazol) - 1H at 5.89 ppm (D of D, Jχ=9 Hz, J2=4 Hz, H7)

[433]

- 1H at 5.13 ppm (D, J=13 Hz, CH^OCO) - 1H at 4.95 ppm (D, J=4 Hz, Hg) - 3H at 4.55 ppm (M, CH2ON and CH20C0)

[434]

- 1H at 3.82 ppm (A of AB, J=17 Hz, CH2SO) - 1H at 3.55 ppm (B of AB, J=17 Hz, CH2SO) - 2H at 2.60 ppm (M, CH2NH2) - 1H at 2.21 ppm (M, CH C02) - 4H at 1.80 ppm, (M, CH2 cyclohexane) - 1H at 1.45 ppm (M, CHCH2NH2) - 2H at 1.25 ppm (M, CH2 cyclohexane) - 2H at 0.90 ppm (M, CH2 cyclohexane).

[435]

NMR n° 59 - (bΐ;

[436]

1H at 8.67 ppm (D, J≈9 Hz, CONH) - 3H at 7.70 ppm (S.e., ΐfHg) - 3H at 7.30 ppm (S.e., NH3) - 1H at 6.82 ppm (S, H thiazol) - 1H at 5.94 ppm (D of D, Jx=9 Hz, J2≈4 Hz, Hy)

[437]

- 1H at 5.13 ppm (D, J=13 Hz, CHgOCO) - 1H at 4.95 ppm (D, J=4 Hz, H6) - 1H at 4.56 ppm (D, J=13 Hz, CH2OCO)1H at 3.87 ppm (A Of AB, J≈17 Hz, CH2SO) - 2H at 3.55 ppm (B of AB, J≈17 Hz, CHjjSO) - 2H at 2.60 ppm (M, CH2NH2) - 5H between 2.0 and 2.5 ppm, 6H between 1.6 and 2.0 ppm, 3H at 1.1 and 1.6 ppm, 2H at 0.90 ppm (M,

[438]

yfCH_2,

[439]

CEj \

[440]

CH2

[441]

X

[442]

co2h

[443]

and

[444]

u CH,CH,

[445]

- \ rH2a

[446]

oc

[447]

0

[448]

XX"-

[449]

CH2CH2

[450]

NMR na 60 -fb>:

[451]

CONH)* - 3H at 7.70 ppm

[452]

1H at 6.82 ppm (2S, H thiazol)* - 1H at 5.95 ppm (D of D, Jλ=9 Hz, J2=4 1H at 8.60 ppm (2D, J=9 Hz,

[453]

(S.e, NH3) - 3H at 7.30 ppm (S.e., NH3)

[454]

5 10 15 20 25 30 35 Hz, H7) - 1H at 5.13 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.95 ppm (2D, Hg)* - 2H at 4.60 ppm (M, CH2OCO + CHON)1H at 3.86 ppm (2D, J=17 Hz, CH^SO)* - 1H at 3.56 ppm (2D, J=17 Hz, CHgSO)* ■- 2H at 2.75 ppm (M, CH2NH2) - 2H at 2.40 ppm (T, J=7 Hz, CH2C02) - 2H at 1.75 ppm (M, CH2CH2CH2NH2) - 3H at 1.39 ppm (D, J==7 Hz, CH3CH) .

[455]

NMR n· 61 - fbï: ~

[456]

1H at 8.70 ppm (2D, J=9 Hz, CONH)* - 3H at 7.70 ppm (S.e., NH3) - 3H at 7.30 ppm (S.e., NH3) - 1H at 6.82 ppm (2S, H thiazol)* - 1H at 5.95 ppm (D of D, Ji=9 Hz, J2≈4 Hz, H7) - 1H at 5.12 ppm (D, J=13 Hz, CH^OCO) - 1H at 4.94 ppm (2D, Hg)* - 2H at 4.60 ppm (M, HCON, and CH2OCO) - 1H at 3.86 ppm (A of AB, J=17 Hz, CÎ^SO) - 1H at 3.55 ppm (B of AB, J=17 Hz, CH2SO) - 2H at 2.75 ppm (M, CH2NH2) - 2H at 2.31 ppm (M,~CH2C02) - 4H at 1.50 ppm (M, CH2CH2CH2CH2NH2) - 3H at 1.45 ppm (D, J=7 Hz, CH^CH).

[457]

NMR n" 62 - (bï:

[458]

2H at 8.60 ppm (M, CONH, NH3) - 1H at 8.40 ppm (S.e., NHj*) - 3H at 7.30 ppm (S.e., NH3) - 1H at 6.82 ppm (2S, H thiazol)* - 1H at 5.95 ppm (D of D, Jx≈9 Hz, J2=4 Hz, H7) - 1H at 5.14 ppm (D, J≈13 Hz, CHgOCO) - 1H at 4.95 ppm (2D, Hg)* - 2H at 4.60 ppm (M, CH-ON, and CH2OCO)1H at 3.88~ ppm (2D, J=17 Hz, CH2SO) - 1H at 3/55 ppm (D, J=17 Hz, CHgSO) - 2H at 3.20 ppm and 2H at 2.95 ppm (M, CH2NH ) - 1H at 2.66 ppm (M, CHC02) - 2H at 1.95 ppm CH2_

[459]

and 2H at 1.70 ppm

[460]

CHg

[461]

(M, 02C

[462]

\hj.

[463]

3H at 1.45 ppm (D,

[464]

J≈7 Hz, CH^CH).

[465]

NMR n° 63 - :

[466]

1H at 8.70 ppm (2D, J=9 Hz, CONH)* - 3H at 8.20 ppm (S.e., NIPj) - 2H at 7.95 ppm (D, J= Hz, H ortho C02)2H at 7.55 ppm (D, J=8 Hz, H meta C02) - 3H at 7.30 ppm (S.e., NH3) - 1H at 6.82 ppm (2S, H thiazol)* - 1H at 5.95 ppm °f 0, Jχ=9 Hz, J2=4 Hz, H7) - 1H at 5.44 ppm (D, J=13 Hz, CH2OCO) - 1H at 4.96 ppm (2D, Hg)*1H at 4.84 ppm (D, jΞi3 Hz, CH2OCO) - 1H at 4.60 ppiiT(Q, J≈7 Hz, CHON) - 2H at 4.10 ppm (M, CH2NH2) - 1H at 3.90 5 ppm (D, J=17 Hz, CH^SO) - 1H at 3.70 ppm (D, J=17 Hz, CH^SO) - 3H at 1.45 ppm (D, J=7 Hz, CH3CH).

[467]

NMR n° 64 - fb):

[468]

1H at 8.60 ppm (2D, J=9 Hz, CONH)* - 3H at 7.70 ppm (S.e·, NH3) - 1H at 6.80 ppm (2S, H thiazol)* -■ 1H at 10 5.95 ppm (D of D, J3=9 Hz, J2=4 Hz, H7) - 5H between 4 and 6 ppm (S.e., NH3 C02H) - 1H at 5.13 ppm (D, J=13 Hz, CH^OCO) - 1H at 4.95 ppm (2D, Hg) * - 2H at 4.60 ppm (M, CHgOCO and CHON) - 1H at 3.86 ppm (A of AB, J=17 Hz, CHgSO) - 1H at 3.55 ppm (B Of AB, J=17 Hz, CH2SO) - 2H

[469]

15 at 2.61 ppm (M, CH2NH2) - 1H at 2.21 ppm (M, CHC02) - 4H ,C^Z «Ig

[470]

at 1.80 ppm (M,\ ) ) - 3H at 1.45 ppm (D, J=7 C«2 <*2

[471]

Hz, CH3CH) - 2H at 1.25 ppm and 2H at 0.90 ppm

[472]

[473]

NMR n° 67 - (bl;

[474]

3H at 8.50 ppm (M, N%2 and CO NH) - 2H at 7.50 ppm 10 (Se., NH2 thiazol) - 1H at 6.79 ppm (S, H thiazol) - 1H at 5.99 ppm (D of D, J3 ≈ 9 Hz, J2 = 4 Hz, H7) - 1H at 5.16ppm (2D, J = 13 Hz, CH2 O CO) - 1H at 4.95 ppm (D, J = 4 Hz Hg) - 1H at 4.66 ppm (D, J = 13 Hz, O CO) - 1H at 3.92 ppm (D, J = 17 Hz, CH2 SO) - 1H at 3.58 ppm (D, 15 J = 17 Hz, CH2 so) - 1H at 3.36 ppm (M, Cî^T H2) - 1H at 3.25 ppm (M, CH2 Ï®H2) - 1H at 2.95 ppm (M, CH2cX 1$H2)

[475]

- 2H at 2.60 ppm (2D superposed CH2 C02) - 3H at 1.70 ppm (M, H piperidine) - 6H at 1.48 ppm (2S (CH3)2 C) 3H at 1.45 ppm (M, H piperidine).

[476]

20 NMR n° 68 - fbl:

[477]

1H at 8.60 ppm (Se., N®k2 piperidine) - 1H at 8.45 ppm (Se., NH^jp piperidine) - 1H at 8.45 ppm (D, J = 9 Hz, CO NH) - 1H at 7.50 ppm (Se., NH2 thiazol) - 1H at 6.70 ppm (S, H thiazol) - 1H at 5.97 ppm (D of D, Jx = 9 Hz, J2 = 25 4 Hz, H7) - 1H at 5.10 ppm (D, J ≈ 13 Hz, CH2 O CO) - 1H at 4.97 ppm (D, J =■ 4 Hz, Hg) - 1H at 4.63~ppm (D, J = 13 HZ, CH2 o CO) - 1H at 3.90 ppm (D, J = 17 Hz, CH2 SO)

[478]

- 1H at 3T57 ppm (D, J ≈ 17 Hz, CHg SO) - 2H at 3.20 ppm (M, CHj (X *®H2) "2H at 2·70 PPm (M, CH2o4 N®^2) "2H at 30 2.30 ppm (D, J ≈ 7 Hz, CH2 C02) - 1H at 2.05 ppm (M, CH CH2 C02) - 3H at 1.55 ppm (M, CH2 piperidine) - 6H at lT48 ppm (2 S, (CH3)2 C) - 1H at 1.20 ppm (M, CH2 piperidine).

[479]

NMR n' 69 - (bl;

[480]

35 1H at 10.9 ppm (Se., Ar NH CO) - 1H at 8.45 ppm (D, J = 9 Hz, CO NH) - 4H at 8.15 ppm (2 S, CH2ΐβn3 and H Ar 2') - IE at 7.81 ppm (D, J = 7 Hz, H Ar 6') - 1H at 7.67 ppm (D, J ≈ 7 Hz, H Ar 4') - 1H at 7.50 ppm (T, J = 7 Hz, H Ar 5') - 2H at 7.20 ppm (Se., NH2 thiazol) - 1H at 6.78 ppm (S, H thiazol) ~ 1H at 6.00 ppm (D of D, J3 = 9 Hz, J2 = 4 Hz, H7) - 1H at 5.45 ppm (D, J = 13 Hz, 5 CH2 O CO) - 1H at 5.00 ppm (D, J = 4 Hz, H6) - 1H at 4.84 ppm (D, J = 13 Hz, CH2 O CO) - 1H at 4. <K> ppm (D, J = 17 Hz, CHg SO) - 1H at~3.75 ppm (M, - C - CH2 *$h3 O

[481]

and CH2 SO) - 6H at 1.47 ppm (2 S, (CH3)2 C).

[482]

10 NMR n1 70 - ;

[483]

1H at 8.70 ppm (D, J = 9 Hz, CO NH) - 3H at 8.50 ppm (Se., CH2~Î^H3) - 1H at 8.05 ppm (S, H Ar 2') - 1H at 7.80 ppm (D, J = 7 Hz, H Ar 6') - 1H at 7.34 ppm (D, J = 7 Hz H Ar 5') - 1H at 6.95 ppm (S, H thiazol) - 1H at 15 6.00 ppm (D of D, Jχ = 9 Hz, J2 = 4 Hz, H7) - 1H at 5.45 ppm (D, J = 13 Hz, CHg O CO) - 1H at 5.05 ppm (D, J = 4 Hz, Hg) - 1H at 4.82 ppm (D, J = 13 Hz, CH2 O CO) - 3H at 4.05 ppm (M, Ar CH2 *Φΐ3 and CH2 SO) - 1H at 3.80 ppm (D, J ≈ 17 HZ, CH2 SO) - 3H at 2.37 ppm (S, CH3 Ar) - 6H 20 at 1.48 ppm (2S, (CH3)2 C).

[484]

NMR n* 71 - (bΐ;

[485]

1H at 8.70 ppm (D, J ≈ 9 Hz, CO NH) - 9H at 8.50 ppm (Sθ·, CH2 ï$H3) - 2H at 7.78 ppm (M, B Ar 2', 6') - 1H at 7.50 ppm (D, J ≈ 7 Hz, H Ar 5') - 1H at 6.92 ppm (S, 25 H thiazol) - 1H at 6.00 ppm (D of D, Jx ≈ 9 Hz, J2 = 4 Hz, H7) - 1H of 5.45 ppm (D, J ≈ 13 HZ, CH2 O CO) - 1H of 5.00 ppm (D, J = 4 Hz, Hg) - 1H at 4.81 ppm (D, J =13 Hz, CH2 0 CO) - 3H at 4.05 ppm (M, Ar CH2 Ï$H3 CHg SO)1H at 3.75 ppm (D, J ≈ 17 Hz, CHg SO) ~ 3H at 2.36 ppm 30 (S, CHg Ar) - 6H at 1.47 ppm (2 S, (CH3)2 C).

[486]

NMR n° 72 - ; ~

[487]

1H at 8.70 ppm (D, J = 9 Hz, CO NH) - 2H at 7.95 ppm (D, J ≈ 8 Hz, H Ar 2', 6') - 2H at 7.67 ppm (D, J = 8 Hz, H Ar 3', 5') - 1H at 6.95 ppm (S, H thiazol) - 1H at 6.00 35 ppm (D of D, Jx = 9 Hz, J2 = 4 Hz, H7) - 1H at 5.45 ppm (D, J = 13 Hz, CHg 0 CO) - 1H at 5.00 ppm (D, J = 4 Hz, H6) - 1H at 4.82 ppm (D, J = 13 Hz, CH2 O CO) - 2H at 4.16ppm (M, Ar CH2 NHCH3) - 1H at 4.08 ppm (D, J = 17 Hz, CH2 SO) - 1H at 3.78 ppm (D, J = 17 Hz, CH2 SO) 3H at 2.43 ppm (S, CH3 N) - 6H at 1.48 ppm (2 S, (CH3)2 C) .

[488]

5 NMR n° 73 - fb):

[489]

1H at 8.70 ppm (D, J = 9 Hz, CO NH) - 2H at 7.95 ppm (D, J = 8 Hz, H Ar 2', 6') - 2H at 7.67 ppm (D, J = 8 Hz, H Ar 3', 5') - 1H at 6.92 ppm (S, H thiazol) - 1H at 6.00 ppm (D of D, J·L = 9 Hz, J2 = 4 Hz, H7) - 1H at 5.43 ppm 10 (D, J = 13 HZ, CH2 O CO) - 1H at 5.00 ppm (D, J = 4 Hz, H6) - 1H at 4.82 ppm (D, J = 13 Hz, CH2 O CO) - 2H at 4.18 ppm (M, CH^ Ar) - 1H at 4.10 ppm (d7 J = 17 Hz, CHg SO) - 1H at 3.76 ppm (D, J = 17 Hz, CH2 SO) - 2H at 2.90 ppm (M, CH3 CH^ NH) - 6H at 1.47 ppm (2 S, (CH3)2 C)15 3H at 1.16 ppm (T, J = 7 Hz, CH3 CH2). ~

[490]

NMR n* 74 - fbΐ:

[491]

1H at 8.70 ppm (D, J = 9 Hz, CO NH) - 2H at 7.95 ppm (D, J = 8 Hz, H Ar 2', 6') - 2H at 7.67 ppm (D, J = 8 Hz, H Ar 3', 5') - 1H at 6.95 ppm (S, H thiazol) - 1H at 6.00 20 ppm (D of D, = 9 Hz, J2 = 4 Hz, H7) - 1H at 5.45 ppm (D, J = 13 Hz, CHg O CO) - 1H at 5.00 ppm (D, J = 4 Hz, Hg) - 1H at 4.82 ppm (D, J ≈ 14 Hz, CH2 O CO) - 2H at 4.16ppm (M, Ar CH2 N Pr) - 1H at 4.08~ ppm (D, J = 17 Hz, CH2 SO) - 1H at” 3.78 ppm (D, J ≈ 17 Hz, CH2 SO) 25 1H at 3.20 ppm (M, NH-CJJ (CH3)2) - 6H at 1.41 ppm (2S, (CH3)2 C) - 6H at 1.26 ppm (57 J = 7 Hz, (CH3)2 CH).

[492]

NMR~n° 75 r (b) :

[493]

1H at 8.62 ppm (D, J ≈ 9 Hz, CO NH) - 3H at 8.10 ppm (Sa., CH2 t®K3) - 1H at 7.68 ppm (D, J = 7 Hz, H Ar 6') 30 - 1H at 7.55 ppm (D, J ≈ 7 Hz, H Ar 4') - 1H at 7.34 ppm (T, J ≈ 7 Hz, H Ar 5#) - 1H at 6.92 ppm (S, H thiazol)1H at 6.00 ppm (D of D, ≈ 9 Hz, J2 = 4 Hz, H7) - 1H at 5.37 ppm (D, J ≈ 13 Hz, CH2 0 CO) - 1H at 5.00 ppm (D, J = 4 Hz, H6) - 1H at 4.84 ppm (D, J = 13 Hz, CH2 O 35 CO) - 3H at 4.10 ppm (M, CH2 *Aï3 et CH2 SO) - 1H at 3.75 ppm (D, J = 17 Hz, CH2 SO) - 3H at 2.40 ppm (S, CH3 Ar) - 6H at 1.47 ppm (2S, TcH3)2 C).

[494]

NMR n° 76 - (b3:

[495]

1H at 8.62 ppm (D, J = 9 Hz, CO NH) - 3H at 8.00 ppm (Se., CH2 - 1H at 7.31 ppm (D, J ≈ 7 Hz, H Ar 4') 5 - 1H at 7.14 ppm (D, J ≈ 7 Hz, H Ar 5') - 1H at 6.90 ppm (S, H thiazol) - 1H at 6.00 ppm (D of D, = 9 Hz, J2 = 4 Hz, Hy) - 1H at 5.27 ppm (D, J = 13 Hz, CH2 O CO) - 1H at 5.00 ppm (D, J = 4 Hz, H6) - 1H at 4.92 ppm (D, J = 13 Hz, CH2 O CO) ~ 3H at 4.00 ppm (M, CH2 lfàï3 et CH2 10 SO) - 1H at 3.64 ppm (D, J = 17 Hz, CH2 SO) - 6H at 2.18 ppm (S, CH3 - Ar) - 6H at 1.48 ppm (2 S, (CH3)2 C).

[496]

NMR n° 77 (b3:

[497]

1H at 8.65 ppm (D, J = 9 Hz, CO NH) - 3H at 7.90 ppm (Se. , CH2 îAî^) - 1H at 7.00 ppm (S, H Ar) - 1H at 6.90 15 ppm (S, H thiazol) - 1H at 6.00 ppm (D of D, = 9 Hz, J2 = 4 Hz, H7) - 1H at 5.25 ppm (D, J = 13 Hz, CH2 O CO)

[498]

- 1H at 5.00 ppm (D, J - 4 Hz, Hg) - 1H at 4.92 ppm (D, J = 13 Hz, CH2 O CO) - 3H at 4.00 ppm (M, Ar CH2 *Φh3 and CH2 SO) - 1H at 3.65 ppm (D, J = 17 Hz, CH2 SO) - 3H 20 at 2.31 ppm (S, CH3 Ar) - 3H at 2.25 ppm (sT CH3 Ar)3H at 2.14 ppm (S, CH3 Ar) 6H at 1.45 ppm (2S, (CH3)2 C) . “

[499]

7.8_,.r_(.b,).:

[500]

1H at 8.70 ppm (D, J =< 9 Hz, CO NH) - 3H at 8.00 ppm 25 (Se., CH2 N+H3) - 1H at 7.45 ppm (D, J ≈ 7 Hz, H Ar 4')

[501]

- 2H at 6.92 ppm (M, H thiazol and g Ar 5') - 1H at 6.00 ppm (D of D, Ji ≈ 9 Hz, J2 = 4 Hz, H7) - 1H at 5.42 ppm (D, J ≈ 13 Hz, CH^ 0 CO) - 1H at 5.00 ppm (D, J = 4 Hz, Hg) - 1H at 4.84 ppm (D, J = 13 Hz, CH2 O CO) - 3H at 30 3.95 ppm (M, CH2ΐβa3 and CH2 SO) - 3H at 3.78 ppm (S, O CH3) - 3H at 3.73 ppm (S, 0~CH3) - 1H at 3.58 ppm (D, J ≈ 17 Hz, CH2 SO) - 6H at 1.47 ppm (2 S, (CH3)2 C).

[502]

NMK n° 79 - (b) :

[503]

1H at8.62 ppm (D, J = 9 Hz, CO NH) - 5H at8,00 ppm (M, CH^ i^r^and H Ar 2', 6')1H at 7.20 ppm (D, J = 7 Hz, H Ar 51) - 1H at6.95 ppm (S, H thiazol ) -

[504]

1H at 6,00 ppm (D of D, Jj = 9 Hz, J2 = 4 Hz, H?) - l·H at 5.45 ppm (0, J = 13 Hz 5 CH2 0 CO) - 1H at 5 00 ppm (D, J = 4 Hz, Hg) - lHat4.82 ppm (D, J =» 13 Hz,

[505]

CH2 0 CO) - 3H at 4.00 ppm (M, CH2 N^and CH2 SO) - 3H at 3 .88 ppm (S, 0 CH3) 1H at3.72 ppm (D, J = 17 Hz, CH2 SO) - 3Hat 1.48 ppm (S, (CH3)2 C) -

[506]

3H at 1.47 ppm (S, (CH^)2 C)

[507]

NMR n° 80 - (B) :

[508]

10 1H at 8.66 ppm (D, J = 9 Hz, CO NH) - 3H ats.05 ppm (Se., CH2 N®H3) -

[509]

3H at 7,50 ppm (M, ji Ar) - 1H at 6.95 ppm (S, H thiazol) - 1H at 6,00 ppm

[510]

(D of D = 9 Hz, J2 = 4 Hz, H?) - 1H at5.45 ppm (D, J = 13 Hz, CH2 0 CO) 1H atδ.OO ppm (D, J = 4 Hz, Hg) - lHat 4.84 ppm (D, J ≈ 13 Hz, CH2 0 CO) 3H at4.00 ppm (M, CH2 et CH2 SO) - 3H at3,86 ppm (S, CH30 - Ar) ~

[511]

IS 1H at3.75 ppm (D, J = 17 Hz, Cli, SO) - 3H at 1,48 ppm (S, (CH3)2 C) -

[512]

3H at 1.47 ppm (S, (CH3)2 C)

[513]

20

[514]

25

[515]

NMR n° 81 - (b) :

[516]

1H at 8.82 ppm (D, J ≈ 9 Hz, CO NH) - 3H at 8.20 ppm (Se., CH N^3) -

[517]

1H at 8.13 ppm (Se., H Ar 2') - 1H at7.95 ppm (D, 0 = 7 Hz, H Ar 6') -

[518]

1H at7.69 ppm (D, J = 7 Hz, H Ar 4') - 1H at 7.55 ppm. (T, J = 7 Hz, H Ar 5') 1H at 6.95 ppm (S, H_ thiazol) - 1H à 6.00 ppm (D of D, ≈ 9 Hz, J2 = 4 Hz, Hy) - 1H at 5.48 ppm (D, J = 13 Hz, CH2 0 CO) - 1H at 5.00 ppm (D, J = 4 Hz, Hg) 1H at 4.86 ppm (D, J = 13 Hz, CH 0 CO) - 3Hat4.05 ppm (M, CH2 N®H3 and

[519]

CH2 SO) - 1H at 3.75 ppm (D, 0 ≈ 17 Hz, CH2 SO) - 4H at 2.40 ppm

[520]

• CH,

[521]

(M, CH;

[522]

■ 0)

[523]

cΐn

[524]

2H at 1.90 ppm (M, t-j 0)

[525]

CO

[526]

10

[527]

15

[528]

20

[529]

1H at 8.82 ppm (D, J = 9 Hz, CO NJJ) - 3Hat8.20 ppm (Se., CH2 ^3) -

[530]

2H at 7.80 ppm (M, H Ar 2' , 6') - lHat 7.45ppm (D, J ≈ 7 Hz, H Ar 5') -

[531]

1H at 6.92 ppm (S, H thiazol) - 1H à 5.97 ppm (D of D, J1 = 9 Hz, J2 = 4 Hz, H?) - 1H at 5.45 ppm (0, J ≈ 13 Hz, CH2 0 CO) - 1H at 5.00 ppm (D, J = 4 Hz, Hg) 1H at 4 .82 ppm (D, J = 13 Hz, CH2 0 CO) - 3Hat 4.05 ppm (M, CH2 fF^and CH2 SO) -

[532]

|-CH2

[533]

1H at3.75 ppm (0, J = 17 Hz, CH2 SO) - 4H at2·40 ppm (M, CH2-j-- 0) "

[534]

“ “CO

[535]

ch2-

[536]

3H at2 .34 ppm (S, CH^ Ar) - 2H at 1,90 ppm (M, t 0)

[537]

“ CO

[538]

NMRΠ° 83 - (b) :

[539]

1H at8.97 ppm (D, 0 ≈ 9 Hz, CO NH) - 2Hat 8.79 ppm (Se., CH2 N^2) -

[540]

2H atδ.OO ppm (D, J = 8 Hz, JJ.Ar 2' , 5') - 2Hat 7.58 ppm (D, J = 8 Hz,

[541]

JH Ar 3', 5') - 1H at6 95 ppm (S, JJ thiazol) - lHat 5.97 ppm (D of D,

[542]

J1 = 9 Hz, J2 = 4 Hz, H7) - 1H at 5.45 ppm (D, J ≈ 13 Hz, CH2 0 CO) -

[543]

1H atδ.OO ppm (D, J = 4 Hz, Hg) - lHat 4.84 ppm (0, J = 13 Hz, CH2 0 CO) -

[544]

2H at 4,19 ppm' (M, CH2U%2 - CH3) - lHat 4.08 ppm (D, J = 17 Hz, CHg SO) lHat 3.75 ppm (0, J ≈ 17 Hz, CH2 SO) - 3H at 2.50 ppm (M, CH2 ^2 - CH3) -

[545]

CH,

[546]

4H at 2.40 ppm (M, CHg ■

[547]

NMRn0 84 (b) :

[548]

0) - '2Hat 1.90 ppm (M,

[549]

Cl-L-

[550]

.0)

[551]

CO

[552]

CO

[553]

25 1Hat 10.7 ppm (S, CO NH Ar) - 1H atδ.60 ppm (D, J = 9 Hz, CO NJJ) -

[554]

1H at 8.20 ppm (S, H Ar 2') - 1H at 7.80 ppm (D,J≈8Hz,HAr6')~

[555]

3 “

[556]

3H at 7.65 ppm (Se., CH2 N+H ) - 1H at7.60 ppm (D, J = 8 Hz, JJ Ar 41) -

[557]

lHat 7.45 ppm (T, J = 8 Hz, JJ Ar 51) - 1H at℮.92 ppm (S, JJ thiazol) -

[558]

lHat 6,00 ppm (D of D, = 9 Hz, J2 = 4 Hz, H?) - lHat 5.45 ppm (D, J = 13 Hz, 30 CH2 0 CO) - lHat 5,00 ppm (D, J = 4 Hz, Hg) - lHat 4.84 ppm (0, J = 13 Hz,

[559]

CH2 0 CO) - 1H at 4.00 ppm (D, J = 17 Hz, CH2 SO) - lHat 3.75 ppm (D, J = 17 Hz, CH2 SO) - 2H at 3.05 ppm (Q, J = 7 Hz, CH2 CH2 N^3) - 2Hat2.70 ppm (T, J = 7 Hz, CH2 CH2 f^H3) - 6H at 1,47 ppm (2 S, (CH3)2 C)

[560]

[561]

S 1H at 4.98 ppm (D, J ≈ 4 Hz, Hg) - 1H at 4.78ppm (D, J = 13 Hz, CH2 0 CO) -

[562]

10 3H at 8.07 ppm (Se., CH2 I'ftg) - 2Hat 7.94 ppm (0, J = 8 Hz, H Ar 2' 6') -

[563]

15 and CHg ^H3) - 6H at 1.48 ppm (2 S, (CH3)2 C)

[564]

20

[565]

25

[566]

5H at 1,85 ppm (M, 3H^ of the piperidine εnd

[567]

0) -

[568]

30

[569]

3H at 1.45 nnm (M, 3H piperidine)

[570]

5 10 IS 20 25 îJMR ∩° 88 - (b) :

[571]

lHat 8,80 ppm (D, J = 9 Hz, CO N_H) - 1H at 8.60 ppm (Se., ΐ^l2 P “· pé>”i dine) 1H at 8.45 ppm (Se., I^2 piperidine) - 2Hat7.25 ppm (Se., NH2 thiazol ) 1H at 6,79 ppm (S, H thiazol) - 1H at 6.00 ppm (Dot D, = 9 Hz, J2 ≈ 4 Hz, Hy) - 1H at 5.16 ppm (D, J = 13 Hz, CH2 0 CO) - lHat 5.00 ppm (D, J = 4 Hz, Hg) - 1H at 4.69 ppm (D, 0 = 13 Hz, CH2 0 CO) - lHat 3.90 ppm (D, J = 17 Hz, CH2 SO) - 1H at3.60 ppm (D, J * 17 Hz, CH2 SO) - 2Hat 3.24 ppm (M, CH2 in

[572]

of ΐ^2 piperidine) - 2H at2.70 ppm (M, CH2 in o< of piperidine) -

[573]

r~ch

[574]

6Hat 2,40 ppm (M, CH2-ΐ-- 0 and CH2 C00) - 6Hbetweenl.5 and 2.2 ppm

[575]

” CO ■ ~

[576]

CH2-.

[577]

(M, t- 0 , CHI CHg C02 , 3H piperidine) - lHat 1.20 ppm (M, H piperidine) CO

[578]

NMR n° 89 - (b) :

[579]

lHat 8.80 ppm (D, J = 9 Hz, CO NH) - 2H at 8.30 ppm (2 Se., NH®piperidine) 2H at 7,40 ppm (Se., NHg thiazol ) - 1H at6,78 ppm (S, H thiazol ) -

[580]

lHat 5.92 ppm (D of 0, Jj = 9 Hz, J2 = 4 Hz, H?) - lHat 5.14 ppm (D, J = 13 Hz, CH2 0 CO) - lHat 4,96 ppm (D, J = 4 Hz, Hg) - lHat 4.60 ppm (D, J = 13 Hz, CH2 0 CO) - lHat 3.89 ppm (D, J = 17 Hz, CHg SO) - lHat 3.58.ppm (D, 0 = 17 Hz, CH2 SO) - 2H at 3,18 ppm (M, H N®k2 piperidine) - 2H at 2.81 ppm (M, H «<

[581]

CH

[582]

N H2 piperidine) - 4Hat 2.40 ppm (M, CH2-

[583]

0) - 2H at 2.28 ppm (0, J = 7 Hz,

[584]

CO

[585]

CH.

[586]

CH2 CO - 0) - 5Hat 1.90 ppm (M, ΐl 0, CH CH2 COO, 2H β piperidine) CO

[587]

2H at 1.30 ppm (M, 2H β Oz

[588]

piperidine)

[589]

1H at8 .45 ppm (D, J = 9 Hz, CO NH) - 1H at 8,50 ppm (Se., NH? piperidine) -

[590]

, © -

[591]

lHat8,20 ppm (Se., piperidine) - 2H at 7.30 ppm (Se., NH2 thiazol ) -

[592]

1H atδ.77 ppm (S, H thiazol ) - 1H 5.95 ppm (D of 0, J1 = 9 Hz, J2 = 4 Hz,

[593]

5 H?) - 1Hat 5.11 ppm (D, J = 13 Hz, CH2 0 CO) - 1H at4.95 ppm (D, J = 4 Hz,

[594]

Hg) - 1Hat 4.51 ppm (D, J = 13 Hz, CH2 0 CO) - lHat 3.89 ppm (D, J = 17 Hz, CH2 SO) - 1H at 3.58 ppm (D, J = 17 Hz, CH2 SO) - 2Hat 3.21 ppm (M, CHgancKX N^2 piperidine) - 2Hat2.81 ppm (M, CH2 in lf®H2 piperidine) - 2Hat 2.27 ppm (D, 0 = 7 Hz, CH2 COO) - lHat 1.95ppm (M, CH CH2 COO) - 2H at 1.75 ppm

[595]

10 (M, CH2β ^2 piperidine) - 6H at 1.47 ppm (2 S, (CH3)2 C) -

[596]

2H at 1,40 ppm (M, CH2β N+H2 piperidine)

[597]

NMR n° 91 - (b) :

[598]

2H at 8.70 ppm (Se., CHgl^CH-j") - 1H at 8.50 ppm (D, J = 9 Hz, CONH) -

[599]

1H at 8.10 ppm (Se., H Ar 2 ' ) - 1H at 7.96 ppm (D, J = 8 Hz, Ji ar 6' ) -

[600]

15 1H at7.75 ppm (D, J ≈ 8 Hz, H Ar 4' ) - 1H at 7.56 ppm (T, J = 8 Hz, H ar 5') 1H at6,92 ppm (S, H thiazol ) - 1H cit6.00 ppm (D of D, = 9 Hz, J2 = 4 Hz, H?) - lHat 5.45 ppm (0, ϋ ≈ 13 Hz, CH2 0 CO) - lHats.oo ppm (D, J = 4 Hz, Hg) 1H at4.87 ppm (D, J = 13 Hz, CH2 0 CO) - 2H at 4.16 ppm (M, Ar CHgAgCHg) 1H at4.05 ppm (D, J = 17 Hz, CHg 'SO) - lHat 3.75 ppm (D, J = 17 Hz, CH2 SO) 20 3H at 2.50 ppm (M, CH3 N^2 CH) - 6H at 1.45 ppm (2 S, (CH3)2 C)

[601]

NMR n° 92 - (b) :

[602]

2H at8.70 ppm (Se., CHg ^ CH2CH3) - 1H at8.60 ppm (0, J = 9 Hz, CO NH) 1H atδ.10 ppm (Se., H Ar 2') - 1H at7.96 ppm (D, J = 8 Hz, H Ar 6') -

[603]

1H at 7,75 ppm (D, J = 8 Hz, H Ar 4') - 1H at7.56 ppm (T, J = 8 Hz, H Ar 5’) 25 1H at 6,92 ppm (S, H_ thiazol ) - lHat 5.02 ppm (D of D, = 9 Hz, J2 ≈ 4 Hz, Hy) lHat 5.45 ppm (0, J * 13 Hz, CH2 0 CO) -‘lHat 5.00 ppm (D, J = 4 Hz, Hg) lHat 4.87 ppm (0, J = 13 Hz, CH2 0 CO) - 2H at 4.17 ppm (Se., Ar, CH2 Et) 1H at4.05 ppm (D, J = 17 Hz, CH2 SO) - 1H at3.75 ppm (D, J » 17 Hz, CH2 SO) 2H at2.95 ppm (M, CH3CH2 l^2) - 6H atl.45 ppm (2 S, (CH3)2 C) -

[604]

.30 3H at 1.15 ppm (T, J ≈ 7 Hz, CH^rPk,)

[605]

NMR n° 93 (b) ;

[606]

1H at8.75 ppm (D, J ≈ 9 Hz, CO NH) - 2H ate.70 ppm (Se., CH2 ^-i Pr) 1H at8.10 ppm (Se., H Ar 2') - 7.95 ppm (D, J = 8 Hz, ή Ar 6') -

[607]

1Hat7.75 ppm (D, J = 8 Hz, H_ Ar 4') - lHat 7.58 ppm (T, J = 8 Hz, _H Ar

[608]

5 5' ) - 1H at7.00 ppm (S, H thiazol ) - lHat 6.00 ppm (D of D, Jχ= 9 Hz, J2 = 4 Hz, H7) - 1H at 5.46 ppm (D, J = 13 Hz, CH2 0 CO) - lHatδ.OO ppm (D, 0 = 4 Hz, Hg) - lHat4.87 ppm (D, J = 13 Hz, CH2 0 CO) - 2Hat4.19 ppm (M, Ar CH2 #h2 i Pr) - lHat 4.05 ppm (D, J = 17 Hz, CH2 SO) -

[609]

1H at3.79 ppm (D, 0 ≈ 17 Hz, CH2 SO) - lHat 3.31 ppm (M, (CH3)2“CH) -

[610]

10 6H atl.45 ppm (2S, (CH3)2 C) - 6Hnt 1.22 ppm (D, J = 7 Hz, (CH3)2 CH ^H) -

[611]

15

[612]

20

[613]

NMK ∩° 94 - (b) :

[614]

1Hat8.90 pprn (D, J =* 9 Hz, CO NH) - 3Hat 8.10 ppm (Se., CH2 N®H3) -

[615]

1H at7.66 ppm (D, J = 8 Hz, H Ar 6') - lHat 7.55 ppm (D, J = 8 Hz, H Ar 4') - 1H at7.45 ppm (T, J = 8 Hz, H Ar 5') - lHat 6.95 ppm (S, H thiazol) 1H at6.00 ppm (0 of D, = 9 Hz, J2 ≈ 4 Hz, Hy) - 1H at5.40 ppm (D,

[616]

J » 13 Hz, CH2 0 CO) - lHat 5.00 ppm (D, J = 4 Hz, Hg) - 1H at4.86 ppm (D, 0 * 13 Hz, CH2 0 CO) - 3H at 4.07 ppm (M, Ar CH ^and CH2 SO) -

[617]

1H at3.67 ppm (D, J = 17 Hz^ CH2 SO) - 3Hat 2.40 ppm (S, CH3 Ar) -

[618]

4H at2.50 ppm (M,

[619]

CH

[620]

-CH.

[621]

) - 2H at 1.90 ppm (M,Clj12

[622]

-0

[623]

) -

[624]

CO

[625]

CO

NMR n° 95 - (b) :

[626]

1H at 8.90 pprn (D, J = 9 Hz, CO NH) - 3Hat 8.05 ppm (Se., CH2 iN®h3) -

[627]

1H at 7,40 ppm (D, J = 8 Hz, H A r 4') - lHat7.20 ppm (D, J = 8 Hz, H

[628]

Ar 51 ) - lHat 6.95 ppm (S, H thiazol ) - lHat 6.00 ppm (D of D, J1 = 9 Hz, J2 = 4 Hz, H?) - 1H at5.30 ppm (D, J = 13 Hz, CH2 0 CO) -

[629]

1H at 5.00 ppm (D, J = 4 Hz, Hg) - lHat 4.95 ppm (D, J = 13 Hz, CH2 0 CO) 3H at 4.00 ppm (Ar CH2 N®^3 et CH2S0) - lHat3.63 ppm (D, 0 = 17 Hz, CH2 S0)

[630]

4Hat2.40 ppm (M,

[631]

_CH

[632]

2 ) - 6H at2.20 ppm (S, CH3 Ar) -

[633]

CH

[634]

2H at 1.90 ppm (M,CH2'

[635]

il

[636]

C0

[637]

C0

[638]

NMR∩° 96 - (b) :

[639]

1H at8.90 ppm (D, 0 = 9 Hz, C0 MH) - 3Hat7.90 ppm (Se., CH2 ^3) -

[640]

1H at7.00 ppm (S, H_ Ar) - 1H a.t6.9 ppm (S, H_ thiazol ) - lHat6.00 ppm (D of D, J1 = 9 Hz, J2 = 4 Hz, H?) - lHat 5.30 ppm (D, J = 13 Hz, CH2 0 C0) 1H at5.00 ppm (D, 0 = 4 Hz, Hg) - lHat4.94 ppm (D, J = 13Hz, CH2 0 C0) 3H at4.00 ppm (M, Ar CH2 et CH2 S0) - lHat 3.62 ppm (0, J = 17 Hz,

[641]

] ™2

[642]

CH2 SO) - 4H at 2.50 ppm (M, CHg-ψ-0) - 3Hat2.32 ppm (S, CH3 Ar) __ “ CO ~

[643]

3H at2.2 ppm (S, CH3 Ar) ~ 3H at2.1β ppm (S, CH3Ar) - 2Hat 1.90 ppm

[644]

NM R ∩° 97 - (b) :

[645]

lHat 10.30 ppm (S, Ar NH CO) - 1H at8.70 ppm ( D, J = 9 Hz, CO NH) -

[646]

lHat 8.30 pprn (Se., H Ar 2') - 3H at8.05 ppm (M, CH2 N®H3) -

[647]

2Hai 7.70 ppm (M, H Ar 5' , 6' ) - 1H atδ.95 ppm (S, H_ thiazol ) -

[648]

5 1Hat 6.00 ppm (Dof 0, J1 = 9 Hz, J2 = 4 Hz, H?) - 1H at5.45 ppm (D, J = 13 Hz, CH2 0 CO) - lHat 4.97 ppm (D, J = 4 Hz, Hg) - lHat4.80 ppm (D, J ≈ 13 Hz, CH2 0 CO) - 1H aΐ4.03 ppm (D, J = 17 Hz, CH2 SO) - 2H at 3.85 ppm (M,

[649]

CH2 îβ^) - lHat3.75 ppm (D, J ≈ 17 Hz, CH2 SO) - 5H at 1.47 ppm (2S, (CH3)2 C) -

[650]

NMR π° 98 - (b) :

[651]

10 lHat 9.90 ppm (S, Ar NH CO) - lHat8.65 ppm (D, 0 ≈ 9 Hz, CO NH) -

[652]

lHat 8.28 ppm (S, H Ar 2') - 5Hat 7.70 ppm (M, H Ar 5' , 5' at CH2 iPh3) lHat 6.95 ppm (S, H thiazol ) '− lHat 6. 00 ppm (D of D, ≈ 9 Hz, J2 = 4 Hz, H?) - 1H at5,45 ppm (0, J ≈ 13 Hz, CHλ, 0 C0) - lHat5.00 ppm (D, J = 4 Hz, H) - 1H at4.84 ppm (D, J ≈ 13 Hz, CH2 0 C0) - lHat4.03 ppm (0, J = 17 Hz,

[653]

15 CH? SO) - 1H at3.68 ppm (D, 0 = 17 Hz, CH? SO) - 2H at3.05 ppm (M, - C - CH?

[654]

- - 0e CH2 N®H3) - 2H at.2.75 ppm (T, J = 7 Hz, - C -CHg CH2 N®H3) -

[655]

6Hat 1.46 ppm (2 S, (CH3)2 C)

[656]

NMRπ° 99 - (b) :

[657]

lHat 10.5 ppm (S, Ar NH CO) - lHat8.56 ppm (D, J = 9 Hz, CO NH) -

[658]

20 2Hat 7.89 ppm (D, 0 = 8 Hz, H Ar 21, 6’) - 2Hat7.70 ppm (D, J = 8 Hz,

[659]

H Ar 3’, 5') - 3H at7.70 ppm (Se., (CH2)2 lφf3) - lHat6.95 ppm (S, H

[660]

thiazol ) - 1Hat5.98 ppm (D of D, = 9 Hz, J2 = 4 Hz, H^) -

[661]

1H at5.40 ppm (D, J = 13 Hz, CH2 0 CO) - 1H at4.98 ppm (D, 0 = 4 Hz, Hg) 1H at4.79 ppm (D, J ≈ 13 Hz, CH2 0 CO) - lHat4.05 ppm (D, J = 17 Hz, CH2 SO) -

[662]

25 1H at3.75 ppm (D, J = 17 Hz, CH2 SO) - 2H at3.06 ppm (M, -C-CHg CH£ f^3)

[663]

(!

[664]

2Hat 2.70 ppm (M, -C-CH2 CH fβi3) - 6Hatl.45 ppm (2S, (CH3)2 C)

[665]

0

[666]

NM R ∩° 100 - (b) :

[667]

1H at 12 ,75 ppm (Se., thiazol NH CO) - lHat8.90 ppm (D, 0 = 9 Hz, CO NH) 4Hat8.15 ppm (M, CH^ NH^andjl thiazol in 3) - lHat6,96 ppm (S, _H thiazol ) 1Hat 5.00 ppm (D of D, = 9 Hz, J2 ≈ 4 Hz, H?) - lHat5.40 ppm (D, J = 13 Hz, CH2 0 CO) - 1H at 4,98 ppm (D, J = 4 Hz, Hg) - 1H at4,81 ppm (D, J ≈ 13 Hz, CH2 0 CO) - 1Hat4.0 ppm (D, J = 17 Hz, CH2 SO) - 2Hat3.86 ppm (M, CH N^3) -

[668]

CH,

[669]

1H at3.66 ppm (D, J = 17 Hz, CH SO) - 4Hat2.5 ppm (M, CHg.

[670]

CH„-

[671]

.0) -

[672]

2H at 1.90 ppm (M, Ll.

[673]

CO

[674]

.0)

[675]

CO

[676]

NM R n° 101 - (b) :

[677]

1H at 10.8 ppm (S, Ar NH CO) - lHat 8.95 ppm (D, J = 9 Hz, CO NH) -

[678]

3H at8.15 ppm (Se., C»2 1^3) - 2Hat7.90 ppm (0, J ≈ 8 Hz, H Ar 2’, 5') -

[679]

2H at 7 .70 ppm (D, J = 8 Hz, H_ Ar 3', 5' ) - 1H at6.97 ppm (S, H_ thiazol ) lHat 6.00 ppm (D of D, ≈ 9 Hz, J2 = 4 Hz, H-,) - lHat5.36 ppm (D, J = 13 Hz, CH2 0 CO) - lHatδ.OO ppm (D, J = 4 Hz, Hg) - 1H at4.82 ppm (D, J = 13 Hz, CH2 0 CO) - lHat4.05 ppm (D, J = 17 Hz, CH2 SO) - 3H at3.80 ppm (M, CH2 #k3

[680]

CH

[681]

antlCHg SO) - 4H at2.40 ppm (M, CHg

[682]

.0) - 2H at 1.90 ppm (M,

[683]

,0)

[684]

CO

[685]

CO NMR∩° 102 - (b) :

[686]

lHat 8,45 ppm (0, J = 9 Hz, CO NH) - 3Hat8.0 ppm (Se., CH2 ^3) -

[687]

1H at6.79 ppm (S, H thiazol ) - 1H at5.98 ppm (D of D, = 9 Hz, J2 = 4 Hz, H7) - 1H at5.15 ppm (2 D, J = 13 Hz, CH2 0 CO)

[688]

1H at4,97 ppm (0, J = 4 Hz, Hg) - 11^62 ppm (D, J = 13 Hz, CHg 0 CO) -

[689]

1H at4.15 ppm (De., J = 12 Hz, H^Eq piperidine) - 3H at 3.84 ppm (M, CH2.1^3 andCH2 SO) - 2Hat 3.58 ppm (M, CH2 SO andHg Eq piperidine) - 1Hat3.05 ppm (Te., J = 12 Hz. H,, 4x piperidine) - 1H at2,Sl ppm (Te., J ≈ 12 Hz, Hg Ax piperidine) - lHat2.50 ppm (M, CH C02) - 2H atl.84 ppm (M, H3andHg piperidine) 2Hatl.50 ppm (M, H3 and Hg piperidine) - 6Hat 1.45 ppm (2 0, (CH3)2 C)

[690]

NMR∩° 103 - (b) :

[691]

1H at 8.72 ppm (D J = 9 Hz, CO NH) - 3Hat8.25 ppm (Se., CH2 N®H3) -

[692]

3H at 7.75 ppm (M, _H Ar) - 1H at 6,97 ppm (S, H thiazol ) -

[693]

1H at6.00 ppm (D of D, ^ = 9 Hz, J2 » 4 Hz, H?) - lHat5.45 ppm (D,

[694]

J = 13 Hz, CH2 0 CO) - 1Hat5.00 ppm (D, J = 4 Hz, Hg) -

[695]

1H at4.84 ppm (D, J ≈ 13 Hz, CH2 0 CO) - 3Hat4.05 ppm (M, CH2 N^and

[696]

CH2 SO) - 1H at3.75 ppm (D, J ≈ 17 Hz, CH2 SO) - 6Hatl.45 ppm (2S,

[697]

(ch3)2 C) -

[698]

NMR n° 104 - (b) :

[699]

2H at8,80 ppm (Se., CHg ^2 GH3) - lHat8.77 ppm (D, J = 9 Hz, CO NH) -

[700]

3H at7.75 ppm (M, H Ar) - lHat6.95 ppm (S, H thiazo.l ) - lHatβ.OO ppm

[701]

(D of D, = 9 Hz, J2 = 4 Hz, H?) - 1Hat5.45 ppm (D, J = 13 Hz, CH2 0 CO) 1H at5,00 ppm (D, J ≈ 4 Hz, Hg) - 1H at4.8δ ppm (D, J ≈ 13 Hz, CH 0 CO) 2H at4.25 ppm (M, CH2 I'ftlg CH3) - 1H at4.10 ppm (D, J = 17 Hz, CH2 SO) -

[702]

1H at3,74 ppm (D, J ≈ 17 Hz, CH2 SO) - 3Hat2.58 ppm (M, CH2 ^H2 - CH3) 6H at 1.45 ppm (2 S, (CH3)2 C)

[703]

NMRn° 105 - (b) :

[704]

1H at 10.70 ppm (S, Ar NH CO) - 2Hat8.70 ppm (Se., CH2 #k2 CH3) -

[705]

1H at8.68 ppm '(0, J ≈ 9 Hz, CO NH) - 1H at8.16 ppm (S, H Ar 2’) -

[706]

1H at7,92 ppm (D, J = 8 Hz, H Ar 6') - lHat7.66 ppm (D, J = 8 Hz, H Ar 4') 1H at7.50 ppm (T, 0 = 8 Hz, H Ar 51 ) - lHat6.95 ppm (S, H thiazol ) lHatβ.OO ppm (Dof D, Jχ = 9 Hz, J2 = 4 Hz, Hy) - lHat5.45 ppm (D, J = 13 Hz CH2 0 CO) - lHat 5.00 ppm (D, 0 = 4 Hz, Hg). - lHat4.82 ppm (D, 0 = 13 Hz, CH2 0 CO) - 1H at4,02 ppm (D, J = 17 Hz, CH2 SO) - 2Hat 3.90 ppm (M, CH2 CH3) - 1H at 3.74 ppm (D, J = 17 Hz, CH2 SO) - 3Hat2.60 ppm (M, CH2 i^H2 CH3) 6Hat 1.45 ppm (2 S, (CH3)2 C)

[707]

NMR° 106 - (b) :

[708]

1H at 10,80 ppm (S, A r NH CO) - 3Hat8.70 ppm (M, CHg N^gtCHj et CO NH) 2Hat7.92 ppm (0, J = 8 Hz, H Ar 2', 6') - 2H at7.69 ppm (D, J = 8 Hz,

[709]

H. Ar 3' , 5' ) - 1Hat6.95 ppm (S, H_ thiazol ) - lHat 6.00 ppm (D of D,

[710]

= 9 Hz, 02 ≈ 4 Hz, H?) - 1H at5,42 ppm (D, J = 13 Hz, CH 0 CO) -

[711]

lHat 5.00 ppm (D, J = 4 Hz, Hg) - 1H at4.81 ppm (D, J = 13 Hz, CH2 0 CO) lHat 4.05 ppm (D, J = 17 Hz, CH2 SO) - 2H at3.95 ppm (M, CH2 N®H2 CH3) lHat 3.75 ppm (D, J = 17 Hz, CH2 SO) - 3H at 2.62 ppm (M, CH2 ^ CH3) 6Hat 1.45 ppm (2S, (CH3)2 C) -

[712]

NMRn0 107 - (b) :

[713]

1H atg.95 ppm (S, Ar NH CO) - 1H ate.75 ppm (D, J = 9 Hz, CO NH) -

[714]

3H at8.05 ppm (Se., CH2 N%3)'- lHat 7.61 ppm (D, J = 8 Hz, H Ar 6‘ ) -

[715]

1H at7.52 ppm (D, J = 8 Hz, H_ Ar 4‘ ) - 1H at7.31 ppm (T, J = 8 Hz, H_ Ar 61 )-1H at6.96 ppm (S, H_ thiazol ) ~ lHaΐδ.OO ppm (Dof D, = 9 Hz, J2 = 4 Hz, H7) - lHat 5.40 ppm (0, J ≈ 13 Hz, CH2 0 CO) - lHat 5.00 ppm (D, J = 4 Hz, H) - lHat4.81 ppm (D, J ≈ 13 Hz, CH2 0 CO) - lHat 4.05 ppm (D, J = 17 Hz, CH2 SO) - 2H at3,81 ppm (M, CHg iβy - 1H at3.72 ppm (D, 0 ≈ 17 Hz, CH2 SO) 3H at2.28 ppm (S, Ar CH3) - 6H at 1.45 ppm (2S, (CH3)2 C) -

[716]

NMRΠ° 108 - (b) :

[717]

lHat9.75 ppm (S, Ar NH_ CO) - lHat8.70 ppm (D, J =9 Hz, CO NH_) -

[718]

3H at7,70 ppm (Se., CH2 CH2 !^H3) - lHat7.60 ppm (D, J = 8 Hz, _H Ar 6’) 1H at7.50 ppm (D, J = 8 Hz, H. Ar 41 ) - 1H at7.25 ppm (I, J = 8 Hz, JH Ar 51 ) 1H at6.95 ppm (S, H_ thiazol ) - 1H at6.00 ppm (D of D, = 9 Hz, J2 = 4 Hz, H?) - 1H at5.39 ppm (0, 0 = 13 Hz, CHg 0 CO) - 1H at5.00 ppm (D, J = 4 Hz, Hg) - lHat4.82 ppm (D, J = 13 Hz, CH 0 CO) - lHat 4.05 ppm (D, J = 17 Hz, CH2·S0) - 1H at3.72 ppm (D, J = 17 Hz, CH2 SO) - 2H at3.02 ppm (M, CH

[719]

CH2 ^3) - 2H at2.69 .ppm (T, J ≈ 7, CH2 CHg ^H3) - 3H at2.29 ppm (S, Ar CH3) 6H atl.45 ppm (2S, (CH3)2 C) -

[720]

NM R n° 109 - (b) :

[721]

5 10 15 20 25 30 1H at 12.7 ppm (Se., NJH CO thiazol ) - lHat8,79 ppm (D, J = 9 Hz, CO NJH) -

[722]

1H atδ.03 ppm (S, JH thiazol in 3) - 3H at7.75 ppm (Se., CH? I'Ph.,) ~

[723]

ppm

[724]

lHat.6,98 ppm (S, H thiazol ) - lHat6.00v(0 of D, = 9 Hz, J2 = 4 Hz,

[725]

Hy) - lHat5.37 ppm (D, J = 13 Hz CH^ 0 CO) - 1H atδ.OO ppm (D, J = 4 Hz,

[726]

Hg) - 1H at 4.81 ppm (D, J = 13 Hz, CHg 0 CO) - lHat4.03 ppm (D, J = 17 Hz, CH2 SO) - 1Hat3.68 ppm (D, J ≈ 17 Hz, CH, SO) - 2Hat3.06 ppm (M, CH2 CH2 i#H3) - 2Hat 2,77 ppm (T, J = 7 Hz, CH2 CH2 N®k3) - 6Hatl.45 ppm (2S't (CH3)2 C)

NMR ∩° 110 - (b) :

[727]

1Hat8.70 ppm (D, J ≈ 9 Hz, CO NH_) - 5Hat7.96 ppm (M, H Ar 2', 6' and

[728]

CH2 γ!®H3) - 2H at7.55 ppm (D, J = 8 Hz, H Ar 3' , 5') -

[729]

1H at6.95 ppm (S, JH thiazol )*- 1H atβ.OO ppm (D of C, vh≈ 9 Hz, Jg = 4 Hz, H7) - 1H at5.46 ppm (D, J = 13 Hz, CH2 0 CO) - 1Hat 4.99 ppm (D, j"≈ 4 Hz, Hg) - 1H at4,84 ppm (0, J = 13 Hz, CH2 0 CO) - lHat4.06 ppm (D, J = 17 Hz, CH2 SO) - IHat 3.74 ppm (D, J = 17 Hz, CH2 SO) - 2H at3.55 ppm (Se., CH2 ^l3) - 3H at 3.25 ppm (Se., N Ch'3) - 6Hatl.45 ppm (2S, (CH3)2 C)

[730]

NMR n° 111 - (b) :

[731]

IHat 10.5 ppm (Se:, Ar NJH CO) - IHat 8.95 ppm (D, J = 9 Hz, CO NJH) -

[732]

2H at 7.89 ppm (D, J = 8 Hz, H Ar 2', 6') - 2Hat7.71 ppm (D, J ≈ 8 Hz,

[733]

JH Ar 5' , 5' ) - 1H at6.96 ppm (S, JH thiazo ) - 1H at 5.98 ppm (D of D,

[734]

Jχ = 9 Hz, 02 * 4 Hz, H?) - 1H at5.42 ppm (D, J = 13 Hz, CH2 0 CO) -

[735]

1H at5.00 ppm (D, J = 4 Hz, Hg) - 1H at4.80 ppm (D, J ≈ 13 Hz, CH2 0 CO) 1H at4.05 ppm (D, J ≈ 17 Hz, CH2 SO) - lHat3.75 ppm (D, J = 17 Hz, CH2 SO) 2H at3.05 ppm (M, CH2 CH2 ^H3) - 2H at2.70 ppm (T, J = 7 Hz, CH2 CH2 ) I-^2

[736]

4H at 2.40 ppm (M, CH2

[737]

-0 )

[738]

CO

[739]

CH.

[740]

-0 )

[741]

CO

[742]

2H at 1.90 ppm (M,

[743]

NM R n° 112 - (b) :

[744]

1H at 8,80 ppm (D, J = 9 Hz, CO NH) - 3Hat7,go ppm (Se., CH2 |φ)3) -

[745]

1H at6.80 ppm (S, H thiazol ) - lHat5.95 ppm (D of d, J1 = 9 Hz, J2 = 4 Hz,h7) - 1H at5-17 ppm (2 D, J = 13 Hz, CH2 0 CO) - lHat4.96 ppm (D, J = 4 Hz, Hg) ~ lHa-t4.60 ppm (D, J = 13 Hz, CH2 0 CO) - 1H at4.18 ppm (M, H2℮ piperidine) 3H at3.90 ppm (M, CH2 I^H3andCH2 S0) - 2Hat3.58 ppm (M, CH2 S0 et H^e piperidine) - 1Hat3.06 ppm (M, H2a piperidine) - 1Hat 2.75 ppm (M, H,a piperidine) - lHat2.60 ppm (M, H^ piperidine) - 4H at2.40 ppm

[746]

0

[747]

(M, CH, CH2 CO) - 4H at 1.80 ppm et 2H 1.50 ppm ( ch2-i -CO et h3 et h5

[748]

piperidine)

NMR n° 113 - (b) :

[749]

lHat8.75 ppm (D, J ≈ 9 Hz, CO NH) - 3Hat8.40 ppm (Se., CH f^3) -

[750]

1H at8.13 ppm (S, H Ar 6') - lHatβ.OO ppm (D, J ≈ 8 Hz, H Ar 2') -

[751]

1H aΐ7.64 ppm (D, J = 8 Hz, H_ Ar 3') - 1H aΐ6.97 ppm (S, H_ thiazol ) lHatβ.OO ppm (D ofO, ^ ≈ 9 Hz, J2 => 4 Hz, H?) - 1H at5.45 ppm (D, J » 13 Hz, CH2 0 CO) - 1H at 5.00 ppm (D, J == 4 Hz, Hg) - 1H at4.86 ppm (D, J = 13 Hz, CH2 0 CO) - 2H at4.19 ppm (M, CH2 ^H3) - lHat4.10 ppm (D, J = 17 Hz, CH SO) 1H at3.76 ppm (D, J = 17 Hz, CH2 SO) - 6Hatl.45 ppm (2 S, (CH3)2 C)

[752]

NM R n° 114 - (b) :

[753]

1H at8.72 ppm (D, J = 9 Hz, CO NH) - 3Hat8.40 ppm (Se., CH2 lΦi3) -

[754]

2H at8.ll ppm (M, H Ar 2', 6’) - 1H at7.86 ppm (M, H Ar 3') -

[755]

1Hat6.99 ppm ( S, H thiazol ) - 1H atβ.Ol ppm (D ofO, = 9 Hz,

[756]

J2 = 4 Hz, H?) - 1H at5.46 ppm (D, J = 13 Hz, CH2 0 CO) -

[757]

lHat 5.00 ppm (D, J = 4 Hz, Hg) - lHat4.89 ppm (D, J = 13 Hz, CH2 0 CO) 2Hat4.18 ppm (M, CH2 tpHj) - lHat 4.06 ppm (D, J = 17 Hz, CH2 SO) lHat3.78 ppm (D, J = 17 Hz, CH2 SO) -,6Hatl.45 ppm (2S, (CH3)2 C) -

[758]

NMR ∩° 115 - (b) :

[759]

lHat 10.20 ppm (Se., Ar NH CO) - lHat8.70 ppm (D, J = 9 Hz, CO NH) -

[760]

1Hat 8.16 ppm (Se. , H Ar 2') - 1H at7.84 ppm (D, J = 8 Hz, H Ar 6') -

[761]

3Hat 7.66 ppm (Se. , CH2 rf^3) - lHat 7.60 ppm (D, J = 8 Hz, H Ar 4') -

[762]

S 1H at7,45 ppm (I, J = 8 Hz, _H Ar 5') - 1H at6.97 ppm (S, H thiazol ) -

[763]

lHat 6.00 ppm (D of D, = 9 Hz, = 4 Hz, Hy) - lHat5.45 ppm (D, J = 13 Hz, CH2 0 CO) - 1H at5,00 ppm (D, J = 4 Hz, Hg) - lHat 4.84 ppm (D, J ≈ 13 Hz, CH2 0 CO) - 1Hat4,05 ppm (D, J = 17 Hz, CH2 SO) - 1H at3.75 ppm (D, J = 17 Hz, CH2 SO) - 2H at2.81 ppm (M, CH2 - f^3) - 2H at2.40 ppm (T, J = 7 Hz,

[764]

10 CH2 C02) - 2H at 1.82 ppm (M, CH2 CH2 C02) - 6H at 1.45 ppm (2 S, (CH3)2 C)

[765]

NMR ∩° 116 - (b) :

[766]

lHat 10.3 ppm (Se., Ar NH CO) - lHat8.70 ppm (D, J = 9 Hz, CO NH) -

[767]

2Hat 7.90 ppm (D, J = 8 Hz, H ·Ar 2', 6') - 1H at7.67 ppm (D, J = 8 Hz, H Ar 3', 5') - 3H at 7.60 ppm (Se., CH2 #H3) - lHat 6.95 ppm (S, H thiazol.) -

[768]

15 1H atδ.OO ppm (D of D, = 9 Hz, J2 = 4 Hz, Hy) - lHat5.42 ppm (D, J = 13 Hz CH2 0 CO) - 1H at4,98 ppm (D, J = 4 Hz, Hg) - 1H at4.79 ppm (D, J = 13 Hz, CH, 0 CO) - 1H at4.06 ppm (D, J = 17 Hz, CH2 SO) - 1H at3.75 ppm (D, J ≈ 17 Hz, CH2 SO) - 2Hat 2.79 ppm (M, CH2Ph^) - 2Hat2.42 ppm (M, CH2 - CO NH Ar) 2H atl.84 ppm (M, CH2 CH2 N<®H3) - 6H at 1.48 ppm (2 S, (CH3)2 C)

[769]

20 NMRn° 117 - (b) ;

[770]

lHat 10.30 ppm (Se., Ar NH CO) - lHat8',75 ppm (D, J = 9 Hz, NH CO) -

[771]

2H at 7.84 ppm (0,0 = 8 Hz, H Ar 2’, 6') - 2H at7.72 ppm (D, J = 8 Hz, H Ar 3', 51) - 3Hat7.60 ppm (Se., CH2 ^3) - lHat6,97 ppm (S, _H thiazol ) 1H atδ.OO ppm (D of D, Jχ ≈ 9 Hz, J2 = 4 Hz, Hy) - lHat 5.40pprn (ds j = 13 Hz, 25 CH2 0 CO) - lHat4.90 ppm (D, 0 = 4 Hz, Hg) - lHat4.78 ppm (D, J ≈ 13 Hz,

[772]

CH2 0 CO) - lHat 4.05 ppm (D, J = 17 Hz, CH SO) - lHat 3.75 ppm (D, J = 17 Hz, CHg.'SO) - 2Hat2.75 ppm (M, CH2 N^3) - 2H at2.36 ppm (M, CH2 CONH Ar) -

[773]

4H at 1,58 ppm (M, -CO CH2 (CH2)9 CH2^3) - 6H atl.45 ppm (2 S, (CH3)2 C)

[774]

1H at 12.7 ppm (Se, NH CO thiazol) - 1H at 8.65 ppm (D, J = 9 Hz, CO NH) - 3H at 8.20 ppm (Se, CH2 t$k3) - 1H at 5 6.93 ppm (S, H thiazol) - 1H at 6.00 ppm (D of~D, = 9 Hz, J2 = 4 Hz, Hy) - 1H at 5.45 ppm (D, J = 13 Hz, CH2 O CO) - 1H at 5.02 ppm (D, J = 4 Hz, H6) - 1H at 4.75 ppm (D, J = 13 Hz, CH2 O CO) - 1H at 4.02 ppm (D, J = 17 Hz, CH2 SO) - 2H at 3.90 ppm (M, CH2 Gly) - 1H at 3.70 10 ppm (DT J = 17 Hz, CH2 SO) - 3H at 2.50 ppm (S, CH3 thiazol) - 6H at 1.45 ppm (2S, (CH3)2 C) .

[775]

NMR n· 119 - fbΐ:

[776]

1H at 8.45 ppm (D, J = 9 Hz, CO NH) - 3H at 7.80 ppm (Se., CH-I$H3) - 1H at 6.80 ppm (S, H thiazol) - 1H at 15 6.00 ppm (D of D, ^ = 9 Hz, J2 = 4 Hz, H7) - 1H at 5.10 ppm (D, J = 13 HZ, CH2 O CO) - 1H at 4.95 ppm (D, J = 4 Hz, H6) - 1H at 4.58 ppm (D, J = 13 Hz, CH2 O CO) - 1H at 3.90 ppm (D, J = 17 Hz, CH2 SO) - 1H at 3.56 ppm (D, J = 17 Hz, CH2 SO) - 1H at 3.00 ppm (2M CH 1<%3) - 1H at 20 2.25 ppm (M, Cg C02) - 4H at 1.80 ppm and 4H at 1.40 ppm (M, CH2 cyclohexane) - 6H at 1.44 ppm (2S, (CH3)2 C).

[777]

MMR Π~12!0 - (b) ;

[778]

1H at 8.75 ppm (D, J = 9 Hz, CO Njg) - 2H at 7.80 ppm (Se., ϋ Ar 2', 6') - 3H at 7.65 ppm (Se., CH2 *Φh3) - 1H 25 at 7.57 ppm (D, J => 8 Hz H Ar 4') - 1H at 7.47 ppm (T, J = 8 Hz, H Ar 5') - 1H at 7.00 ppm (S, H thiazol) - 1H at 6.00 ppm (D Of D, Jχ => 9 HZ, J2 = 4 Hz, Hy) - 1H at 5.45 pprn (D, J ≈ 13 HZ, CH2 O CO) - 1H at 4.98 ppm (D, J ≈ 4 Hz, H6) - 1H at 4.82 ppm (D, J = 13 Hz, CH2 O CO) - 1H 30 at 4.05 ppm (D, J = 17 Hz, CH2 SO) - 1H at 3.75 ppm (D, J = 17 Hz, CH2 SO) - 3H at 3.00 ppm (M, CH CH2

[779]

ch3

[780]

iΦh3) - 6H at 1.50 ppm (2S, (CH3)2 C) - 3H at 1.20 ppm (D, J ≈ 7 Hz, CH CH2 K®H3)

[781]

35 CH3

[782]

NMR ∩° 121 - (b) :

[783]

1H at 10.0 ppm (Se., Ar NH CO) - 1H atδ.85 ppm (D, J = 9 Hz, CO NH) 3Hat8.05 ppm (Se., CH2 l^3) - 1H at 7.45 ppm (S, H Ar 6' ) - lHat7.30 ppm (S,. H Ar 41 ) - 1Hat 7.00 ppm (S, thiazol ) - 1H at6.00 ppm (D of D, = 9 Hz, J2 = 4 Hz, Hy) - 1H at5.43 ppm (D, J = 13 Hz, CH2 0 CO) - lHatδ.OO ppm

[784]

(D, J = 4 Hz, Hg) - 1H at4.78 ppm (D, J = 13 Hz, CHg 0 CO) - lHat4.05 ppm (D, J = 17 Hz, CH SO) - 2H at 3.80 ppm (M, CH2 Gly) - lHat3.75 ppm (D,

[785]

J = 17 Hz, CH2 SO) - 6Hat 2.25 ppm (2 S, CH3 Ar) - 6H at 1.50 ppm (2 S, (CH3)2 C) NMR ri° 12 2 - (b) :

[786]

1H atlθ.45 ppm (Se., Ar NH CO) - 1Hat8.70 ppm (D, J = 9 Hz, CO NH) lHat8.50 ppm (Se., ΐFllg, piperidine) - lHat8.20 ppm (Se. , Filg, piperidine) 2H at7.84 ppm (D, J = 8 Hz, H Ar 21, 6' ) - 2Hat 7.70 ppm (D, J = 8 Hz, H Ar 3', 5') - 1H atβ,98 ppm (S, _H thiazol ) - lHatδ.OO ppm (D of 0, = 9 Hz, J2 = 4 Hz, H?) - 1H at5,42 ppm (D, J = 13 Hz, CH2 0 CO) - lHat4.98 ppm (D, J = 4 Hz, Hg ) - 1H at4.78 ppm (D, J » 13 Hz, CHg 0 CO) - lHat4.05 ppm

[787]

(D, J = 17 Hz, CH2 SO) - 1H at3.75 ppm (D, J ≈ 17 Hz, CH2 SO) -

[788]

2H at3.30 ppm (M, CH2 in !^®Hg piperidine) - 2Hat2.9Q ppm (M, CH2 in

[789]

rPπ2 piperidine) - lHal2.66 ppm (M, CH CO NH) - 4H at 1.80 ppm (M, CH2 in β piperisine) - 6H at 1.45 ppm (2 S, (CH3)2 C)

[790]

NMR n° 123 - (b) :

[791]

1H at 10.25 ppm (Se., Ar NH CO) - lHat8.70 ppm (D, J = 9 Hz, CO NH) lHat8.50 ppm (Se., iFkg, piperidine) - lHat8,25 ppm (Se, N®Hg, piperidine) 1Hat8.19 ppm (Se, H Ar 2') - 1H at7.85 ppm (D, J = 8 Hz, Hr 5') -

[792]

IHat 7.60 ppm (D, J = 8 Hz, H Ar 4') - lHat7.42 ppm (T, J = 8 Hz, H Ar 5') 1H at6.95 ppm (S, H thiazol ) - IHat 6.00 ppm (D of D, = 9 Hz, J2 = 4 Hz, H7) - IHat 5.45 ppm (D, J ≈ 13 Hz, CHg 0 CO) - lHatδ.OO ppm (D, J = 4 Hz, Hg) - IHat 4.81 ppm (D, J 13 Hz, CHg-.O CO) - lHat4.05 ppm (D, J = 17 Hz, CHg SO) - 1H at 3. 71 ppm (D, J » 17 Hz, CHg SO) - 2H at3.30 ppm (M, CHg in^ fFiΐg Piperidine) - 2Hat2.90 ppm (M, CHg in N®kg piperidine) -

[793]

IHat 2.66 ppm (M, CH CO NH) - 4H at 1.80 ppm (M, CHg in jb, ^g piperidine) 6Hat 1.45 ppm (2 S, (CHglg C) -

[794]

NMR n° 124 - (b) :

[795]

[796]

5 1H at6,00 ppm (D ofD, = 9 Hz, J2 ≈ 4 Hz, Hyj - 1H at5.45 ppm (D, J = 13 Hz, CH2 0 CO) - 1Hat 5,00 ppm (D, J ≈ 4 Hz, Hg) - lHat4,80 ppm (D, J = 13 Hz, CH2 0 CO) - 2Hat 4,00 ppm (M, Hx AlaandCHg SO) - 1H at3.75 ppm (D, J = 17 Hz, CH2 SO) - 6H at 1,50 ppm (2S, (CH3)2 C) - 3Hatl.42 ppm (D, J ≈ 7 Hz, CH3 Ala) -

[797]

10 1H atlO,80 ppm (Se., Ar NH CO) - 1H at9,00 ppm (D, J = 9 Hz, CO NH) -

[798]

IS CH2 0 CO) - 2H at4.00 ppm (M, H o( Ala and CH SO) - 1H at3.75 ppm (D, J = 17 Hz,

[799]

20 NMRn° 126 -(b) :

[800]

1H at 6,00 ppm (Oof 0» Oj = 9 Hz, J2 ≈ 4 Hz, Hy) - lHat 5,20 ppm (M, CH2 0 CO) 1H at4,95 ppm (D, ϋ = 4 Hz, Hg) - lHat 4.50 ppm (0, CH2 0 rθ) - lHat 3.15 ppm 25 (M, Ha piperidine) - lHat2,80 ppm (M, Hga piperidine) - lHat 2,60 ppm

[801]

NMR n° 127 - (b) :

[802]

1H at8.43 ppm (D, J = 9 Hz, CO NH) - 6H at7.50 ppm (Se., -

[803]

1H at 6.80 ppm (S, H thiazol) - lHatβ.OO ppm (D of D, = 9 Hz,

[804]

J2 = 4 Hz/H?) - 1Hat 5.16 ppm (2D, J ≈ 13 Hz, CH2 0 CO) -

[805]

1H at 4.95 ppm (D, J ≈ 4 Hz, Hg) - 1H at4.58 ppm (D, J = 13 Hz, CH2 0 CO) 1Hat4.20 ppm (M, Hgθ piperidine) - IHat^O ppm (D, J = 17 Hz CH2 SO) 1H at3.64 ppm (M, Hge piperidine) - lHat3.57 ppm (D, J ≈ 17 Hz, CH2 SO) lHat3.07 ppm (M, H2a piperidine) - 2Hat2.96 ppm (M, CH2 N®H3) -

[806]

1H at 2.75 ppm (M, Hga piperidine) - 3H at2.65 ppm (M, CH C02andCH2 CO N) 2H at 1,80 ppm et 2Hatl,50 ppm (H^anclHζ piperidine) -6Hatl,45 ppm (2S, (ch3)2 C) -

[807]

NMRn° 128 - (b) :

[808]

1H at 8.45 ppm (D, J = 9 Hz, CO NH) - 6H at7,70 ppm (Se., NΦH3) lHat6,80 ppm (S, H thiazol ) - 1H at 5.98 ppm (D de D, = 9 Hz,

[809]

J2 ≈ 4 Hz, H?) - 1H at5.20 ppm (2 C, J = 13 Hz, CHg 0 CO) -

[810]

1H at4,96 ppm (D, J = 4 Hz, Hg) - lHat4.58 ppm (D, J = 13 Hz, CH2 0 CO) lHat4.18 ppm (H2℮ piperidine) - lHat3.90 ppm (D, J = 17 Hz, CH2 SO) lHat3.75 ppm (M, Hge piperidine) - lHat3·.55 ppm (D, J ≈ 17 Hz, CH2 SO) lHat3.00 ppm (M, H2a piperidine) - 4Hat 2.65 ppm (M, CH2 I^Hg, Hga ℮t H4 piperidine) - 2Hat2,40 ppm (T, CH2 CO N) - 4H at 1.70 ppm (M, CH CH2

[811]

Λ ****

[812]

CH2 λvH3, HjandH- piperidine) - -Hat 1.50 ppm (M, H^andHg piperidine) 6H at 1.44 ppm (2S, (CH3)2 C) -

[813]

lHaΐ8.50 ppm (Se., N$H2 piperidinium) - 1H at8.45 ppm (D, J = 9 Hz,

[814]

CO NH) - 1H at8,25 ppm (Se., NΦH2 piperidinium) - 3Hat7,40 ppm (Se.,

[815]

N®H3 thiazol ) - lHatβ.80 ppm (S, H thiazol ) - lHatβ.OO ppm (D of D,

[816]

5 Jj = 9 Hz, J2 = 4 Hz, H?) - 1H atδ.16 ppm (D, J ≈ 13 Hz, CH2 0 CO) -

[817]

lHat4 15 ppm (M, H2℮ piperidine) - 2H at 3 .90 ppm (M, Hg℮ piperidine and CH2 SO) - 1Hat 3.55 ppm (D, J = 17 Hz, CH2 SO) - 2Hat 3.25 ppm (M, Hgβ andHδe piperidinium) - lHat3.15 ppm (M, H2a piperidine) - 3Hat2.85 ppm (M,

[818]

Hga piperidine and H2a and Hga piperidinium) - 2Hat2.70 ppm (M, H^

[819]

10 piperidineandH^ piperidinium) - 6H atl.75 ppm and 2H at 1.50 ppm (2M, H^andHg piperidinium H^andHg piperidine) - 6Hatl.44 ppm (2S, (CH3)2 C) -

NM R n° 130 - (b) :

[820]

lHat8.75 ppm (D, J 9 Hz, CO NH) - 3H at 8.20 ppm (Se., CH2 N®H3) -

[821]

1H at7.80 ppm (D, J = 8 Hz, H Ar 6') - 2H at7.45 ppm (M, H Ar 3', 5')

[822]

15 1H at7,00 ppm (S, H thiazol ) - lHatβ.OO ppm (D ofD, = 9 Hz,

[823]

02 = 4 Hz, H7) - 1H aΐ5.42 ppm (D, J => 13 Hz, CH2 0 CO) - 1H at 5.00 ppm (D, 0 = 4 Hz, Hg) -1Hat 4.80 ppm (D, J a ‘13 Hz, CH2 0 CO) -

[824]

3Hat4.00 ppm (M, CH2 l^gβndCHg SO) - 1H aΐ3.75 ppm (D, 0 = 17 Hz,

[825]

CH2 SO) - 3Hat2.45 ppm (S, CH3 Ar) - 6Hatl.45 ppm (2S, (CH3)2 C) -

[826]

20 NM Rn° 131 - (b) : NM Rn° 131 - (b) :

[827]

lHat8.85 ppm (D, J ≈ 9 Hz, CO NH) - 3Hat 8.20 ppm (Se., CH2 NΦH3) -

[828]

1H at7,80 ppm (D, J = 8 Hz, H Ar 5') - 2Hat7 45 ppm (M, H Ar 3', 5') lHat6.95 ppm (S, H_ thiazol ) - lHatβ.OO ppm (D of D, = 9 Hz,

[829]

J2 = 4 Hz, Hy) - 1H at5.45 ppm (D, J ≈ 13 Hz, CH2 0 CO) - lHats.OO ppm

[830]

25 CD, J = 4 Hz, Hg) - lHat4.80 ppm (D, J ≈ 13 Hz, CH2 0 CO) - CD, J = 4 Hz, Hg) - lHat4.80 ppm (D, J ≈ 13 Hz, CH2 0 CO) -

[831]

3H at4.00 ppm (M, CH2 NΦH3 et CH2 SO) - 1H at3.73 ppm (D, J a 17 Hz,

[832]

CH2 SO) - 3H at2.50 ppm (S, CH3 Ar) - 4Hat2.40 ppm (M, CO ) 2H at 1.80 ppm (M, 0 ) - CH, ) - CH,

[833]

-CO -CH, -CH,

[834]

30 CH, CH,

[835]

NMR∩° 132 - (b) :

[836]

1H at8.80 ppm (D, J = 9 Hz, CO NH) -3H atδ.10 ppm (Se., CH2 N^3) -

[837]

1H at7.55 ppm (S, ji Ar) - 1H at7,45 ppm (S, H_ Ar) - 1H at7.00 ppm (S, H thiazol ) - 1Hat6.00 ppm (D of D, Jj ≈ 9 Hz, J2 = 4 Hz, H?) -

[838]

1H at5,40 ppm (D, J = 13 Hz, CH2 0 CO) - 1H at 5.00 ppm (D, J = 4 Hz, Hfi) lHat4,83 ppm (D, J = 13 Hz, CH2 0 CO) - 3Hat3.70 ppm (M, CH2 N®H3 et

[839]

CH2 SO) - 1Hat 3.70 ppm (D, J = 17 Hz, CH2 SO) - 3H at2.4θ ppm (S, CH3 Ar) - 3H at2,34 ppm (S, CH3 Ar) - 6Hatl.45 ppm (2S, (CH3)2 C) -

[840]

NMR n° 133 - (b) :

[841]

1Hat 12.5 ppm (Se., Ar NH CO) - lHat8.78 ppm. (D, J = 9 Hz, CO NH) -

[842]

3H at 8.30 ppm (Se., - CH - N®H3) - 1H at 8.20 ppm (S, H thiazol in 3) -

[843]

ch3 "

[844]

1H at 7,00 ppm (S, H thiazol) - 1H at 6.00 ppm (D of D, = 9 Hz, J2 = 4 Hz, H7) - 1Hat 5.42 ppm (2 D, J = 13 Hz, CHg 0 CO) - lHatδ.OO ppm (D, J = 4 Hz, Hg) - 1Hat4.90 ppm (D, J = 13 Hz, CH2 0 CO) - 1H at4.15 ppm (M, CH ^3) “ ~ ch3

[845]

1H at4.00 ppm (D, J = 17 Hz, CH2 SO) - lHat3.76 ppm (D, J = 17 Hz, CH2 SO) 6H at 1.44 ppm (2 S, (CH3)2 C) - 3Hat 1.40 ppm (D, 0 = 7 Hz, CH3 CH)

[846]

NMRn° 134 - (b) :

[847]

1H at8,85 ppm (D, J = 9 Hz, CO NH) - 1H at8.50 ppm (S, H thiazol in 3) 3Hat 7.90 ppm (Se., CH2 1^3) ~ lHat7.00 ppm (S, H_ thiazol ) -

[848]

lHat 6.00 ppm (D of D, = 9 Hz, J2 = 4 Hz, H?) - 1H at5.42 ppm (D, J = 13 Hz CH2 0 CO) - 1H at4.99 ppm (D, J = 4 Hz, Hg) - lHat 4.84 ppm (D, J ≈ 13 Hz, CH2.0 CO) - lHat4.00. ppm (D, J ≈ 17 Hz, CH2 SO) - lHat3.75 ppm (D, J = 17 Hz CH2 SO) - 4H at3,20 ppm (M, CH2 CH2 l^3) - 6H at 1.45 ppm (2 S, (CH3)2 C)

[849]

NM R n° 135 ~ (b) :

[850]

lHaΐ8.80 ppm (D, J ≈ 9 Hz, CO NH) - 1H at8,57 ppm (S, _H thiazol in 3) 3Hat8.50 ppm (Se., CH2 ^3) - 1H at 7.00 ppm (S, H_ thiazol ) - lHatδ.OO ppm (D of D, Jχ = 9 Hz, J2 = 4 Hz, H7) - 1H at5.40 ppm (D, J = 13 Hz, CH2 0C0) -

[851]

5 lHatδ.OO ppm (D, J = 4 Hz, Hβ) - 1H at4.90 ppm (D, J = 13 Hz, CH 0 CO) 2Hat4.45 ppm (M, CH2 N®H3) - lHat4.00 ppm (D, J ≈ 17 Hz, CH2 SO) -

[852]

1H at 3.72 ppm (D, J ≈ 17 Hz, CH2 SO) - 6Hatl,45 ppm (2 S, (CH3)2 C)

[853]

10

[854]

15

[855]

NMR n° 136 - (b) :

[856]

lHat 8.90 ppm (D, J = 9 Hz, CO NH) - 1H at 8.60 ppm (S, H_ thiazol in 3) lHat 8.50 ppm (Se., CH2 N®H3) - 1H at6.98 ppm (S, H_ thiazol ) -

[857]

lHatδ.OO ppm (D ofD, = 9 Hz, Jg ≈ 4 Hz, Hy) - lHat5.42 ppm (D,

[858]

J = 13 Hz, CH2 0 CO) - lHatδ.OO ppm (D, J = 4 Hz, Hg) - lHat4.84 ppm (D,

[859]

J = 13 Hz, CH2 0 CO) - 2Hat 4.45 ppm (M, CH2 f^H3) - lHat4.00 ppm (D,

[860]

0 = 17 Hz, CH2 SO) -lHat 3.72 ppm (D, 0 ≈ 17 Hz, CHg SO) -

[861]

0 0

[862]

4H at2.40 ppm (M, CH2

[863]

-CO) - 2Hatl.86 ppm (M,

[864]

-CO)

[865]

■■CH,

[866]

CH,

[867]

NMR n° 137 - (b) :

[868]

lHat8.90 ppm (T, J = 8 Hz, C NH CH?) - lHat8.75 ppm (D, J = 9 Hz, CO NH) -

[869]

0e

[870]

20 3H 3.58.00 ppm (Se., CH2 N®k3) - 2H at7. 88 ppm (D, 0 = 8 Hz, H 4r 2', 6') -

[871]

2H at^.40 ppm (D, J = 8 Hz, ' 1H Ar 3', 5' ) - 1H at6 .96 ppm (S, HI thiazol ) 1H at6.00 ppm (D of 0, Jj_ = 9 Hz, J2 = 4 Hz, Hy) - 1H atδ.44 ppm (0, J = 13 Hz,rH2 0 CO) - 1Hat4.98 ppm (D, J = 4 Hz', Hg) - 1H at4.80 ppm (D, 0 = 13 Hz, CH2 0 CO) - 2Hat4,40 ppm (D, J = 8 Hz, Ar CHg NH) - 1H at4.06 ppm lHat3.70 ppm (D, J = 17 Hz, CH2 S -> 0) - 2H at3.57 ppm (M, OC CH2 N^3) 2Hatl.47 ppm (2 S, (CH3)2 C)

[872]

25

[873]

By operating as in Example 2 of Example 3, the compounds according to the invention are obtained, in the form of trifluoroacetates described in Table n 5 below.

[874]

[875]

These compounds are identified by a reference number and for each of them are given the values of Rl7 15 R2, n and B and the NMR spectrum.

[876]

The chromatography eluant is also given which serves to isolate (V) : the last intermediate product before deblocking of the acid and amine functions of the molecule. This intermediate V is characterized by its 20 infra-red spectrum, the wavelengths indicated in cm-1 correspond in order to the elongation vibration frequencies of the carbonyl at the 8 position of the beta lactam, the tertiobutylic esters and the thioester at the 3 position, the amide at the 7 position and the 25 protective carbonate of the amine. When 2 wavelengths only are indicated the second corresponds to a wide band which covers the elongation vibration frequecies both of the esters, the amide and the protective carbonate of the amine and the thioester.

[877]

30 It happens for certain products that the vibration frequency of the thioester is at the same wavelength as that of the tertiobutylic esters. This is indicated in the table by + COS opposite the corresponding vibration frequency.

[878]

/ TABLE II /

[879]

SR nen-c \Rκ2BChromatography eluant from intermediate V vol/volIR t>CO cm * intermediate VNMR no.
419700X CH3 ch3- (CH2)3 nh2CH2 Cl2 90 Ac 0 Et 101800 1720 1590i
41971»"- (ch2)4 nh2CH2 Cl2 90 Ac 0 Et 101300 1715 15902
41972""- <cVsNH2CH2 Cl2' 92 Ac 0 Et aooo3
41973■'«OCH2 Cl2 90 Ac 0 Et 10laoo 1725 16904
42074""-O ® '-NHCH2 Cl2 90 , Ac o εt' io1800 1725 16905
42076""- {CHj }3 NH CH3CH2 Cl2 90 Ac 0 Εt 101300 1725 15506
42077"- (CH2>7NH2CH2 Cl2 . 95 Ac 0 Εt 51800 1720 16907

[880]

I no.Λ -Cn*23Chromât opera ph\ rlπant from ΐ ntormocli ate V vol/volIR t) CO cm * intermediate VNMK no.
421180> CHj CH3^“■»℮h2nh2'CH2 Cl2 95 Ac 0 εt 5iao3 1720 16908
42119~^Q^- ch2 nh2CHjClj 92.5 Ac 0 Εt ' 7.513Q5 17209
42187"«/O 'CH2 Cl2 95 Ac 0 Εt 51805 172510
42199"- C«2 -OCH2 Cl2 90 Ac 0 Εt 101300 1725 169011
42218"-a,"CH2 Cl2 92.5 Ac 0 Εt 7.51305 1725 169012
42219-O’CH2 Cl2 · 92.5 Ac 0 Εt 7.51805 1725 169013
42229- CH2-<0>ch2 nh2CH2 Cl2 95 Ac 0 Εt 51800 172014 ·
42221iH CHj«CH2 Cl2 95 Ac 0 Εt 51800 172015
42222"CH, Cl2 95 Ac 0 Εt 51805 172016

[881]

SR nonA -C ABChromatography eluant from intermediate V vo1/volIR t> CO cm'1 intermediate VNMR no.
42 5310Λ CH3 ch3X '"CHgNHgCH2 Cl2 100 Me OH 0.51800 172017
42 532-A ^ CH2NH2CH2 Cl2 100 Me OH 0.51800 172018
42533-ch3 ch3h(Ô)-ch2nhch3CH2 Cl2 100 Me OH 0.51800 1720 169019
42 534»-(oy CH2NHCH3CH2 Cl2 100 Me OH 0.51800 1720 169020
42 535-A ch3 ch3A ch3 ch2nh2CH2 Cl2 95 Ac 0 Et 51800 172021
42 535"6A ch3 ch2nh2CH2 Cl2 95 Ac 0 Et 51800 172022
42 659-A ch3 ch3-{q)-CH3CH2 Cl2 100 Me OH 0.41802 172023
42 650-% ch3CHjNH2CH2 Cl2 100 Me OH 0.51802 172024
42661"A ch3 ch3-/θV ch2nh2 ch3CH2 Cl2 95 Ac 0 Et 51802 172025

[882]

SR ncvn/S1 -C *28Chromatography eluant from intermediate V vol/volIR ΰCO cm1 intermediate VNMR no.
426620H O- CH3"-<o)-ch2nh2 ^ch3CH2 Cl2 95 Ac 0 Et 51802 172026
42663"X ch3 ch3CH, 1 3 - c -ch2nh2 ch3CH2 Cl2 100 Me OH 0,41802 1720 168027
42664"II-NHCOCHgHH^CH2 Cl2 95 Ac 0 Et 51802 172028
42665«-^Ôy-NHC0CH2NH2CH2 Cl2 95 Ac 0 Et 51802 172029
426721Λ ch3 ch3γ.C℅-QnΠCH2 Cl 2 90 Ac 0 Et 1C1802 CHpCl0 1720 i £ 168030
426730"-y^N-C-C^NHgch2 ci2 100 Me OH 11802 CHoClp 1715 “ i69031
42674"-/ Vc-ch2nh2ch2 Cl 2 100 Me OH 11802 CH-Cl, 1715 i 1690 ■32
42635«Λ ch3 ch3NHCQCH2NH2CH2 Clj 95 Ac 0 Et 51805 ' 1725 169533
42686-6nhcoch2nh2CH2 Cl 2 95 Ac 0 Et 51805 1725 169534
42847Λ ■ch3 ch30 ^N-C(CH2)2NH2ch2 Cl 2 100 Me OH 11800 CHjCl 171035

[883]

SR no.-cδChromatography *lua∩t from intermediate V vol/volIR % CO cm"1 intermediate VNMR no.
428500A ch3 ch3-<5>:h2nh2 ch3CH2 Cl2 100 Me OH 0.71805 172036
42851»-{o}“CH2nh2 / CH3ch2 ci2 100 Me OH 0.71805 172037
42853-Λ ch3 ch3A ^■CH-CH2NH2 ch3CH2 Cl2 95 Ac 0 Et 51802 172038
42854«iH32 2ch2 Cl, 100 Me OH 0.41802 172039
42855"Λ ch3 ch3/À J-'NHC0CH2CH2NH2 (TCH2 Cl2 85 Ac 0 Et 151803 1720 168540
42858-«-y ^-NHC0CH2NH2 N ^ch2 ci2 100 Me OH 11802 1725 159041
42859-"-<^)-NHCOCH2CH2NH2CH2 Cl2 70 Ac 0 Et 301802 1720 169042
42850"à■<(θ^-NHC0CH2CH2NH2CH2 Cl2 70 Ac 0 Et 301302 172043
1

[884]

78

[885]

SR nαn/R1 _ :8Chromatography eluant from intermediate V voi/VOÎIR CO cm"1 intermediate VN'MR no.
42 8630/\ ch3 ch3-^Ôy-NHCOCHjNHCHjCH2 Cl2 90 Ac 0 Et 101800 1720 169044
42 868"//)-ch2nh2 NXch2 Cl, 100 He OH 0.7.1802 172045
42 902"<^0ycH2NHC0CH2NH2CH2 Cl2 100 He OH 11802 1720 167046

[886]

NMR Spectra

[887]

The spectra are recorded at 60 MHz, indicated by (a) or at 250 Mllz, indicated by (b); when two steroisomers exist in the molecule, the split signals are indicated by *.

[888]

NMR n° 1 - fa):

[889]

8H between 6 and 9 ppm (wide signal, CH2, TFA, C02H)1H at 8.40 ppm (D, J=9 Hz, CONH) - 1H at~6.86 ppm (S, H 5 thiazol) - 1H at 6.00 ppm (D of D, J3=9 Hz, J2=4 Hz, H7)

[890]

- 1H at 4.97 ppm (D, J=4 Hz, Hg) - 1H at 4.20 ppm (AB, JAB=13 Hz, CH2 SCO) - 3H at 3.70 ppm (M, CH^ SCO and CH2SO) - 4H at 2.75 ppm (M, CH2NH2 and CH2COS) - 2H at 1.77 ppm (M, CH2CH2CH2) - 6H at~1.45 ppm (s’, (CH3)2C).

[891]

10 NMR n· 2 - (a):

[892]

8H between 6.5 and 9 ppm (wide signal, C02H, TFA, NH2)1H at 8.40 ppm (D, J=9 Hz, CONH) - 1H at 6.88 ppm (S~, Ξ thiazol) - 1H at 6.0 ppm (D of D, Jλ=9 Hz, J2=4 Hz, Hγ)

[893]

-1H at 5.0 ppm (D, J=4 Hz, Hg) - 1H at 4.20 ppm (A of 15 AB, J=13 Hz, CH2SCO) - 3H at 3.80 ppm (M, CHgSO and CH^SCO) - 4H at 2.65 ppm (M, CH2NH2 and CH^COS) - 10H at 1.45 ppm (S.e., (CH3)2C and CH2 (CH^j·CH^.

[894]

NMR n° 3 - fa^ ;

[895]

8H between 6.5 and 8.7 ppm (wide signal (NH2, C02H, TFA) 20 - 1H at 8.40 ppm (D, J=9 Hz, CONH) - 1H at~6.87 ppm (S, H thiazol) - 1H at 6.0 ppm (D of D, J^=9 Hz, J2=4 Hz, H7) - 1H at 5.0 ppm (D, J]_=4 Hz, Hg) - 1H at 4.20 ppm (A of AB, J≈13 Hz, CH2SO) - 3H at 3.70 ppm (M, CH2SCO and CH2SO) - 4H at 2.80 ppm (M, CH2NH2 and CH2C0) - 12H at 25 1.45 ppm (S.e., (CH3)2 c and CH2 (CH2)3 CH2).

[896]

NMRn· 4 - (a)i ~ ~

[897]

7H between 6.5 and 9.5 ppm (wide signal, NH2, NH, co2H, TFA) - 1H at 8.40 ppm (D, J=9 Hz, CONH) - lF at 6.90 ppm (S, H thiazol) - 1H at 6.0 ppm (D of D, Jx=9 Hz, J2=4 30 Hz, H7) - 1H at 5.0 ppm (D, J=4 Hz, Hg) - 1H at 4.20 ppm (A Of AB, JAB=13 Hz, CH2SCO) - 3H at 3.70 ppm (M, CH2SCO and CH2SO) - 5H at 3.0 ppm (M, CH2N and CHCOS) - 4H at 1.90ppm (M, CH2CH2N) - 6H at 1.45 ppm (S, (CH3)2C).

[898]

NMR n' 5 - (bΐ:

[899]

35 5H between 7 and 9 ppm (wide signal, NH2, TFA, NH) - 1H at 8.34 ppm (2D, J=9 Hz, CONH)* ~ 1H at 6.8 ppm (S, H thiazol) - 1H at 5.97 ppm (D of D, J3=9 Hz, J2=4 Hz, H7)

[900]

- 1H at 4.95 ppm (D, J=4 Hz, H6) - 1H at 4.16 ppm (2D, J=13 HZ, CH2SCO)* - 1H at 3.76 ppm (D, J=13 Hz, CH2SCO)

[901]

- 2H at 3.66 ppm (S, CH2SO) - 1H at 3.4 ppm, 1H at 3.16 ppm and 2H at 2.95 ppm (M, CH2N) - 1H at 2.80 ppm (M, 5 CHCOS) - 4H between 1.5 and 2.1 ppm (M, CH2CH2CH2N) - 6H at 1.44 ppm (S, (CH3)2C).

[902]

NMR n' 6 - (a^:

[903]

3H at 8.50 ppm (S.e., CONH, NH2) - 3H at 7.80 ppm (S.e., NH3) - 1H at 6.85 ppm (S, H thiazol) - 1H at 6.00 ppm (D 10 of D, J-l≈Θ Hz, J2=4 Hz, H7) - 1H at 5.00 ppm (D, J==4 Hz, Hg) -1H at 4.15 ppm (A of AB, JAB=13Hz/ CH2SCO) - 1H at 3.80 ppm (B of AB, Jab=13 Hz / CH2SCO) ~ 2H at 3.70 ppm (S.e., CH2SO) - 7H at 2.50 ppm (M, CH3NH, CH2NH, CH2 C ~ ~ 0

[904]

15 S) - 2H at 1.80 ppm (M, CH2CH2CH2NH) - 6H at 1.45 ppm (2S, (CH3)2C).

[905]

NMR n· 7 - <a);

[906]

1H at 8.35 ppm (D, J=9 Hz, CONH) - 8H between 6.5 and 10 ppm (C02H, NH2, TFA) - 1H at 6.82 ppm (S, H thiazol)20 1H at 6.00 ppm (D of D, Jχ=9 Hz, J2=4 Hz, H7) - 1H at 5.00 ppm (D, J≈4 Hz, Hg) - 1H at 4.15 ppm (A of AB, Jab≈13 Hz, CH2SC0) - 3H~"at 3.66 ppm (M, CH2S0 and B of AB, CH2SCO) - 4H at 2.65 ppm (M, CH2C0 and~CH2NH2) - 6H at 1.42 ppm (S, (CH3)2C) - 10H at l725 ppm (sTe., (013)5 25 CH2 NH2). ~

[907]

NMR n” 8 - (b);

[908]

1H at 8.34 ppm (D, J≈9 Hz, CONH) - 3H at 7.80 ppm (S.e., &Hτ,) - 3H at 7.40 ppm (S.e., fobj) - 1H at 6.78 ppm (S, H thiazol) - 1H at 5.94 ppm (D of D, Jx=9 Hz, J2≈4 Hz, Ej) 30 - 1H at 4.94 ppm (D, J≈4 Hz, Hg) - 1H at 4.14 ppm (D, J=13 HZ, CH2SCO) - 1H at 3.69 ppm (D, J=13 Hz, CH2SO)2H at 3.63"ppm (S, CH2S0) - 2H at 2.60 ppm (M, CH2NH2)1H at 2.45 ppm (M, CHCOS) - 4H at 1.84 ppm (M, CH^CHCOS) - 6H at 1.44 ppm (2S, (CH3)2C) - 2H at 1.40 35 ppm and 2H at 1.0 ppm (M, CH2CH CH2 NH2).

[909]

NMR n1 9 - fbΐ ;

[910]

[911]

5 10 15 20 25 30 35 CH2

[912]

(M, CH COS and NH) - 2H at 1.95 ppm and 2H atCHJ.^

[913]

CH2

[914]

1.70 ppm (M, SC h/ ) - 3H at 1.45 ppm (D, J=7 Hz,

[915]

oXch2

[916]

CH3CH).

[917]

NMR n· 13 - (b):

[918]

2H at 8.70 ppm (M, CONH and NH^) - 1H at 8.40 ppm (M, NH2) - 3H at 7.40 ppm (S.e·, NH3) - 1H at 6.79 ppm (S, H thiazol) - 1H at 5.90 ppm (D of D, Jχ=9 Hz, J2=4 Hz, H7)

[919]

- 1H at 4.94 ppm (D, J=4 Hz, H6) - 1H at 4.16 ppm (D, J=13 Hz, CH2 SCO) - 1H at 3.74 ppm (D, J≈13 Hz, CH2 SCO) 2H at 3.70 ppm (S, CH2S0) - 2H at 3.25 ppm (M, CH2NH) 3H at 2.90 ppm (M, CH2NH and CH COS) - 4H at 2.40 ppm

[920]

(M, CH2

[921]

and SCO

[922]

O

[923]

-j C02H) - 6H at 1.80 ppm (M, CH2

[924]

ch2 ch2

[925]

,ch2

[926]

)•

[927]

0

[928]

co2h ch2

[929]

ch2

[930]

MR n" 14 - (b) :

[931]

1H at 8.65 ppm (D, J=9 Hz, CONfl) - 3H at 8.20 ppm (S.e., NH3) - 2H at 7.92 ppm (D, J≈8 Hz, H ortho CO) - 2H at 7.56 ppm (D, J=8 Hz, H meta CO) - 3H at 7.30 ppm (S.e., NH3) - 1H at 6.82 ppm (S, H thiazol) ~ 1H at 5.88 ppm (D of D, Jχ=9 HZ, J2≈4 Hz, H7) - 1H at 4.92 ppm (D, J=4 Hz, H$) - 2H at 4.55 ppm (S, CH^ON) - 1H at 4.37 ppm (D, J=13 Hz, CHjSCO) - 2H at 4.13 ppm (M, CH2NH2) - 1H at 4.42 ppm (D, J=13 Hz, CHgSCO) - 2H at~ 3.74 ppm (S, CHjSO).

[932]

NMR n‘ 15 - (bΐ:

[933]

1H at 8.60 ppm (2D, J=9 Hz, CONH)* - 3H at 8.20 ppm (S.e., $113) - 2H at 7.92 ppm (D, 3=8 Hz, H ortho CO)2H at 7.56 ppm (D, J=8 Hz, H meta CO) - 3H at 7.30 ppm (S.e., NH3) - 1H at 6.82 ppm (2S, H thiazol)* - 1H at 5.92 ppm (D of D, Jχ=9 Hz, J2=4 Hz, H7) - 1H at 4.95 ppm (2D, superposed, Hδ)* - 1H at 4.60 ppm (Q, J=7 Hz, CHON) - 1H at 4.40 ppm (D, J=13 Hz, CH2SCO) - 2H at 4.13 ppm (M, CH_2NH2) - 1H at 3.90 ppm (D, J=13 Hz, CH2S CO)5 2H at 3.75 ppm (S, CH2 SO) - 3H at 1.45 ppm (D, J=7 Hz, CH3 CH).

[934]

NMR n' 16 - i

[935]

1H at 8.61 ppm (D, J=9 Hz, CONH) - 5H at 8.40 ppm (S.e., NH3, C02H) - 2H at 7.95 ppm (D, J=8 Hz, S ortho CO) - 2H 10 at 7.61 ppm (D, j+8 Hz, H meta CO) - 3H at 7.30 ppm (S.e., NH3) - 1H at 6.76 ppm (S, H thiazol) - 1H at 5.92 ppm (D of D, Ji=9 Hz, J2=4 Hz, H7) - 1H at 4.93 ppm (D, J=4 Hz, H6) - 1H at 4.42 ppm (D, J=13 Hz, CH2SCO) - 2H at 4.10 ppm (S.e., CH2NH2) - 1H at 3.92 ppm (D, J=13 Hz, 15 CH^SCO) - 2H at 3.74"ppm (S, CH2 SO) - 4H at 2.35 ppm

[936]

0 ^ch20

[937]

(M, CH2 ) C02H) - 2H at 1.85 ppm (M, CHg ^ ).

[938]

ch2 ch2 co2h NMR n* 17 - ~7b^ :

[939]

20 1H at 8.62 ppm (D, J => 9 Hz, CO Nϋ) - 3H at 8.20 ppm (Se., CH2 l^j) - 1H at 8.00 ppm (Se., g Ar 2') - 1H at 7.90 ppm (D, J = 8 Hz, g Ar 6') - 1H at 7.72 ppm (D, J ≈ 8 Hz, g Ar 4') - 1H at 7.55 ppm (T, J = 8 Hz, H Ar 5')1H at 6.93 ppm (S, H thiazol) - 1H at 5.95 ppm (D of D, 25 Jx => 9 Hz, J2 => 4 Hz, Hj) - 1H at 4.93 ppm (D, J = 4 Hz H6) - 1H at 4.43 ppm (D, J ≈ 13 Hz, CH2SC0) - 2H at 4.10 ppm (Q, J = 7 Hz, CH2 N®H3) - 1H at 3*794 ppm (D, J = 13 HZ, CH2 SCO) - 2H at 3.75 ppm (Se., CHg SO) - 6H at 1.45 ppm (2S, (013)3 C).

[940]

30 NMR n‘ 18 - (b):

[941]

1H at 8.80 ppm (D, J = 9 Hz, CO NH) - 3H at 8.20 ppm (Se., CH2 #ÎH3) - 1H at 8.00 ppm (Se., H Ar 2') - 1H at 7.90 ppm (D, J = 8 Hz, HAr 6') - 1H at 7.72 ppm (D, J = 8 Hz, H Ar 4') - 1H at 7.55 ppm (T, J = 8 Hz, HAr 5')35 1H at 6.92 ppm (S, H thiazol) - 1H at 5.94 ppm (D of D, Jx = 9 Hz, J2 = 4 Hz, H7) - 1H at 4.96 ppm (D, J = 4 Hz, H6) - 1H at 4.44 ppm (D, J = 13 Hz, CH2 SCO) - 2H at 4.10 ppm (Q, J = 7 Hz, CH2 lΦï3) - 1H at 3.94 ppm (D, J «,ï n r-J

[942]

Lλλ

[943]

10 15 20 25 30 35 = 13 Hz, CH2 SCO)

[944]

at 2.40 ppm (M,

[945]

CH2

[946]

84

[947]

2H at 3.77 ppm (Se.

[948]

-CH2

[949]

)

[950]

O

[951]

CH2 SO) - 4H

[952]

CO

[953]

2H at 1.90 ppm (M,

[954]

ch21

[955]

CO

[956]

NMR n‘ 19

[957]

JM:

[958]

J = 2', 2H at 8.80 ppm (Se., ï$^2 CH3) - 1H at 8.60 ppm (D, 9 Hz, CO NH ) - 2H at 7.95 ppm (D, J = 8 Hz, H Ar 6') - 2H at 7.60 ppm (D, J = 8 Hz, Ar 3', 5') - 1H at 6.94 ppm (S, H thiazol) - 1H at 5.95 ppm (D of D, J3 = 9 Hz, J2 = 4 Hz, H7) - 1H at 4.95 ppm (D, J = 4 Hz, H6)1H at 4.42 ppm (D, J ≈ 13 Hz, CH2 SCO) - 2H at 4.16 ppm (T, J ≈ 7 Hz, CH2 iΦh2 CH3) - 1H at 3.92 ppm (D, J ≈ 13 Hz, CH2 SCO) - 2H at 3.75 ppm (Se., CH2 SO) - 3H at 2.55 ppm (T^ J ≈ 7 Hz, CH2 iΦh2 CH3) - 6H at 1.45 ppm (2S, (CH3)2 C).

[959]

NMR n° 20 - (b):

[960]

1H at 8.84 ppm (D, J = 9 Hz, CO NH ) - 2H at 8.80 ppm (Se., #H2 - CH3) - 2H at 7.95 ppm (D, J ≈ 8 Hz, H Ar, 2', 6') 2H at 7.60 ppm (D, J ≈ 8 Hz, H_ Ar 3', 5')1H at 6.95 ppm (S, H thiazol) - 1H at 5.94 ppm (D of D, Jχ ≈ 9 Hz, J2 ≈ 4 Hz, H7) - 1H at 4.95 ppm (D, J ≈ 4 Hz, Hg) - 1H at 4.45 ppm (D, J ≈ 13 Hz, CH2 S CO) - 2H at 4.16 ppm (T, J ≈ 7 Hz, CH2 N®H2 CH3) - 1H at 3.92 ppm (D, J ≈ 13 HZ, CH2 S CO ) - 2H at 3.75 ppm (Se., CH2 SO)

[961]

- 3H at 2.55 ppm (T, J = 7 Hz, CH2 b®H2 - CH3) - 4H~at

[962]

I ∞2

[963]

2.40 ppm (M, CH2

[964]

(M,

[965]

CH,

[966]

tz_

[967]

-O) - 2H at 1.90 ppm

[968]

CO

[969]

•O)

[970]

CO

[971]

NMR n· 21 - (bΐ:

[972]

1H at 8.66 ppm (D, J = 9 Hz, CO NH) (Se., CH2 - 2H at 7.55 ppm (M, 5 at 7.37 ppm (T, J = 8 HZ, HAr 5') H thiazol) - 1H at 5.96 ppm (D of D, Hz, H7) - 1H at 4.96 ppm (D, J = 4 Hz ppm (D, J = 13 Hz, CH2 S CO) - 2H at 4 H©H3) - 1H at 3.90 ppm (D, J = 13 Hz, 10 3.78 ppm (S, CH2s°) - 3H at 2.26 ppm at 1.45 ppm (2 S, (CH3)2 C).

[973]

- 3H at 8.10 ppm H Ar 4', 6') - 1H 1H at 6.95 ppm (S,

[974]

= 9 Hz, J2 = 4 , H) - 1H at 4.39 .07 ppm (M, Ar CH2 CHg S CO) - 2H at (S, CH3 Ar ) - 6H NMR ∩° 22 - (b) :

[975]

5 10 15 20 25 1H at 8.89 ppm (D, J = 9 Hz, CO NH) - 3H at 8.10 ppm (Se., CH2 |^3) -

[976]

2H at 7.55 ppm (M, H Ar 4', 5') - 1H at 7.37 ppm (T, J = 8 Hz, H Ar 5’) 1H at 6.95 ppm (S, H thiazol ) - 1H at5.95 ppm (D of D, = 9 Hz, J2 = 4 Hz, H7) - 1H at 5,0 ppm (D, 0 = 4 Hz, Hg) - 1H at 4.40 ppm (0, J = 13 Hz, CH2 S CO) 2Hat4.05 ppm (M, Ar CH2 ,^3) - 1H at 3.90 ppm (D, J ≈ 13 Hz, CH2 S CO) -

[977]

2H at 3.79 ppm (S, CH2 SO) - 4H at 2.40 ppm (M, CIL- CO) - 3H at 2.25 ppm ~ TL- ch„

[978]

CH,

[979]

(S, CH- Ar) - 2Hat'1.90 ppm (M, tz_

[980]

.0)

[981]

CO

[982]

NMR n° 23 - (b) :

[983]

1H at 8.64 ppm (D, J = 9 Hz, CO NH) - 3Hat8.14 ppm (Se., CH2 fpH-j) -

[984]

1H at 7.95 ppm (S, H Ar 2') - 1H at 7,60 ppm (D, J = 8 Hz, H_ Ar 6' ) -

[985]

1H at 7.39 ppm (D, 0= 8 Hz, H_ Ar 5' ) - 1Hat 6.95 ppm (S, H. thiazol ) lHat5.95 ppm (D of D, = 9 Hz, J2 = 4 Hz, H^) - 1H at4.96 ppm (D,

[986]

J ≈ 4 Hz, Hg) - 1Hat 4.37 ppm (D, J = 13 Hz, CH2 SCO) -

[987]

2H at4,08 ppm (M, CHg iftg) - 1H at3.94'ppm (D, J ≈ 13 Hz, CH2 SCO) -

[988]

2H at3,74 ppm (Se., CH2 SO) - 3Hat2.37 ppm (S, Ar CH3) -

[989]

6H at 1.45 ppm (2S, (CH3)2 C) -

[990]

NMRn° 24 - (b) :

[991]

1H at 8.80 ppm (2D, J ≈ 9 Hz CO NH) - 3H at 8.20 ppm (Se., CHg ^H3) -

[992]

1H at 7.94 ppm (S, H Ar 2') - 1H at 7.80 ppm (D, J = 8 Hz, H Ar 61) -

[993]

1H at 7,39 ppm (D, J ≈ 8 Hz, H_ Ar 5' ) - 1Hat 6,95 ppm (2S, H_ thiazol ) 1H at 5 ,94 ppm (Dof D, = 9 Hz, J2 = 4 Hz, Hy) - 1H at 4.95 ppm (2D,

[994]

J = 4 Hz, Hg) - 1H at 4.70 ppm (M, CH3 .CH ON) - 1H at 4.37 ppm (2D,

[995]

0 = 13 Hz, CH2 SCO) - 2H at4.08 ppm (M, CH2 ^H3) - lHat3.94 ppm (D,

[996]

J = 13 Hz, CH2 SCO) - 2H at 3.73 ppm (Se., CHg·SO) - 3Hat2.36 ppm (S,

[997]

Ar CH3) - 3H atl',42 ppm (D, J = 7 Hz, CH3 CH ON) -

[998]

30 'NMR n° 25 - (b) :

[999]

1H at 8.66 ppm (D, J = 9 Hz, CO NH) - 3H atβ,17 ppm (Se., CH2 1^H3) -

[1000]

2H at7.80 ppm (M, H Ar 2' , 6') - 1H at7.50 ppm (D, J = 8 Hz, H Ar 5') -

[1001]

1H at6,95 ppm (S, H_ thiazol) - 1H- 5.95 ppm (D °fD, J1 = 9 Hz, 02 = 4 Hz, 5 Hy) - 1H at 4.95 ppm (D, J = 4 Hz, H) - lHat 4,40 ppm (D, J ≈ 13 Hz, CH2 S CO) 2H at 4.06 ppm (M, CH2 i^3) - 1H at 3.90 ppm (D, J = 13 Hz, CH2 S CO) -

[1002]

2H at 3.74 ppm (S, CH2 SO) - 3H at 2,46 ppm (S, Ar CH3) - 6H at 1.46 ppm

[1003]

(2 S, (CH3)2 C)

[1004]

NM R n° 26 - (b) :

[1005]

10 1H at 8.80 ppm (2D, J = 9 Hz, CO NH) - 3H at8.20 ppm (Se., CH2 N^U) -

[1006]

2H at 7.80 ppm (M, H Ar 2', 6') - 1H at 7.46 ppm (D, J ≈ 8 Hz, H Ar 5') -

[1007]

1H at6,95 ppm (2S, IH thiazol ) - lHaΐ5.94 ppm (D ofD, 0^ = 9 Hz,

[1008]

J2 = 4 Hz, Hy) - 1H at4 ,95 ppm (2D, J ≈ 4 Hz, Hg) -

[1009]

1H at4.66 ppm (M, CHg CH- ON) - 1H aΐ4.40 ppm (2D, J ≈ 13 Hz, CH2 SCO) -

[1010]

15 2H at4.06 ppm (M, CH2 Λj) - lHat3.90 ppm (D, J ≈ 13 Hz, CH2 SCO) -

[1011]

2H at 3.76 ppm (Se., CH2 SO) - 3H at 2.40 ppm (S, Ar CHg) - 3H at 1.44 pm

[1012]

(D, 0 = 7 Hz, CH3 CH ON)

[1013]

NMRπ0 27 - (b) :

[1014]

1H at8.66 ppm (D, J = 9 Hz, CO NH) - 3H at7.80 ppm (Se., CH2 N3^) -

[1015]

20 1H at6,95 ppm (S, _H thiazol ) - lHàt5.98 ppm (D of D, J1 = 9 Hz,

[1016]

^2= ^ ^7) " 1H at 4.95 ppm (D, J ≈ 4 Hz, Hg) - lHat4.18 ppm (D,

[1017]

J = 13 Hz, CH2 S CO) - 1H at 3.78 ppm (D, J = 13 Hz, CH2 SO) -

[1018]

2H at3.69 ppm (Se., CH2 SO) - 2H at 2.95 ppm (M, CH2 ^ ) -

[1019]

6H at 1.45 ppm (2S, (CH3)2-C-0) - 6Hatl,22 ppm (S, (CH3)2 C COS) -

[1020]

NMR n° 28 - (b) :

[1021]

1H at 10,80 ppm (S, Ar NH CO) - 1H at 8.66 ppm (D, J = 9 Hz, CO NH) -

[1022]

3H at 8.05 ppm (Se., CH2 f^) - 2H at7,89 ppm (D, J = 8 Hz H Ar 2', 6') 2H at7.74 ppm (D, J = 8 Hz H_ Ar 3' , 5' ) - 1H at 6,96 ppm (S, thiazol)

[1023]

5 1H at 5.95 ppm (D of D, = 9 Hz, = 4 Hz, H^) ~ 1H at 4.95 ppm (D,

[1024]

J = 4 Hz, Hg) - 1H at 4.42 ppm (D, J = 13 Hz, CH S CO) -

[1025]

lHat3.88 ppm (D, J ≈ 13 Hz, CH2 S CO) - 4H at 3.80 ppm (M, CH2 SO and

[1026]

CH2 ^H3) - 6H atl .45 ppm (2S, (CH3)2 C)

[1027]

10

[1028]

15

[1029]

NMR n° 29 - (b) :

[1030]

1H atlθ.83 ppm (S, Ar NH CO) - 1H at8.89 ppm (D, 0 = 9 Hz, CO NH) -

[1031]

3H at 8.10 ppm (Se., CH2 γPh^) - 2H at 7,90 ppm iQ , J = 8 Hz, H Ar 21, 6‘) 2H at 7.71 ppm (D, J ≈ 8 Hz, H_ Ar 3' , 51 ) - 1H at 6,95 ppm (S, H_ thiazol ) 1H at5.94 ppm (D of D, Jχ = 9 Hz, J2 * 4 Hz, H?) - lHat4.95 ppm (D, J = 4 Hz, H ) - lHatT745 ppm (D, J = 13 Hz, CH? S CO)

[1032]

-6.

[1033]

1H àt3.87 ppm (D, 0 = 13 Hz, CHg S CO) - 4H at 3.80 ppm (M, CH2 S0andCH2 ^3)

[1034]

CHr

[1035]

4H at2,40 ppm (M, CHg-

[1036]

0) - 2H at 1.90 ppm (M,

[1037]

CH9-

[1038]

[1039]

L-0)

[1040]

CO

[1041]

Co

[1042]

NMRn° 30 (b) :

[1043]

20 1H at 8.50 ppm (Se., N®H2 piperidine) - 1H at 8.20 ppm (Se., N®ll2 piperidine) 1 H at 8,36 ppm (D, J = 9 Hz, CO NH_) - 1H at 6.76 ppm (S, H_ thiazol ) -

[1044]

1 H at 5.95 ppm ( C of D, = 9 Hz, J2 = 4 Hz, H?) - IHat 4.92 ppm (D,

[1045]

0 ≈ 4 Hz, Hg) - IHat 4.16 ppm (D, J = 13 Hz, CH2 S CO) - IHat 3.72 ppm

[1046]

(D, J = 13 Hz, CH2 S CO) - 2H at 3.14 ppm (S, CH2 SO) - 2H at 3.17 ppm

[1047]

25 2H at 2.80 ppm (M, CHg in≈< fpHg) - 2H at 2.55 ppm (D, J = 7 Hz CH2 CO S) -

[1048]

1H at2.00 ppm (M,. CH CH2 CO S) - 2H at 1.75 ppmand2H 1.30 ppm (M, CH2 injβ N®H2) - 6H at 1.45 ppm (2S, (CH3)2 C) -

[1049]

NMR ∩° 31 - (b) :

[1050]

1Hat 8.34 ppm

[1051]

3H at 7 .30 ppm

[1052]

1H at 5 .95 ppm

[1053]

1H at4,92 ppm

[1054]

1H at 4.15 ppm

[1055]

lHat3.72 ppm

[1056]

piperidine) -

[1057]

1Hat 2.87 ppm

[1058]

2H at 1,86 ppm

[1059]

5 piperidine)

[1060]

(D, J = 9 Hz, CO NH) - 3H at7.92 ppm (Se., CH2 l^kg) -

[1061]

(Se., I^3 thiazol ) - lHat6,76 ppm (S, H, thiazol ) -

[1062]

(D of 0, J1 = 9 Hz, J2 = 4 Hz, H?) -

[1063]

(D, J = 4 Hz, Hg) - 1H at 4.26 ppm (DE, J = 12 Hz, H^piperidine) (D, J = 13 Hz, CH2 SCO) - 2H at 3.84 ppm (M, CH2 |φ*3) -

[1064]

(D, J = 13 Hz, CH2 SCO) - 3H at 3.60 ppm (M, CH2 SO + Hβ Eq lHat3.05 ppm (TE, J = 12 Hz, H2 Ax piperidine) -

[1065]

(TE, CH COS) -· 1H at2.74 ppm (TE, J = 12 Hz, Hg Ax piperidine) (M, H en 3 in 5 piperidine) - 2H at 1.45 ppm (M, H en 3 and

[1066]

- 6H at 1.45 ppm (2S, (CH3)2 C) -

[1067]

NMR∩° 32 - (b) ;

[1068]

1H at8,66 ppm (D, 0 ≈ 9 Hz, CO NH) - 3H at7.90 ppm (Se., CH ^3) -

[1069]

3Hat7.30 ppm (Se., - NΦH3 thiazol ) - lHat6.78 ppm (S, H thiazol ) -

[1070]

1H at 5,90 ppm (D of D, ≈ 9 Hz, J2 ≈ 4 Hz, Hy) - 1H at 4.94 ppm (0, J = 4 Hz, Hg) - 1H at 4.26 ppm (De., J =» 12 Hz, H2 Eq piperidine) - lHat4.16 (D, 0 » 13 Hz, CH2 S CO) - 2Hat 3.82 ppm (M, CH2 Gly) - 1H at 3.74 ppm (D, J = 13 Hz, CHg SO) 3Hat3.63 ppm (Se., CH2 SO Hg Eq piperidine) - lHat3.05 ppm (Te., 0 = 13 Hz,

[1071]

H? Ax piperidine) - lHat2.87 ppm (Te., 0 = 12 Hz, S - C CH ) -lHat2.75 ppm

[1072]

- ΰ

[1073]

(Te., J = 12 Hz, Hfi Ax piperidine) - 4Hat2.44 ppm (M, CH,-

[1074]

ti

[1075]

■CO)

[1076]

4H at 1.90 ppm (M,

[1077]

CH2t

[1078]

CH,

[1079]

-0 andH3 EqandHg Eq piperidine) -

[1080]

CO

[1081]

2H at 1.50 ppm (M, H3 AxandHg Ax piperidine)

[1082]

NMRπ° 33 - (b) :

[1083]

1H at 10.70 ppm (S, Ar NH CO) - 1H at 8.70 ppm (D, J = 9 Hz, CONH) -

[1084]

1H at 8 .30 ppm (S, H Ar 2') - 3Hat8.10 ppm (Se., CH2 f^3) - lHat7.75 ppm (D, J = 8 Hz, H Ar 6') - 1H at 7.60 ppm (0, J = 8 Hz, H Ar 4') - 1H at 7.50 ppm 5 (T, J = 8 Hz, H Ar 5’) - 1H at6.95 ppm (S, H_ thiazol ) - lHat 5.95 ppm

[1085]

(Dof D, J1 = 9 Hz, 02 = 4 Hz, H?) - lHat4.95 ppm (D, J = 4 Hz, Hβ) -

[1086]

1H at 4 .45 ppm (D, J ≈ 13 Hz, CH2 S CO) - 1H at 3.90 ppm (D, J ≈ 13 Hz, CH2 S CO) 4H at 3 .75 ppm (M, CH2 S0andCH2 Gly) - 6H at 1.45 ppm (2 S, (CH3)2 C)

[1087]

10

[1088]

IS

[1089]

20

[1090]

25

[1091]

NMRn° 34 - (b) :

[1092]

1H at 10.65 ppm (Se., Ar NH CO) - lHat8.80 ppm (D, J = 9 Hz, NH CO) -

[1093]

1H at8 .25 ppm (Se. , H Ar 2' ) - 3Hat 8.05 ppm (Se., CH2 I^3) - 1H at 7 .75 ppm (D, J = 8 Hz, H Ar 6') - 1H at 7.58 ppm (0, J = 8 Hz, H Ar 4') - 1H at 7.50 ppm (T, J = 8 Hz, H Ar 5' ) - 1H at 6.95 ppm (S, H_ thiazol ) - 1 IIat5.95 ppm

[1094]

(D of D, J1 = 9 Hz, J2 = 4 Hz, Hy) - 1 Hat 4.95 ppm (D, J = 4 Hz, Hg) -

[1095]

1H at 4.45 ppm (D, J = 13 Hz, CH2 S CO) - lHat 3.90 ppm (D, J = 13 Hz, CH2 S CO) 4H at 3,75 ppm (M, CHg SOandCHg Gly) -

[1096]

I

[1097]

4H at2.40 ppm (M, CH,,·

[1098]

•CH

[1099]

CH,

[1100]

■0) - 2H at 1.90 ppm (M,

[1101]

+L

[1102]

0)

[1103]

CO

[1104]

CO

[1105]

NMRn0 35 - (b) :

[1106]

1H at 8.40 ppm (D, J = 9 Hz, CO NH) - 6H at7.60 ppm (Se., N®H3) -

[1107]

1H at6.80 ppm (S, H_ thiazol ) - 1H at 5,95 ppm (D de D, = 9 Hz, J2 = 4 Hz, Hy) - lHat 4.95 ppm (D, J = 4 Hz, Hg) - lHat 4.30 ppm (M, H2℮ piperidine) lHat4.16 ppm (D, J = 13 Hz, CH2 S CO) - lHat 3,75 ppm (D, J ≈ 13 Hz, CH2 S CO) 2H at 3.60 ppm (S, CH2 SO) - 1H at3.55 ppm (M, Hg℮ piperidine) - 4H at 2.90 ppm (Mi CH2 ^3 et H2aandH5a piperidine) - 3Hat 2.60 ppm (M, CH2 CH2 N^i3 H^-piperidine) - 2H at1.80 ppm et 2H at 1,50 ppm (2 M, H3 at Hg piperidine) 6H at 1.45 ppm (2 S, (CH3)2 C)

[1108]

NMRΠ0 36 - (b) :

[1109]

5

[1110]

10

[1111]

15

[1112]

lrl at 8.70 ppm (D, 0 = 9 Hz, CO NH) - 3H at 8.20 ppm. (Se., CH2 A3) -

[1113]

1H at 7.75 ppm (0, J = 8 Hz, H Ar 6') ~ 2H at 7.43 ppm (M, H Ar 3', 5') -

[1114]

1H at6.98 ppm (Se., H thiazol ) - 1H at 6.00 ppm (D of D, 0j = 9 Hz,

[1115]

J2 = 4 Hz, H7) - 1H at4.97 ppm (D, J = 4 Hz, Hg) - 1H at 4.34 ppm (D, 0 = 13 Hz, CH2 S CO) - 2H at4.00 ppm (M, CH2 A3) - 1H at 3.90 ppm (D, 0 = 13 Hz, CH2 S CO) 2H at 3.77 ppm (Se., CH2 SO) - 1H at 2.34 ppm (S, CH3 Ar) - 6Hat 1.46 ppm

[1116]

(2 S, (CH3)2 C)

[1117]

NMRΠ° 37 - (b) :

[1118]

1H at 8.80 ppm (D, J = 9 Hz, CO NH) - 3Hat8.15 ppm (Se., CHg N®H3) -

[1119]

1Hat7.72 ppm (D, J = 8 Hz, H; Ar 6') - 2H at7.40 ppm (M, H Ar 3', 5') -

[1120]

1H at 6.95 ppm (S, H_ thi azol ) - 1H at 5.95 ppm (0 of D, 9 Hz,

[1121]

J2 = 4 Hz, Hy) - 1H at 4,93 ppm (D, J ≈ 4 Hz, Hβ) - 1H at 4.34 ppm (D,

[1122]

J = 13 Hz, CH2 S CO) - 2H at 4.00 ppm (M, CH2 A3) -lHat3.90 ppm (D,

[1123]

0 ≈ 13 Hz, CH2 S CO) - 2H at 3,78 ppm (Se., CH2S0) - 2Hat2.34 ppm (S,

[1124]

CH3 Ar) - 0 0

[1125]

4H at2.30 ppm (M, CH0·

[1126]

t:

[1127]

-CO) - 2H at 1.80 ppm (M, CHg-

[1128]

■C0

[1129]

-CH,

[1130]

NMRn° 38 - (b) :

[1131]

20 1H at8.60 ppm (D, J = 9 Hz, CO NH) - 7H at 7.70 ppm (M, H Ar et CH2 A3) -

[1132]

1H at 6.98 ppm (S, H thi azol ) - 1H at5.9S ppm (D of D, = 9 Hz, J2 ≈ 4 Hz, H7) - lHat4.96 ppm (D, J = 4 Hz, H5) - lHat4.38 ppm (D, J = 13 Hz, CH2 S CO) 1H at 3 .94 ppm (0, J » 13 Hz, CH2 S CO) - 2H at 3.75 ppm (Se., CH2 SO) -

[1133]

3H at 3.00 ppm (M, CH CH2 NΦH3) - 6H at 1.47 ppm (2 S, (CH3)2 C) -

[1134]

25 3H at 1,19 ppm (D, J = 7 Hz, CH3 CH)

[1135]

5

[1136]

10

NMR n° 39 - (b) :

[1137]

lH·at3.80 ppm (D, J = 9 Hz, CO NH) -7Hat7.80 ppm (M, H Ar et N®H3 CH2) 1Hat6.95 ppm (S, H thiazol ) - 1H at 5.95 ppm (D de 0, ≈ 9 Hz,

[1138]

J2 = 4 Hz, Hy) - 1H at 4.97 ppm (D, J = 4 Hz, Hg) - lHat 4.40 ppm (D,

[1139]

J = 13 Hz, CH2 S CO) - 1H at3.93 ppm (D, J = 13 Hz CH2 S CO) -

[1140]

2Hat3.75 ppm (Se., CH2 SO) - 3H at 3.00 ppm (M, CH CH2 N®H3) -

[1141]

0 0

[1142]

4Hat2.40 ppm (M, CHg-

[1143]

• CO) - 2H at i ,85 ppm (M, CH

[1144]

CH,

[1145]

CO

[1146]

3H at 1.25 ppm (D, 0 = 7 Hz, CH-j CH.)

[1147]

NMR∩° 40 - (b) :

[1148]

1H at 12.5 ppm (Se., Ar NH CO) - 1H et 8.75 ppm (D, 0 = 9 Hz, CO NH) lHatδ.OO ppm (S, JH thiazol in 3) - 3Hat7.75 ppm (Se., CH2 ff^H·j) -

[1149]

1H at7.00 ppm (S, H thiazol ) - 1H at 5.98 ppm (D of D, => 9 Hz, J2 ≈ 4 Hz, 15 H7) - lHat4.95 ppm (D, J » 4 Hz, Hg) ~ 1H at 4 .40 ppm (D, J = 13 Hz, CH2 S CO)1H at3.78 ppm (D, J ≈ 13 Hz, CHg S CO) - 2Hat3.75 ppm (Se., CH2 SO) -

[1150]

2H at3.50 ppm (M, CHg N®H3) - 2H at2.80 ppm (M, CH2 CHg ^3) -

[1151]

6H at 1.45 ppm (2 S, (CH3)2 C)

[1152]

NM R n° 41 - (b) :

[1153]

20 1H atl2.8 ppm (Se., NH CO CHg) - lHat8.80 ppm (D, J = 9 Hz, CO NH) 3Hat8.25 ppm (Se., CH2 N^H^) - lHat8.16 ppm (S, JH thiazol i∩ 3) lHat7.00 ppm (S, JH thiazol) - lHat5.96 ppm (D of D, = 9 Hz, J2 = 4 Hz, H7) - 1H at4 .97 ppm (D, J = 4 Hz, Hg) - lHat4.40 ppm (D, J ≈ 13 Hz, CH2 S CO) 3H at 3.90 ppm (M, CH2 f^3 et CH2 S CO) - 2Hat3.75 ppm (Se., CH2 SO) -

[1154]

25 5H atl .44 ppm (2 S, (CH3)2 C)

[1155]

NMR ∩° 45 - (b) :

[1156]

IH at8.75 ppm (0, J = 9 Hz, CO NIH) - lHat8.55 ppm (D, H_ thiazol in 3) 3Hat8.50 ppm (Se., CH^ N%3) “ lHat7.00 ppm (S, H_ thiazol) - 1H at 5.95 ppm (D of D ≈ 9 Hz, J2 = 4 Hz, H^) - lHat4.96 ppm (0,0=4 Hz, Hg) -

[1157]

5 2H at 4.46 ppm (M, CH2 i^H3) - lHat4.30 ppm (D, J = 13 Hz, CH2 S CO) -

[1158]

IH at 3 .90 ppm (0, J = 13 Hz, CH2 S CO) - 2H at 3.73 ppm (Se., CH2 S0) -

[1159]

6H at 1.44 ppm (2 S, (CH3)2 C)

[1160]

NMR∩° 46 - (b) :

[1161]

IH at 8.87 ppm (T, J = 8 Hz, NH CH? Ar) -lHat8.64 ppm (0, J = 9 Hz, NH CO) 10 3H at 8.00 ppm (Se., H3 N® CH£·) - 2H at 7.84 ppm (D, J = 8 Hz, H Ar 2', 6') 2H at 7.42 ppm (0. 0 = 8 Hz, HI Ar 3' , 5' ) - 1H at 6.94 ppm (S, IH thiazol ) 1Hat 5.95 ppm (D ofQ, = 9 Hz, J2 = 4 Hz, H?) - IH at4.95 ppm (D of 0, 0 = 4 Hz, Hg) - 3H at 4.40 ppm (M, Ar CH2 NH et CHg S C0) - IH at 3.88 ppm D, J ≈ 13 Hz, CH2 S CO) - 2H at3.74 ppm (Se., CH2 S->0) - 2H at 3.58 ppm

[1162]

15 (M, 0C CH2 N®H3) - 6H at 1.47 ppm (2 S, (CH3)2 C)

[1163]

The products of the invention have been studied as regards their pharmacological properties and, more especially, bacteriostatic action. This has been determined in vitro by the dilution method, and the study was on.

[1164]

20 Gram negative strains.

[1165]

Results, expressed in minimum inhibiting concentrations (MIC - ^μg/ml ) , are collected in the following table (Table III).

TABLE III

[1166]

.Mic_(^giπii2 25_9!Eperent_strains

[1167]

ID
( ( { ( PRODUCTS ( SR No. ( ( Isr R A I N s
Escherichia coli SOL RL 90Ci trobacter 49Proteus vulqaris RL 99 bisSerratia RL 72Klebsiella R0 30Enterobacter RO 154Pseudomonas RL 112
! { 41 7300,5 · :0.254 0.1210.250.254
j 41 733 ( 41 806220.58118
110.540.588
j 41 8540.250.5^ 0.120.50.2524
i 41 8550.251^ 0.120.50,2528
i 41 8560.52^ 0.1220.25416
( 41 858210.540.588
( 41 859 / 41 860120.2540.5816
210.540.5816
( 41 862 ( j 41 885 { 41 887 j 41 888 { 41 8890.250.254 0.120.50.2514
140.540.588
240.2540.588
2218188
110.54188
f 41 8910.50.50.540.588

[1168]

-{=»

[1169]

H= K &

[1170]

cn φ σi

[1171]

Λ
S TRAINS
( fPRODUCTS SR No.Escherichi a col i SOL RL 90Citrobacter 49RcΩtëüi volants RL 99 bisSerratia Rl72Klebsiella RQ"3θEnterobacter R0 154Pseudomonas 'wrm
( { { ( {41 9670.250,54 0.120.5r 0.2524
41 9750.250.50.540.588
41 97610.50.2580.588
( ( (42 0220.50.254 0.120.50.2524
42 0240.50.50.25LO o0.2524
( { {42 0250.50.50.2510.544
42 0260,50.254 0.1210.2548
(. 42 0270.250.254 0.120.50.2524
i42 0280.250.5^ 0.12L∩ o0.2524
* c ( 542 0290.250.254 0.12. 0.50.2528
42 0424 0.124 0.124 0.1224 0.1214
42 07310.50.520.544
( /42 07410.50.540.588
! ( ( (42 1170.250.254 0.120.54 0.1214
42 1181 .0.50.2540.5168
42 1190.50.254 0.1240,588
( ( (42 2080.50.54 0.1210,50.254
42 2090.254.0.124 0-120,50,254 0,124
( <42 21010.50.2510.50.254

[1172]

t

[1173]

vD cr>

[1174]

i

[1175]

w

[1176]

£Π ω φ

[1177]

I
PRODUCTS SR No.STRAINS>
Escherichia col 1 SOL RL 90Citrobacter 49P-Tflteüi vulgaris RL 99 bisSerratia RL 1Z"Klebsiella : RO 3ÔEnterobacter RO 154Pseudomonas ( RL ff2 j
42 2114 0.124 0.124 0.124 0.12; 4 0.124 0.1264 I
42 2124 0.124 0.124 0.120.254 0.124 0.124 (
32 2130.254 0.124 0.120.50.254 0.1215 1
42 2144 0-124 0.124 0.120,54 0.124 0.1216 1
42 2154 0.124 0.124 0.120.254 0.124 0.128 1
42 2164 0.124 0.124 0.120.54 0.124 0.128 \
42 2174 0.12-4 0.124 0.120.25 .4 0.124- 0.1216 i
42 2180.50.250.520.50.564 J
42 2190.54 0.124 0.1210.50.54 Î
42 2210.254 0.124 0.12- 2£ 0.120.2564 J
42 2220.54 0,12 .4 0.1210.50.58 (
42 3204 0,1254 0.1254 0.1250.54 0.1254 0.1254 1
42 3210.50.54 0.12510.50.258\
42 3710.50.254 0.1250.50.250.258 /
42 3720.254 0.1254 0.1250.25. 0.254 0.1254 !
42 3740,50.254 0.12510.250.254
42 3790.254 0.1254 0.1250.54 0.1254 0.1258
42 3804 0.125€ 0.1254 0.12514 0.1254 0.1254 i
42 3954 0.1254 0.1254 0.1250.54 0.1254 0.1254 i

[1178]

κo 03

[1179]

I

[1180]

ro

[1181]

φ Λ STRAINS

[1182]

[1183]

VO 00
Escherichia col i SOL RL 90Citrobacter 49Prateu? vulqaris RL 99 bisSerratia RL 1l 'Klebsiella ROSEnterobacter RÛ 154Pseudomonas RL 112
0.50.254 0.12510.250.58
0.50.254 0.1250.50.250.58
0.250.254 °·125l∩ o0.250,258
0.50.254 0.1250.50.250.258
0.250.1254 0.1250.254 0.1254 0.1254
0.50.254 0.1250.54 0.1250.254
0.50.54 0.125to o4 0.250.58
0.250.254 0.12510.250.254
0.50.254 0.1250.50.250.54
0.254 0.1254 0.125- 0.50.1250.252
0.254 0.1254 0.1250.50.250.254
0.1250.12524
0.250.2528
10.548
0.250.2524
0.250.2584
0.250.25164
0.250.2584
0.250.2548

[1184]

RODUCT SR No.

[1185]

42 535 42 536 42 537 42 538 42 540 42 541 42 542 42 546 42 547 42 548 42 549 42 581 42 582 42 583 42 584 42 585 42 586 42 587 42 657 STRAINS

[1186]

J№

[1187]

cn RODUCï 5R No.

[1188]

I i
Escherichia coli SOL RL 90Citrobacter 49Prstgϋi vulgaris RL 99 bisSerratia RL 72 "Klebsiella ROEnterobacter RÛ~Ï54Pseudomonas RL 112
0.1250.12584
0.50.2518
4148
140.548
0.50.528
10.528
0.1250.12514
0.250.2528
2128
2128
2148
0.1250.2544
0.1250.2544
0.50.584
0.250.12524
0.250.12524
0.250.12528
0.1250.12524
0.50.2588

[1189]

42 658 42 661 42 663 42 664 42 665 42 674 42 675 42 676 42 685

[1190]

-42 686 42 687 42 688 42 689 42 690 42 781 42 782 42 783 42 811 42 814 STRAINS

[1191]

tn tύ & STRAINS

[1192]

o O
f PRODUCTS { SR No. ( (Escheri chia coli SOL RL 90Citrobacter 49Prateus YMloarU RL 99 bisSerratia RL 72 “Klebsiella R0 3ÔEnterobacter R0 154Pseudomonas ' RL 112 ' i
( ( 42 815 j 42 817 ( 42 8180.1250.2588
0.1250.2544!
0.1250.12544 |
| 42 848 ( 42 8490.1250.12524 j
0.125. 0.12524 j
( 42 850 [ 42 8510.50.2528 «
0.50.2518
( 42 8520.250.12518
j 42 8570.5188 !
(

[1193]

№ IS

[1194]

«J ςn ω

[1195]

The results presented in Table III show good activity on Gram negative bacteria of the products according to the invention.

[1196]

To evaluate the stability of these products towards beta-lactamases, their MIC was determined on isogenic strains producing and not producing beta-

[1197]

5 lactamases.

[1198]

The results are expressed in μg/ml in Table

[1199]

IV.

[1200]

TABLE IV

[1201]

10 MIC (μg/ml) ON STRAINS PRODUCING BETA-LACTAMASES AND NOT PRODUCING (indicated by *)

[1202]

PRODUCTS SR no.S T RVINS
Escherichia coliSerratΐa ·Proteusvulgaris
255255/1.7 *SI/326 ASI 1326 S *GN 75/C.lGN 76/C.1/3 *
41 7300.25<0,120,5<0.120.250.25
41 854<0,12<0,120.25<0.120.250.25
41 855<0.12<0.120.25<0.12<0.12<0.12
41 362<0.120.12<0.12<0.12<0.12<0.12
41 967<0.12<0,120.25<0.12<0.12<0.12
41 9730.250.250,25<0.120.50.5
41 9750.50.50,25<0.120.50.5
42 0220.250.25<0.12<0.12<0.12<0.12
42 0240.25■ <0,120.250.060.250.25
42 0270.120.060.25<0.060.120.12
42 0280.120.120.12<0.060.250.25
42 042<0.12<0.12'0,25<0.12<0.12<0.12
42 0730.50.250.25<0,120.50.5
42 0740.50.250.250.120.50.5
42 1170,1250.060,12<0.06<0.06<0.06
CO0.50.250.250 ; 120.50.5
42 1190.250.120.25<0.060.120.12

[1203]

as

[1204]

S T R AINS
PRODUCTS SR no.Escherichia col 1Serratia 1iςuefacie∩sProteus vulαaris
255255/1.7 *Sl/326 ASI 1325 S *GN 76/C.lGN 76/C.1/3 *
42 3200.06250.06250.125S< 0.0312v< 0.03120.125
42 3950.06250.06250.125i 0.03120.0312^ 0.0312
42 4560.06254 0.03120.250.0625^ 0.03120.125
42 4570.125<: 0.03120.06250.06250.03120.0625
42 4660.1250.12514 0.03124 0.03120.0625
42 4670,0625,< 0,03120.1250.1250.03120.0625
42 4740.06250.06250.125^ 0.03120.06250.0625
42 5310.1250,06250,1250.1250.06250.0625
42 5330.1250,06250.125v< 0.03120.06250.125
42 5350.1250,03120.06250.1250.06250.125
42 5460.06254 0.03120.254 0.0312N< 0.03120.125
42 5470.125<• 0,031220,1250.06250.25
42 5480.6250.03120.1254 0.03120.06250.0625
42 5490,1250,06250.1254 0.03124 0.03120.0625
42 6640.250,06250.250.06250.1250.25
42 6730,250.250,250.06250.250.25

[1205]

According to the results of Table IV, the products according to the invention have an equal or comparable activity on strains producing or not producing beta-lactamases, which shows the good stability towards beta-lactamases.

[1206]

The therapeutic effectiveness of the products was determined on the septicemic model of the mouse. The septicemia was initiated by the intraperitoneal 5 innoculation of 0.5 ml of a suitable dilution of a suspension of the Escherichia coli SOL 90 strain. The products were administered in solution in a phosphate buffer pH 7.0 in a volume of 0.2 ml sub-cutaneously to batches of 10 mice, 1 to 5 hours after innoculation of 10 the microorganism. After 4 days of observation in the course of which the mortality was noted, the 50% effective doses (DE 50) were calculated by the Muench and Reed method.

[1207]

The results obtained are shown in Table V.

[1208]

15

[1209]

TABLE V

[1210]

DES0 (mg/kg) IN THE SEPTICEMIC MODEL IN THE MOUSE

[1211]

PRODUCTS SR no.S TRAINS
Escherichia coli SOL 90Klebsiella R0 30
41 7301.40.79
41 8540.230.19
41 8550.160,17
41 8620.13-0.10
41 9730.220.4
42 0420.05ND
42 0730.33ND
42 1170,11ND
42 1190.16ND

[1212]

ND = not determined

[1213]

According to the results of Table V, the products, according to the invention, show good IN VIVO therapeutic activity.

[1214]

In addition, according to tests carried out up till now on animals, the toxicity of the products according to the invention has appeared to be sufficiently low to enable their use in therapeutics.

[1215]

The products of the invention can hence be employed as antibiotics in human or veterinarian medicine. They have a wide spectrum on Gram negative organisms and can be used in all germ sensitive bacterial infections.

[1216]

The products can be administered by the general route (parenteral, oral or topically).

[1217]

The pharmaceutical compositions are produced from the compounds (I) in soluble form obtained by salification of one of the acid functions of the molecule or of one of the amine functions of the B chain.

[1218]

The pharmaceutical compositions can be solid or liquid and be presented, for example, in the form of injectable preparations, tablets, gelules, granules, pommades, creams, gels or suppositories. The posology can vary within wide proportions, in particular according to the type and seriousness of the infection to be treated and according to the mode of administration. Mostly, in the adult, by the injectable route, it is comprised between 0.250 g and 4 g per day.

Bv wav of example of pharmaceutical composition, there mav be prepared injectable solutions of the sodium salt of SR 41 973:

[1219]

5 To a solution of 3 g of dihydrochloride of SR 41 973 in 25 ml of water, is added drop by drop a saturated solution of sodium bicarbonate. When the pH is 3, the solution is filtered. The pH is then adjusted to 3.6 by the addition of some drops of saturated 10 solution of sodium bicarbonate. The solution is cooled to + 4°C and the SR 41 973 starts to crystalline. 75 ml of acetone are added slowly drop by drop. After h hour of stirring at + 4°C, the crystals are filtered and washed twice with a mixture (1-1) of water and acetone 15 and finally washed twice with 20 ml of acetone. The product is dried in the dessicator ove P205. 1.9 g of the compound SR 41 973 is obtained.

[1220]

1.25 g of the SR 41 973 so obtained is suspended in 15 ml of water at + 4°C. A solution of 20 0.168 g of sodium bicarbonate in 3 ml of water is added drop by drop. The clear solution thus obtained is frozen and freeze-dried, after sterile filtration, to obtain the sodium salt of 41 973 ready for injection.



[1221]

The present invention relates to a process for producing antibiotic compounds derived from cephalosporins having formula ; <IMG> (I) in which: . The COOA group at the 4 position is an acid radical, or an alkaline or alkaline-earth salt or an amino acid or amine salt, for example triethylamine or ethanolamines, or an easily hydrolyzable or metabolically labile and pharmaceutically acceptable ester radical. X denotes an oxygen atom or a sulfur atom n is zero or 1. R1 and R2 each denote independently hydrogen or a lower alkyl group, preferably a methyl group, or R1 and R2 taken together with the carbon atom to which they are linked form a cyclobutyl or cyclopentyl nucleus. B is the residue of a primary or secondary amine, said process consists of acylating 4-tertiobutyl-l-S-oxide 7-amino-3-bromomethyl 3-cepheme carboxylate (II) with the acid(IlI) to obtain the compound (IV) described in European patent application 60745 and of adding to compound (IV) an acid B-(CH2)n-COOH or B(CH2)nCOSH.



1. Derivatives of the family of cephalosporins of the formula

in which :

15 - the C00A group in the 4 position is an acid radical or an alkali or alkaline-earth salt, or an amino acid or amine salt, or an easily hydrolyzable or meΐabαlically labile and pharmaceutically acceptable ester radical ;

- X denotes an oxygen atom or a sulfur atom ;

20 - n is zero or 1 ;

- R^ and Rg each denote independently hydrogen or a lower alkyl group, or

. R^ and Rg taken together with the carbon atom to which they are linked form a cyclobutyl or cyclopentyl nucleus;, ' 25 , B is the residue of a primary or secondary amine selected by the following groups :

- Z-NH-R where Z is a straight or branched chain alkylene group having from 2 to 7 carbon atoms, optionally interrupted by a sulfur atom and optionally substituted by a hydroxyl, thiol, 30 methylthio, amino, acetamido, carbamoyl, phenyl, hydroxyphenyl or imidazolyl group,

Z can also be a cyclopentylidene or cyclohexylidene groυp^and R represents a hydrogen atom or an alkyl group having from 1 to 3 carbon atoms^

35 - Z'-Alk-NH-R where V represents a 1,2-phenylene or 1,3-phenylene or 1,4-phenγlene group optionally substituted by a halogen atom or by 1 or 2 methoxy groups or by 1, 2 or 3 methyl groups or Z' represents a 1,2-cyclohexylene, 1,3cyclohexylene or 1,4-cyclohexylene group,

Aik represents a straight or branched alkyl group having from 1 to 3 carbon atoms,

R is as defined above or is aminoacetyl,

-Z'-N-CO-Y-NH-R" where Z' is as defined above,

À'

Y denotes an alkyl (CH2)in group in which m = 1, 2, 3 or 4, a branched alkyl group having 2 or 3 carbon atoms or again Y with NH-R" constitutes a ring

R' and R", identical or different, represent a hydrogen atom or an alkyl group having from 1 to 3 carbon atoms,

-Z"-NH-R where Z" is a 1,3-cyclohexylene or 1,4 cyclohexylene group and R represents a hydrogen atom or an alkyl group having from 1 to 3 carbon atoms,

hydrogen atom or a methyl group,

n = 0 or 1 and Aik is as previously defined and R represents a hydrogen atom or an alkyl group having from 1 to 3 carbon atoms,

Aik is as previously defined and R represents a hydrogen atom or alkyl group having from 1 to 3 carbon atoms,

- a 2-piperidyl, 3-piperidyl or 4-piperidyl group optionally substituted on the nitrogen atom by a -C0-

Alk-NH2 or a -CO NH group where Aik is as previously defined, and the salts of said compounds with pharmaceutically acceptable acids, said derivatives being in one of the syn and anti forms.

2. Derivatives of the family of cephalosporins according to claim 1 of formula (I) in which: and R2 each denote independently hydrogen or a methyl group.

3. Derivatives of the family of cephalosporins according to claim 1 of formula (I) in which the COOA group is a triethylamine or ethanolamine salt.

4. Derivatives according to claim 1, wherein R^ and R2 are each a methyl group; X = oxygen; n = 0 and B is selected from the group consisting of:

-(CH2)4NH2;

ΛO CH2NH2;

Λ0 )~CH2NH2;

'I CH.

u

-<(θ^)-NH--C-CH2-HN2; and

0

y-N-C~CH2-NH2

5.A derivative according to claim 1, wherein R^ and R2 are each a methyl group, X ≈ oxygen, n ≈ 1 and B is

the group )

6.Derivatives according to claim 1, wherein R^ and R2 are each a methyl group; X ≈ sulfur, n = 0 and B is selected from the group consisting of:

7. Process for the preparation of derivatives of the family of cephalosporins according to claim 1 which comprises :

1) acylating 4-tertiobutyl 7-amino 3-bromomethyl· 3-cepheme carboxylate 1-S-oxide of formula II

15 0

20

CΠ)

by the acid of formula III NH-Tr

25 S M

C - COOH

ii

N R, I I1

COOΐSu (III)

30

in which Tp is the trityl group, tBu the tertiobutyl group, and are as defined above,

to obtain the compound of formula IV

35

NH-Tr

R? C00ΐ3u

2)adding to said compound of formula IV an acid B-(CH2)n-C00H or a thioacid B-(CH2)n COSH, in which B is the 10 residue of a primary or secondary amine as defined above, the amine function of said acid having been previously protected, to form the compound of formula V

15

20

in which Tr, R^, Rg, n are as previously defined and 8' represents

25 the group B in which the amine function is protected,,

3) removing the protective groups on the amine and carboxy functions to obtain the compound of formula I in which A is hydrogen.

4) optionally converting said compound obtained into a

30 compound of formula I in which A is other than H by acting on said compound with an inorganic or organic base or by esterification.

5)optionally converting said compound of formula I into one of its salts by reaction with a pharmaceutically acceptable acid.

35 8. Process according to claim 7, wherein the addition of the Ill

acid B-ζCHgJη-COOH is carried out through the intermediate by using the sodium or potassium salt of said acid, said addition being carried out in an aprotic polar solvent.

9. Process according to claim 7 , wherein the addition of the 05 thioacid B’-ζCh^^-COSH is carried out by using the sodium or potassium salt of said acid, said addition being carried out in an apolar solvent.

10. Pharmaceutical compositions containing as active ingredient a derivative according to claim 1 in combination with a 10 pharmaceutically acceptable vehicle.

15

20

25

30

35